Document:

<PAGE>

                                                                     Exhibit 4.1

                                                               EXECUTION VERSION

================================================================================

                          Enzon Pharmaceuticals, Inc.,

                                    as Issuer

                                       and

                            Wilmington Trust Company,

                                   as Trustee

                              ---------------------

                                    INDENTURE

                            Dated as of May 23, 2006

                              ---------------------
                      4% Convertible Senior Notes due 2013

================================================================================

<PAGE>

                              CROSS-REFERENCE TABLE

TIA                                                           Indenture Section
Section                                                       -----------------
-------

310(a)(1)........................................................8.10
     (a)(2)......................................................8.10
     (a)(3)......................................................N.A.
     (a)(4)......................................................N.A.
     (a)(5)......................................................N.A.
     (b).........................................................8.3; 8.8; 11.10
     (c).........................................................N.A.
311(a)...........................................................8.11
     (b).........................................................8.11
     (c).........................................................N.A.
312(a)...........................................................2.5
     (b).........................................................11.3
     (c).........................................................11.3
313(a)...........................................................8.6
     (b)(1)......................................................N.A.
     (b)(2)......................................................8.6
     (c).........................................................3.7; 8.6; 11.2
     (d).........................................................8.6
314(a)...........................................................3.3; 3.7
     (b).........................................................N.A.
     (c)(1)......................................................11.4
     (c)(2)......................................................11.4
     (c)(3)......................................................N.A.
     (d).........................................................N.A.
     (e).........................................................11.5
     (f).........................................................N.A.
315(a)...........................................................8.1(b), 8.1(g)
     (b).........................................................8.5; 11.2
     (c).........................................................8.1(a)
     (d).........................................................8.1(c)
     (e).........................................................7.10
316(a)(last sentence)............................................11.6
     (a)(1)(A)...................................................7.4
     (a)(1)(B)...................................................N.A.
     (a)(2)......................................................N.A.
     (b).........................................................7.6
     (c).........................................................10.7
317(a)(1)........................................................7.7
     (a)(2)......................................................7.8
     (b).........................................................2.4
318(a)...........................................................8.1(g); 11.1

N.A. means not applicable

Note: This Cross-Reference table shall not, for any purpose, be deemed to be
part of this Indenture.

                                      -i-

<PAGE>

                                TABLE OF CONTENTS

<TABLE>
<CAPTION>
                                                                                                             PAGE

<S>                        <C>                                                                                 <C>
                                                    ARTICLE I
                                    DEFINITIONS AND INCORPORATION BY REFERENCE

SECTION 1.1.               Definitions...........................................................................1

SECTION 1.2.               Incorporation by Reference of Trust Indenture Act....................................11

SECTION 1.3.               Rules of Construction................................................................11

                                                    ARTICLE II
                                                    THE NOTES

SECTION 2.1.               Form, Dating and Terms...............................................................12

SECTION 2.2.               Execution and Authentication.........................................................18

SECTION 2.3.               Registrar, Conversion Agent and Paying Agent.........................................19

SECTION 2.4.               Paying Agent To Hold Money and Securities in Trust...................................20

SECTION 2.5.               Holder Lists.........................................................................20

SECTION 2.6.               Transfer and Exchange................................................................20

SECTION 2.7.               Form of Certificate To Be Delivered in Connection with Transfers to
                           Institutional Accredited Investors...................................................22

SECTION 2.8.               Mutilated, Destroyed, Lost or Stolen Notes...........................................23

SECTION 2.9.               Cancellation.........................................................................24

SECTION 2.10.              Payment of Interest; Defaulted Interest..............................................25

SECTION 2.11.              Computation of Interest..............................................................26

SECTION 2.12.              CUSIP Numbers........................................................................26

SECTION 2.13.              Calculations in Respect of the Notes.................................................26

SECTION 2.14.              Issuance, Transfer and Exchange of Common Stock Issuable Upon Conversion of
                           the Notes............................................................................26

                                                   ARTICLE III
                                                    COVENANTS

SECTION 3.1.               Payment of Notes.....................................................................27

SECTION 3.2.               Maintenance of Office or Agency......................................................27

SECTION 3.3.               Compliance Certificate...............................................................28
</TABLE>

                                      -ii-

<PAGE>

                                TABLE OF CONTENTS
                                   (continued)
<TABLE>
<CAPTION>
                                                                                                              PAGE

<S>                        <C>                                                                                 <C>
SECTION 3.4.               Reservation of Common Stock..........................................................28

SECTION 3.5.               Issuance of Shares...................................................................28

SECTION 3.6.               Additional Interest Notices..........................................................29

SECTION 3.7.               SEC Reports..........................................................................29

SECTION 3.8.               Rule 144A Information Requirements...................................................29

SECTION 3.9.               Transfer Taxes.......................................................................29

SECTION 3.10.              Offer To Repurchase upon a Fundamental Change........................................30

                                                    ARTICLE IV
                                                    SUCCESSORS

SECTION 4.1.               Merger, Consolidation, or Sale of Assets.............................................34

SECTION 4.2.               Successor Corporation Substituted....................................................35

                                                    ARTICLE V
                                               REDEMPTION OF NOTES

SECTION 5.1.               Optional Redemption..................................................................35

SECTION 5.2.               Selection and Notice of Redemption...................................................35

SECTION 5.3.               Effect of Notice of Redemption.......................................................36

SECTION 5.4.               Deposit of Redemption Price..........................................................36

SECTION 5.5.               Notes Redeemed in Part...............................................................36

                                                    ARTICLE VI
                                               CONVERSION OF NOTES

SECTION 6.1.               Conversion Right and Conversion Rate.................................................36

SECTION 6.2.               Conversion Consideration.............................................................37

SECTION 6.3.               Exercise of Conversion Right.........................................................37

SECTION 6.4.               Fractions of Shares..................................................................39

SECTION 6.5.               Adjustment of Conversion Rate........................................................39

SECTION 6.6.               Notice of Adjustments of Conversion Rate.............................................47

SECTION 6.7.               Cancellation of Converted Notes......................................................48

SECTION 6.8.               Provision in Case of Consolidation, Merger or Sale of Assets.........................48

SECTION 6.9.               Rights Issued in Respect of Common Stock.............................................49

SECTION 6.10.              Responsibility of Trustee and Conversion Agent for Conversion Provisions.............49
</TABLE>

                                     -iii-

<PAGE>

                                TABLE OF CONTENTS
                                   (continued)
<TABLE>
<CAPTION>
                                                                                                              PAGE

<S>                        <C>                                                                                 <C>
                                                   ARTICLE VII
                                              DEFAULTS AND REMEDIES

SECTION 7.1.               Events of Default....................................................................50

SECTION 7.2.               Acceleration.........................................................................51

SECTION 7.3.               Other Remedies.......................................................................52

SECTION 7.4.               Control by Majority..................................................................52

SECTION 7.5.               Limitation on Suits..................................................................52

SECTION 7.6.               Rights of Holders of Notes To Receive Payment or Effect Conversion...................53

SECTION 7.7.               Collection Suit by Trustee...........................................................53

SECTION 7.8.               Trustee May File Proofs of Claim.....................................................53

SECTION 7.9.               Priorities...........................................................................54

SECTION 7.10.              Undertaking for Costs................................................................54

                                                   ARTICLE VIII
                                                     TRUSTEE

SECTION 8.1.               Duties of Trustee....................................................................54

SECTION 8.2.               Rights of Trustee....................................................................56

SECTION 8.3.               Individual Rights of Trustee.........................................................57

SECTION 8.4.               Trustee's Disclaimer.................................................................57

SECTION 8.5.               Notice of Defaults...................................................................57

SECTION 8.6.               Reports by Trustee to Holders........................................................58

SECTION 8.7.               Compensation and Indemnity...........................................................58

SECTION 8.8.               Replacement of Trustee...............................................................58

SECTION 8.9.               Successor Trustee by Merger..........................................................59

SECTION 8.10.              Eligibility; Disqualification........................................................60

SECTION 8.11.              Preferential Collection of Claims Against Company....................................60
</TABLE>

                                      -iv-

<PAGE>

                                TABLE OF CONTENTS
                                   (continued)
<TABLE>
<CAPTION>
                                                                                                              PAGE

<S>                        <C>                                                                                 <C>

                                                    ARTICLE IX
                            SATISFACTION AND DISCHARGE OF INDENTURE; UNCLAIMED MONEYS

SECTION 9.1.               Satisfaction and Discharge of Indenture..............................................60

SECTION 9.2.               Application by Trustee of Funds Deposited for Payment of Notes.......................61

SECTION 9.3.               Repayment of Moneys Held by Paying Agent.............................................61

SECTION 9.4.               Return of Moneys Held by Trustee and Paying Agent Unclaimed for Two Years............61

SECTION 9.5.               Indemnity for U.S. Government Obligations............................................62

                                                    ARTICLE X
                                      SUPPLEMENTAL INDENTURES AND AMENDMENTS

SECTION 10.1.              Without Consent of Holders...........................................................62

SECTION 10.2.              With Consent of Holders..............................................................63

SECTION 10.3.              Execution of Supplemental Indentures, Agreements and Waivers.........................63

SECTION 10.4.              Effect of Supplemental Indentures....................................................64

SECTION 10.5.              Compliance with Trust Indenture Act..................................................64

SECTION 10.6.              Reference in Notes to Supplemental Indentures........................................64

SECTION 10.7.              Revocation and Effect of Consents and Waivers........................................64

SECTION 10.8.              Notation on or Exchange of Notes.....................................................65

                                                    ARTICLE XI
                                                  MISCELLANEOUS

SECTION 11.1.              Trust Indenture Act Controls.........................................................65

SECTION 11.2.              Notices..............................................................................65

SECTION 11.3.              Communication by Holders with Other Holders..........................................66

SECTION 11.4.              Certificate and Opinion as to Conditions Precedent...................................66

SECTION 11.5.              Statements Required in Certificate or Opinion........................................66

SECTION 11.6.              When Notes Disregarded...............................................................67

SECTION 11.7.              Rules by Trustee, Paying Agent and Registrar.........................................67

SECTION 11.8.              Governing Law........................................................................67

SECTION 11.9.              No Recourse Against Others...........................................................67

SECTION 11.10.             Successors...........................................................................67

SECTION 11.11.             Multiple Originals...................................................................67

SECTION 11.12.             Qualification of Indenture...........................................................67
</TABLE>

                                      -v-
<PAGE>

EXHIBITS
--------

<TABLE>
<S>                 <C>                                                                <C>
EXHIBIT A           Form of Note                                                       A-1

EXHIBIT B           Form of Conversion Notice                                          B-1

EXHIBIT C           Form of Transfer Certificate for Transfer of Restricted Stock      C-1
</TABLE>

                                     -vii-

<PAGE>

                  INDENTURE, dated as of May 23, 2006, between Enzon
Pharmaceuticals, Inc., a corporation incorporated under the laws of the State of
Delaware (the "Company"), as issuer and Wilmington Trust Company, a Delaware
banking corporation (the "Trustee"), as trustee.

                             RECITALS OF THE COMPANY

                  The Company has duly authorized the execution and delivery of
this Indenture to provide for the issuance of up to $225,000,000 principal
amount of the Company's 4% Convertible Senior Notes due 2013, convertible into
common stock, par value $0.01 per share, of the Company (the "Notes").

                  All things necessary have been done to make the Notes, when
executed by the Company and authenticated and delivered hereunder and duly
issued by the Company, the valid obligations of the Company and to make this
Indenture a valid agreement of each of the Company and the Trustee in accordance
with the terms hereof.

                  Each party agrees as follows for the benefit of the other
parties and for the equal and ratable benefit of the Holders of the Notes:

                                   ARTICLE I

                   DEFINITIONS AND INCORPORATION BY REFERENCE

                  SECTION 1.1 Definitions.

                  "Additional Notes" means additional Notes (other than the
Initial Notes), if any, issued under this Indenture in accordance with Section
2.2 hereof, as part of the same series as the Initial Notes.

                  "Additional Shares" means additional shares of Common Stock by
which the Conversion Rate shall be increased for Notes surrendered for
conversion pursuant to an adjustment of the Conversion Rate upon the occurrence
of a Fundamental Change. The number of Additional Shares shall be determined
based on the Effective Date of the Fundamental Change and the Stock Price in
such Fundamental Change transaction, all in accordance with Section 6.5(e).

                  "Affiliate" means, with respect to any specified Person, any
other Person directly or indirectly controlling or controlled by or under direct
or indirect common control with such specified Person. For the purposes of this
definition, "control" when used with respect to any specified Person means the
power to direct the management and policies of such Person, directly or
indirectly, whether through the ownership of voting securities, by contract or
otherwise; and the terms "controlling" and "controlled" have meanings
correlative to the foregoing. No individual shall be deemed to be controlled by
or under common control with any specified Person solely by virtue of his or her
status as an employee or officer of such specified Person or of any other Person
controlled by or under common control with such specified Person.

                  "Agent" means any Registrar, co-registrar, Paying Agent,
additional paying agent or Conversion Agent.

                                       1
<PAGE>

                  "Agent Members" has the meaning set forth in Section
2.1(g)(ii).

                  "Applicable Conversion Price" means, at any given time, $1,000
divided by the Applicable Conversion Rate, rounded to the nearest 1/10th of a
cent.

                  "Applicable Conversion Rate" means, at any given time, the
Conversion Rate then in effect, rounded to the nearest 1/10,000th of a share.

                  "Applicable Procedures" means, with respect to any transfer or
exchange of or for beneficial interests in, or any repurchase or conversion of,
any Global Note, the rules and procedures of the Depositary that apply to such
transfer or exchange.

                  "Authenticating Agent" has the meaning set forth in Section
2.2.

                  "Bankruptcy Law" means Title 11, United States Code or any
similar federal or state law relating to bankruptcy, insolvency, receivership,
winding-up, liquidation, reorganization or relief of debtors or the law of any
other jurisdiction relating to bankruptcy, insolvency, receivership, winding-up,
liquidation, reorganization or relief of debtors or any amendment to, succession
to or change in any such law.

                  "Beneficial Owner" has the meaning assigned to such term in
Rule 13d-3 under the Exchange Act. The terms "Beneficial Ownership" and
"Beneficially Owns" have a corresponding meaning.

                  "Board of Directors" means the board of directors of the
Company or any duly authorized committee thereof.

                  "Board Resolution" means a copy of a resolution certified by
the Secretary or an Assistant Secretary of the Company to have been duly adopted
by the Board of Directors and to be in full force and effect on the date of such
certification, and delivered to the Trustee.

                  "Business Day" means each day that is not a Saturday, Sunday
or other day on which banking institutions in New York, New York are authorized
by law, regulation or executive order to remain closed.

                  "Capital Stock" means:

                  (1) in the case of a corporation, corporate stock;

                  (2) in the case of an association or business entity, shares,
         interests, participations, rights or other equivalents (however
         designated) of corporate stock;

                  (3) in the case of a partnership or limited liability company,
         partnership or membership interests (whether general or limited); and

                  (4) any other interest or participation that confers on a
         Person the right to receive a share of the profits and losses of, or
         distributions of the assets of, the issuing Person.

                                       2
<PAGE>

                  "Closing Sale Price" means, with respect to the Common Stock,
on any date, the last reported closing price per share (or, if no last closing
price is reported, the average of the last bid and ask prices or, if more than
one in either case, the average of the average bid and the average ask prices)
on such date as reported in composite transactions for the principal U.S.
securities exchange on which the Common Stock then is listed or, if the Common
Stock is not listed on a U.S. national or regional exchange, the "Closing Sale
Price" will be the last quoted bid price for the Common Stock in the
over-the-counter market on the relevant dates as reported by the National
Quotation Bureau Incorporated or any similar U.S. system of automated
dissemination of quotations of securities prices. If the Common Stock is not so
quoted, the "Closing Sale Price" will be the price as reported on the principal
other market on which the Common Stock is then traded. In the absence of such
quotations, the Company's Board of Directors will make a good faith
determination of the Closing Sale Price.

                  "Commission" means the United States Securities and Exchange
Commission.

                  "Common Stock" means the common stock of the Company, par
value $0.01 per share, as it exists on the date of this Indenture, or to the
extent such common stock is reclassified or otherwise ceases to exist, any class
of Capital Stock of the Company that (1) is Voting Stock and (2) has no
preference in respect of dividends or of amounts payable in the event of any
voluntary or involuntary liquidation, dissolution or winding up of the issuer
thereof and which is not subject to redemption by the issuer thereof.

                  "Company" means Enzon Pharmaceuticals, Inc., a corporation
incorporated under the laws of Delaware, and, subject to Article IV, its
successors and assigns.

                  "Company Order" has the meaning set forth in Section 2.2.

                  "Continuing Directors" means, as of any date of determination,
any member of the Board of Directors of the Company who:

                  (1) was a member of such Board of Directors on the date of
         this Indenture; or

                  (2) becomes a member of the Board of Directors of the Company
         subsequent to that date and was appointed, nominated for election or
         elected to such Board of Directors with the approval of (a) a majority
         of the Continuing Directors who were members of such Board of Directors
         at the time of such appointment, nomination or election, or (b) a
         majority of the Continuing Directors that were serving at the time of
         such appointment, nomination or election on a committee of the Board of
         Directors that appointed or nominated for election or reelection such
         Board member.

                  "Conversion Agent" means the office or agency designated by
the Company where Notes may be presented for conversion, initially the Trustee
office located at Wilmington Trust FSB, 520 Madison Avenue, 332d Floor, New
York, NY 10022, Attention: Corporate Trust Division (Enzon Pharmaceuticals,
Inc., 4% Convertible Senior Notes due 2013).

                  "Conversion Date" has the meaning set forth in Section 6.3(a).

                  "Conversion Notice" has the meaning set forth in Section
6.3(a).

                                       3
<PAGE>

                  "Conversion Price" shall equal $1,000 divided by the
Conversion Rate (rounded to the nearest 1/10th of a cent).

                  "Conversion Rate" has the meaning set forth in Section 6.1(c).

                  "Corporate Trust Office" means the designated corporate trust
office of the Trustee at which at any time its corporate trust business shall be
administered, which office at the date hereof is located at 1100 North Market
Street, Rodney Square North, Wilmington, Delaware 19890, Attention: Corporate
Trust Division (Enzon Pharmaceuticals, Inc., 4% Convertible Senior Notes due
2013), or such other address as the Trustee may designate from time to time by
notice to the Holders and the Company, or the designated corporate trust office
of any successor Trustee (or such other address as such successor Trustee may
designate from time to time by notice to the Holders and the Company).

                  "Current Market Price" as of any date means:

                  (1) for the purpose of any computation under Section 6.5(a)
         (except for clauses (6) and (8) thereof), the average of the Closing
         Sale Prices for the five consecutive Trading Days ending on the Trading
         Day prior to the Ex-Dividend Trading Day for the event triggering such
         adjustment;

                  (2) for the purpose of any computation under Section
         6.5(a)(6), the average of the Closing Sale Prices for the five
         consecutive Trading Days ending on the Trading Day prior to the
         Ex-Dividend Trading Day for such distribution; and

                  (3) for the purpose of any computation under Section
         6.5(a)(8), the average of the Closing Sale Prices for the five
         consecutive Trading Days beginning on the Trading Day immediately
         following the date of the repurchase triggering the adjustment.

         "Daily Adjustment" for any given Trading Day shall equal a fraction:

                  (1) the numerator of which shall be the Closing Sale Price of
         the Common Stock on such Trading Day plus the closing price of the
         portion of those shares of Capital Stock or similar Equity Interests so
         distributed applicable to one share of Common Stock on such Trading
         Day; and

                  (2) the denominator of which shall be the product of ten (10)
         and the Closing Sale Price of the Common Stock on such Trading Day.

                  "Default" means an event that is, or after notice or passage
of time, or both, would be an Event of Default with respect to the Notes.

                  "Defaulted Interest" has the meaning set forth in Section
2.10.

                  "Definitive Notes" means the Notes that are in registered
definitive form.

                                       4
<PAGE>

                  "Depositary" means The Depository Trust Company, its nominees
and their respective successors and assigns, or such other depositary
institution hereinafter appointed by the Company.

                  "Distributed Assets" has the meaning set forth in Section
6.5(a)(4).

                  "Effective Date" means the date on which a Fundamental Change
transaction becomes effective.

                  "Equity Interests" means Capital Stock and all warrants,
options or other rights to acquire Capital Stock (but excluding any debt
security that is convertible into, or exchangeable for, Capital Stock).

                  "Event of Default" means any event or condition specified as
such in Section 7.1.

                  "Exchange Act" means the Securities Exchange Act of 1934, as
amended, and the rules and regulations promulgated thereunder.

                  "Ex-Dividend Trading Day" means the first date on which the
shares of the Company's Common Stock trade on the applicable national or
regional securities exchange or in the applicable market, regular way, without
the right to receive the issuance, dividend or distribution in question.

                  "Expiration Date" has the meaning set forth in Section
6.5(a)(7).

                  "Fair Market Value" means the value that would be paid by a
willing buyer to an unaffiliated willing seller in a transaction not involving
distress or necessity of either party, determined in good faith by the Board of
Directors of the Company or, unless otherwise provided in this Indenture, by any
Responsible Officer delegated by the Board of Directors to make such
determination on their behalf.

                  "Fundamental Change" will be deemed to have occurred at the
time after the Notes are originally issued that any of the following occurs:

                  (1) the Common Stock (or other common stock into which the
         Notes are convertible) is neither traded on NASDAQ or the NYSE or
         another U.S. national securities exchange or quoted on another
         established automated over-the-counter trading market in the United
         States; or

                  (2) any Person acquires Beneficial Ownership, directly or
         indirectly, through a purchase, merger or other acquisition transaction
         or series of transactions, of shares of the Company's Capital Stock
         entitling such Person to exercise 50% or more of the total voting power
         of all shares of the Company's Capital Stock entitled to vote generally
         in elections of directors, other than an acquisition by the Company,
         any of its Subsidiaries or any of the Company's employee benefit plans;
         or

                  (3) the Company merges or consolidates with or into any other
         Person (other than a Subsidiary), another Person (other than a
         Subsidiary) merges with or into the Company, or the Company conveys,
         sells, transfers or leases all or substantially all of the Company's
         assets to another Person other than any transaction:

                                       5
<PAGE>

                      (a) that does not result in a reclassification,
         conversion, exchange or cancellation of the Company's outstanding
         Common Stock; or

                      (b) pursuant to which the holders of the Common Stock
         immediately prior to the transaction have the entitlement to exercise,
         directly or indirectly, 50% or more of the voting power of all shares
         of Capital Stock entitled to vote generally in the election of
         directors of the continuing or surviving corporation immediately after
         the transaction; or

                      (c) which is effected solely to change the Company's
         jurisdiction of incorporation and results in a reclassification,
         conversion or exchange of outstanding shares of the Common Stock solely
         into shares of common stock of the surviving entity; or

                  (4) at any time the Continuing Directors do not constitute a
         majority of the Company's Board of Directors (or, if applicable, a
         successor Person to the Company).

                  (5) For purposes of this definition and Section 3.10 hereof,
         "Person" includes any syndicate or group that would be deemed a person
         under Section 13(d)(3) of the Exchange Act.

                  "Fundamental Change Notice" has the meaning set forth in
Section 3.10(a).

                  "Fundamental Change Repurchase Date" has the meaning set forth
in Section 3.10(a).

                  "Fundamental Change Repurchase Notice" has the meaning set
forth in Section 3.10(c).

                  "Fundamental Change Repurchase Right Notice" has the meaning
set forth in Section 3.10(c).

                  "GAAP" means generally accepted accounting principles set
forth in the opinions and pronouncements of the Accounting Principles Board of
the American Institute of Certified Public Accountants and statements and
pronouncements of the Financial Accounting Standards Board or in such other
statements by such other entity as may be approved by a significant segment of
the accounting profession of the United States, as in effect on the date hereof.

                  "Global Notes" means Notes that are in the form of the Note
attached hereto as Exhibit A and that are issued to a Depositary.

                  "Government Securities" means direct obligations of, or
obligations guaranteed by, the United States of America, and for the payment of
which the United States pledges its full faith and credit.

                                       6
<PAGE>

                  "guarantee" means, as applied to any obligation, (i) a
guarantee (other than by endorsement of negotiable instruments for collection in
the ordinary course of business), direct or indirect, in any manner, of any part
or all of such obligation and (ii) an agreement, direct or indirect, contingent
or otherwise, the practical effect of which is to assure in any way the payment
or performance (or payment of damages in the event of non-performance) of all or
any part of such obligation. A guarantee shall include, without limitation, any
agreement to maintain or preserve any other Person's financial condition or to
cause any other Person to achieve certain levels of operating results.

                  "Holder" means a Person in whose name a Note is registered.

                  "IAI" means institutional accredited investors (as defined in
Rules 501(a)(1), (2), (3) and (7) under the Securities Act) who are not QIBs.

                  "Indebtedness" of any Person means indebtedness for borrowed
money and indebtedness under purchase money Liens or conditional sales or
similar title retention agreements, in each case where such indebtedness has
been created, incurred, or assumed by such Person to the extent such
indebtedness would appear as a liability upon a balance sheet of such Person
prepared in accordance with GAAP, guarantees by such Person of such
indebtedness, and indebtedness for borrowed money secured by any Lien, pledge or
other lien or encumbrance upon property owned by such Person, even though such
Person has not assumed or become liable for the payment of such indebtedness.

                  "Indenture" means this Indenture as amended or supplemented
from time to time, including, for all purposes of this instrument and any
supplemental indenture or amendment hereto, the provisions of the TIA that are
deemed to be a part of and govern this instrument and any such supplemental
indenture or amendment, respectively.

                  "Initial Notes" means the $225,000,000 aggregate principal
amount of Notes issued under this Indenture on the date hereof.

                  "Interest Payment Date" has the meaning set forth in the form
of Note attached hereto as Exhibit A.

                  "Lien" means any security interest, pledge, lien or other
encumbrance.

                  "Market Capitalization" means the product of (1) the Current
Market Price of the Common Stock and (2) the number of shares of Common Stock
then outstanding on the date of the repurchase of Common Stock triggering the
adjustment set forth in Section 6.5(a)(8) hereof immediately prior to such
repurchase.

                  "Maturity" means, with respect to any Note, the date on which
the principal of such Note becomes due and payable as therein or herein
provided, whether at Stated Maturity, on a Redemption Date or by declaration of
acceleration, offer to repurchase pursuant to Section 3.10 or otherwise.

                  "NASDAQ" means The Nasdaq National Stock Market.

                                       7
<PAGE>

                  "Note" or "Notes" has the meaning stated in the first recital
of this Indenture or, as the case may be, means Notes that have been
authenticated and delivered pursuant to this Indenture, including the Global
Note(s). The Initial Notes and the Additional Notes, if any, shall be treated as
a single class for all purposes under this Indenture, and unless the context
otherwise requires, all references to the Notes shall include the Initial Notes
and any Additional Notes.

                  "Note Register" has the meaning set forth in Section 2.3.

                  "Notes Custodian" means the Trustee or any Person appointed by
the Trustee to act as custodian of Global Notes for the Depositary.

                  "NYSE" means The New York Stock Exchange.

                  "Officer" means an Executive Chairman of the Board, an
Executive Vice President, a Senior Vice President, the President, a Vice
President, the Secretary, an Assistant Secretary, the Treasurer or an Assistant
Treasurer of the Company.

                  "Officers' Certificate" means a certificate signed by any two
Officers of the Company. Each such certificate shall include the statements
provided for in Section 11.5, if and to the extent required by the provisions of
Section 11.4.

                  "Opinion of Counsel" means a written opinion from legal
counsel. The counsel may be an employee of or counsel to the Company. Each such
opinion shall include the statements provided for in Section 11.5, if and to the
extent required by the provisions of Section 11.4.

                  "Outstanding", when used with respect to Notes, means, as of
the date of determination, all Notes theretofore authenticated and delivered
under this Indenture, except:

                  (1) Notes theretofore cancelled by the Trustee or delivered to
         the Trustee for cancellation (including Notes converted and cancelled
         pursuant to this Indenture);

                  (2) Notes for whose payment or redemption money in the
         necessary amount has been theretofore deposited with the Trustee or any
         Paying Agent (other than the Company) in trust or set aside and
         segregated in trust by the Company (if the Company shall act as its own
         Paying Agent) for the Holders of such Notes; provided, that, if such
         Notes are to be redeemed, notice of such redemption has been duly given
         pursuant to this Indenture or provision therefor satisfactory to the
         Trustee has been made; and

                  (3) Notes which have been paid pursuant to Section 2.8 or in
         exchange for or in lieu of which other Notes have been authenticated
         and delivered pursuant to this Indenture, other than any such Notes in
         respect of which there shall have been presented to the Trustee proof
         satisfactory to it that such Notes are held by a bona fide purchaser in
         whose hands such Notes are valid obligations of the Company;

                                       8
<PAGE>

provided, however, that in determining whether the Holders of the requisite
principal amount of the Outstanding Notes have given, made or taken any request,
demand, authorization, direction, notice, consent, waiver or other action
hereunder, Notes owned by the Company or any other obligor upon the Notes or any
Affiliate of the Company or of such other obligor shall be disregarded and
deemed not to be Outstanding, except that, in determining whether the Trustee
shall be protected in relying upon any such request, demand, authorization,
direction, notice, consent, waiver or other action, only Notes which the Trustee
knows to be so owned shall be so disregarded. Notes so owned which have been
pledged in good faith may be regarded as Outstanding if the pledgee establishes
to the satisfaction of the Trustee the pledgee's right so to act with respect to
such Notes and that the pledgee is not the Company or any other obligor upon the
Notes or any Affiliate of the Company or of such other obligor.

                  "Paying Agent" means the office or agency designated by the
Company where Notes may be presented for payment, initially the Trustee.

                  "Person" means any individual, corporation, partnership,
limited liability company, joint venture, association, joint-stock company,
trust, unincorporated organization, government or any agency or political
subdivision thereof or any other entity.

                 "protected purchaser" has the meaning set forth in Section 2.7.

                  "QIB" means any "qualified institutional buyer" (as defined in
Rule 144A under the Securities Act).

                  "Record Date Period" means the period from the close of
business on any Regular Record Date immediately preceding any Interest Payment
Date to the opening of business on such Interest Payment Date.

                  "Redemption Date" when used with respect to any Note to be
redeemed, means the date fixed for such redemption by the Company in a notice of
redemption or pursuant to Section 5.2.

                  "Registrar" means the office or agency maintained by the
Company where Notes may be presented for registration of transfer or exchange,
initially the Trustee.

                  "Registration Rights Agreement" means that certain
registration rights agreement dated as of the date of this Indenture among the
Company, the Guarntors and the Initial Purchasers.

                  "Regular Record Date" has the meaning set forth in the form of
Note attached hereto as Exhibit A.

                  "Repurchase Premium" has the meaning set forth in Section
6.5(a)(8).

                  "Responsible Officer," when used with respect to the Trustee,
means any officer assigned by the Trustee to administer its corporate trust
matters and who is located at the Corporate Trust Office and who shall have the
direct responsibility for the administration of this Indenture.

                  "Restricted Note Legend" means the legend set forth in Section
2.1(d).

                                       9
<PAGE>

                  "Restricted Stock Legend" means the legend required by Section
2.1(e).

                  "Securities Act" means the Securities Act of 1933, as amended.

                  "Settlement" has the meaning set forth in Section 6.3(c).

                  "Significant Subsidiary" has the meaning set for in clauses
(1) and (2) of the definition thereof in Regulation S-X under the Securities
Act.
                  "Special Interest Payment Date" has the meaning set forth in
Section 2.10(a).

                  "Special Record Date" has the meaning set forth in Section
2.10(a).

                  "Spin-off" has the meaning set forth in Section 6.5(a)(5).

                  "Stated Maturity," when used with respect to the Notes, means
June 1, 2013.

                  "Stock Price" means the price paid per share of Common Stock
in the applicable Fundamental Change transaction; provided that (1) if holders
of Common Stock receive only cash in such Fundamental Change transaction, the
Stock Price will be the cash amount paid per share of Common Stock and (2) in
any other Fundamental Change transaction, the Stock Price will be the average of
the Closing Sale Prices on each of the five consecutive Trading Days prior to
but not including the Effective Date of such Fundamental Change.

                  "Subsidiary" means any corporation or other business entity of
which at least a majority of the outstanding stock or membership or other
interest, as the case may be, having voting power under ordinary circumstances
to elect a majority of the board of directors, managers or other governing body
of such corporation or business entity or otherwise direct the business and
affairs of said corporation or business entity is at the time owned by the
Company, or by the Company and one or more Subsidiaries, or by any one or more
Subsidiaries.

                  "TIA" or "Trust Indenture Act" means the Trust Indenture Act
of 1939 (15 U.S.C. ss.ss. 77aaa-77bbbb), as in effect from time to time.

                  "Trading Day" means a day during which trading in securities
generally occurs on NASDAQ, or, if the Common Stock is not then listed on
NASDAQ, then on the NYSE or another national or regional securities exchange on
which the Common Stock is then listed or, if the Common Stock is not listed on a
national or regional securities exchange, on the principal other market on which
the Common Stock is then traded or quoted.

                  "Transfer Restricted Notes" has the meaning set forth in
Section 2.1(d).

                  "Trigger Event" has the meaning set forth in Section 6.9.

                  "Trustee" means the Person identified as "Trustee" in the
first paragraph hereof and, subject to the provisions of Article VIII, shall
also include any successor trustee.

                                       10
<PAGE>

                  "Uniform Commercial Code" means the New York Uniform
Commercial Code as in effect from time to time in the State of New York.

                  "Voting Stock" of any specified Person as of any date means
the Capital Stock of such Person that is at the time entitled to vote in the
election of the Board of Directors of such Person.

                   SECTION 1.2. Incorporation by Reference of Trust Indenture
Act. This Indenture is subject to the mandatory provisions of the TIA, which are
incorporated by reference in and made a part of this Indenture. The following
TIA terms have the following meanings:

                  "indenture securities" means the Notes.

                  "indenture security holder" means a Holder.

                  "indenture to be qualified" means this Indenture.

                  "indenture trustee" or "institutional trustee" means the
Trustee.

                  "obligor" on the indenture securities means the Company and
any other obligor on the indenture securities.

All other TIA terms used in this Indenture that are defined by the TIA, defined
by the TIA by reference to another statute or defined by Commission rule have
the meanings assigned to them by such definitions.

                  SECTION 1.3. Rules of Construction. Unless the context
                               otherwise requires:

                  (1) a term has the meaning assigned to it;

                  (2) an accounting term not otherwise defined has the meaning
         assigned to it in accordance with GAAP;

                  (3) "or" is not exclusive;

                  (4) words in the singular include the plural and words in the
         plural include the singular;

                  (5) the principal amount of any non-interest bearing or other
         discount security at any date shall be the principal amount thereof
         that would be shown on a balance sheet of the issuer dated such date
         prepared in accordance with GAAP;

                  (6) the table of contents and headings of the Articles and
         Sections of this Indenture have been inserted for convenience of
         reference only, are not intended to be considered a part hereof and
         shall not modify or restrict any of the terms or provisions hereof;

                                       11
<PAGE>

                  (7) the words "herein," "hereof" and "hereunder" and other
         words of similar import refer to this Indenture as a whole and not to
         any particular Article, Section or other subdivision;

                  (8) all references to "$" or "dollars" shall refer to the
         lawful currency of the United States of America;

                  (9) the words "include," "included" and "including" as used
         herein shall be deemed in each case to be followed by the phrase
         "without limitation," if not expressly followed by such phrase or the
         phrase "but not limited to";

                  (10) references to sections of or rules under the Securities
         Act, the Exchange Act or the TIA shall be deemed to include substitute,
         replacement or successor sections or rules adopted by the Commission
         from time to time thereunder; and

                  (11) any reference to a Section or Article refers to such
         Section or Article of this Indenture unless otherwise indicated.

                                   ARTICLE II

                                    THE NOTES

                  SECTION 2.1. Form, Dating and Terms.

                  (a) The Notes shall be known and designated as 4% Convertible
Senior Notes due 2013. Pursuant to the provisions of Article VI, the Notes shall
be convertible into Common Stock. Subject to the terms of this Indenture the
Company may, at its option, without consent from the Holders, issue Additional
Notes from time to time. For all purposes under the Indenture, the term "Notes"
shall include the Initial Notes and any such Additional Notes issued after the
date of this Indenture.

                  The Trustee shall authenticate and deliver Initial Notes and
any Additional Notes for original issue in an aggregate principal amount of up
to $275,000,000. Notes may be authenticated and delivered upon registration or
transfer of, or in lieu of, other Notes pursuant to Section 2.6, 2.8 or 10.8.

                  The Notes may have notations, legends or endorsements required
by law, stock exchange rule or usage, in addition to those set forth on Exhibit
A. The Company and the Trustee shall approve the forms of the Notes and any
notation, endorsement or legend on them. Each Note shall be dated the date of
its authentication. The terms of the Note set forth in Exhibit A are part of the
terms of this Indenture and, to the extent applicable, the Company and the
Trustee, by their execution and delivery of this Indenture, expressly agree to
be bound by such terms.

                  The principal of and interest on the Notes shall be payable at
the office or agency of the Company maintained for such purpose in the City of
New York, or at such other office or agency of the Company as may be maintained
for such purpose pursuant to Section 2.3. At the Company's option, however, the
Company may make such payments by mailing a check to the registered address of
each Holder thereof as such address as shall appear on the Note Register or with
respect to Notes represented by a Global Note, by wire transfer of immediately
available funds to the accounts specified by the Depositary. If a payment date
is a date other than a Business Day, payment may be made at that place on the
next succeeding day that is a Business Day and no interest shall accrue for the
intervening period.

                                       12
<PAGE>

                  (b) Notes offered and sold to QIBs in reliance on Rule 144A
and resold to IAIs in the United States of America shall be issued in the form
of one or more permanent Global Notes, without interest coupons, substantially
in the form of Exhibit A. Such Global Notes shall be deposited on behalf of the
purchasers of the Notes represented thereby with the Notes Custodian for the
Depositary for the accounts of participants in the Depositary, duly executed by
the Company and authenticated by the Trustee as hereinafter provided. The
aggregate principal amount of a Global Note may from time to time be increased
or decreased by adjustments made on the records of the Notes Custodian, as
hereinafter provided.

                  (c) The Notes shall be issuable only in fully registered form,
without coupons, and only in denominations of $1,000 and $1,000 integral
multiples thereof.

                  (d) Every Note that bears or is required under this Section
2.1(d) to bear the legend set forth in this Section 2.1(d) (the "Transfer
Restricted Notes") shall be subject to the restrictions on transfer set forth in
this Section 2.1(d) (including those set forth in the legend set forth below),
and the Holder of each such Transfer Restricted Note, by such Holder's
acceptance thereof, agrees to be bound by all such restrictions on transfer. As
used in Sections 2.1(d) and 2.1(e), the term "transfer" includes any sale,
pledge, transfer or other disposition whatsoever of any Transfer Restricted
Note. The Registrar shall not register any transfer of a Transfer Restricted
Note not made in accordance with the restrictions on transfer set forth in this
Section 2.1.

                  Subject to the last paragraph of this Section 2.1(d) and
Section 2.14 with respect to Common Stock, until the expiration of the holding
period applicable to sales thereof under Rule 144(k) under the Securities Act
(or any successor provision), any certificate evidencing any Note (and all
securities issued in exchange therefor or substitution thereof, including Common
Stock, if any, issued upon conversion thereof, which shall bear the legend set
forth in Section 2.1(e), if applicable), shall bear a legend in substantially
the following form:

                  "THIS NOTE AND ANY COMMON STOCK ISSUABLE UPON THE CONVERSION
                  OF THIS NOTE HAVE NOT BEEN REGISTERED UNDER THE U.S.
                  SECURITIES ACT OF 1933, AS AMENDED (THE `SECURITIES ACT'), AND
                  MAY NOT BE SOLD OR OTHERWISE TRANSFERRED IN THE ABSENCE OF
                  SUCH REGISTRATION OR AN APPLICABLE EXEMPTION THEREFROM. EACH
                  PURCHASER OF THIS NOTE IS HEREBY NOTIFIED THAT THE SELLER OF
                  THIS NOTE MAY BE RELYING ON THE EXEMPTION FROM THE PROVISIONS
                  OF SECTION 5 OF THE SECURITIES ACT PROVIDED BY RULE 144A
                  THEREUNDER.

                                       13
<PAGE>

                  THE HOLDER OF THIS NOTE WILL, AND EACH SUBSEQUENT HOLDER IS
                  REQUIRED TO, NOTIFY ANY PURCHASER OF THE NOTE FROM IT OF THE
                  RESALE RESTRICTIONS REFERRED TO ABOVE.

                  THIS NOTE AND ANY COMMON STOCK ISSUABLE UPON THE CONVERSION OF
                  THIS NOTE MAY NOT BE OFFERED, SOLD, PLEDGED OR OTHERWISE
                  TRANSFERRED EXCEPT (A) (1) TO A PERSON WHO THE TRANSFEROR
                  REASONABLY BELIEVES IS A QUALIFIED INSTITUTIONAL BUYER WITHIN
                  THE MEANING OF RULE 144A UNDER THE SECURITIES ACT ACQUIRING
                  FOR ITS OWN ACCOUNT OR FOR THE ACCOUNT OF A QUALIFIED
                  INSTITUTIONAL BUYER IN A TRANSACTION MEETING THE REQUIREMENTS
                  OF RULE 144A, (2) PURSUANT TO AN EXEMPTION FROM REGISTRATION
                  UNDER THE SECURITIES ACT PROVIDED BY RULE 144 THEREUNDER (IF
                  AVAILABLE), (3) TO AN INSTITUTIONAL INVESTOR THAT IS AN
                  ACCREDITED INVESTOR WITHIN THE MEANING OF RULE 501(a)(1), (2),
                  (3) OR (7) OF REGULATION D UNDER THE SECURITIES ACT PURSUANT
                  TO AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT (IF
                  AVAILABLE) OR (4) PURSUANT TO AN EFFECTIVE REGISTRATION
                  STATEMENT UNDER THE SECURITIES ACT, AND (B) IN ACCORDANCE WITH
                  ALL APPLICABLE SECURITIES LAWS OF THE STATES OF THE UNITED
                  STATES AND OTHER JURISDICTIONS.

                  THIS NOTE, ANY SHARES OF COMMON STOCK ISSUABLE UPON ITS
                  CONVERSION AND ANY RELATED DOCUMENTATION MAY BE AMENDED OR
                  SUPPLEMENTED FROM TIME TO TIME TO MODIFY THE RESTRICTIONS ON
                  RESALES AND OTHER TRANSFERS OF THIS NOTE AND ANY SUCH SHARES
                  TO REFLECT ANY CHANGE IN APPLICABLE LAW OR REGULATION (OR THE
                  INTERPRETATION THEREOF) OR IN PRACTICES RELATING TO THE RESALE
                  OR TRANSFER OF RESTRICTED SECURITIES GENERALLY. THE HOLDER OF
                  THIS NOTE AND SUCH SHARES OF COMMON STOCK SHALL BE DEEMED BY
                  THE ACCEPTANCE OF THIS NOTE AND ANY SUCH SHARES TO HAVE AGREED
                  TO ANY SUCH AMENDMENT OR SUPPLEMENT."

                  Any Note (or security issued in exchange or substitution
therefor) as to which such restrictions on transfer shall have expired in
accordance with their terms or that has been transferred pursuant to a
registration statement that has been declared effective under the Securities Act
may, upon surrender of such Note to the Registrar for exchange in accordance
with the provisions of this Section 2.1, be exchanged for a new Note or Notes,
of like tenor and aggregate principal amount, which shall not bear the
Restricted Note Legend required by this Section 2.1(d).

                                       14
<PAGE>

                  (e) Every stock certificate representing Common Stock issued
upon conversion of a Transfer Restricted Note that bears or is required under
this Section 2.1(e) to bear the legend set forth in this Section 2.1(e) shall be
subject to the restrictions on transfer set forth in this Section 2.1(e)
(including those set forth in the legend set forth below), and the Holder of
such Common Stock issued upon conversion of a Transfer Restricted Note, by such
Holder's acceptance thereof, agrees to be bound by all such restrictions on
transfer and the further restrictions set forth in Section 2.14. The Company
shall not register any transfer of Common Stock issued upon conversion of such a
Transfer Restricted Note not made in accordance with the restrictions on
transfer set forth in this Section 2.1.

                  Until the expiration of the holding period applicable to sales
thereof under Rule 144(k) under the Securities Act (or any successor provision),
any stock certificate representing Common Stock issued upon conversion of a
Transfer Restricted Note shall bear a legend in substantially the following
form, unless such Common Stock has been sold pursuant to a registration
statement that has been declared effective under the Securities Act (and which
continues to be effective at the time of such transfer) or such Common Stock has
been issued upon conversion of Notes that have been transferred pursuant to a
registration statement that has been declared effective under the Securities
Act:

                  "THIS SECURITY (OR ITS PREDECESSOR) WAS ORIGINALLY ISSUED IN A
                  TRANSACTION EXEMPT FROM REGISTRATION UNDER THE U.S. SECURITIES
                  ACT OF 1933 (THE `SECURITIES ACT'), AND THIS SECURITY MAY NOT
                  BE OFFERED, SOLD OR OTHERWISE TRANSFERRED IN THE ABSENCE OF
                  SUCH REGISTRATION OR AN APPLICABLE EXEMPTION THEREFROM. EACH
                  PURCHASER OF THIS SECURITY IS HEREBY NOTIFIED THAT THE SELLER
                  OF THIS SECURITY MAY BE RELYING ON THE EXEMPTION FROM THE
                  PROVISIONS OF SECTION 5 OF THE SECURITIES ACT PROVIDED BY RULE
                  144A THEREUNDER.

                  THE HOLDER OF THIS SECURITY AGREES FOR THE BENEFIT OF THE
                  COMPANY THAT (A) THIS SECURITY MAY NOT BE OFFERED, SOLD,
                  PLEDGED OR OTHERWISE TRANSFERRED, EXCEPT (X) (I) TO A PERSON
                  WHOM THE SELLER REASONABLY BELIEVES IS A QUALIFIED
                  INSTITUTIONAL BUYER WITHIN THE MEANING OF RULE 144A UNDER THE
                  SECURITIES ACT ACQUIRING FOR ITS OWN ACCOUNT OR FOR THE
                  ACCOUNT OF ANOTHER QUALIFIED INSTITUTIONAL BUYER IN A
                  TRANSACTION MEETING THE REQUIREMENTS OF RULE 144A, (II)
                  PURSUANT TO AN EXEMPTION FROM REGISTRATION UNDER THE
                  SECURITIES ACT PROVIDED BY RULE 144 THEREUNDER (IF AVAILABLE),
                  (III) TO AN INSTITUTIONAL INVESTOR THAT IS AN ACCREDITED
                  INVESTOR WITHIN THE MEANING OF RULE 501(a)(1), (2), (3) OR (7)
                  OF REGULATION D UNDER THE SECURITIES ACT PURSUANT TO AN
                  EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT (IF
                  AVAILABLE) OR (IV) PURSUANT TO AN EFFECTIVE REGISTRATION
                  STATEMENT UNDER THE SECURITIES ACT, AND (Y) IN ACCORDANCE WITH
                  ALL APPLICABLE SECURITIES LAWS OF THE STATES OF THE UNITED
                  STATES AND OTHER JURISDICTIONS, AND (B) THE HOLDER WILL, AND
                  EACH SUBSEQUENT HOLDER IS REQUIRED TO, NOTIFY ANY PURCHASER OF
                  THE SECURITY FROM IT OF THE RESALE RESTRICTIONS REFERRED TO IN
                  (A) ABOVE.

                                       15
<PAGE>

                  THIS SECURITY AND ANY RELATED DOCUMENTATION MAY BE AMENDED OR
                  SUPPLEMENTED FROM TIME TO TIME TO MODIFY THE RESTRICTIONS ON
                  RESALES AND OTHER TRANSFERS OF THIS SECURITY TO REFLECT ANY
                  CHANGE IN APPLICABLE LAW OR REGULATION (OR THE INTERPRETATION
                  THEREOF) OR IN PRACTICES RELATING TO THE RESALE OR TRANSFER OF
                  RESTRICTED SECURITIES GENERALLY. THE HOLDER OF THIS SECURITY
                  SHALL BE DEEMED BY THE ACCEPTANCE OF THIS SECURITY TO HAVE
                  AGREED TO ANY SUCH AMENDMENT OR SUPPLEMENT."

                  Any stock certificate (or security issued in exchange or
substitution therefor) as to which such restrictions on transfer shall have
expired in accordance with their terms or that has been transferred pursuant to
a registration statement that has been declared effective under the Securities
Act may, upon surrender of such stock certificate to the Registrar for exchange
in accordance with the provisions of this Section 2.1 and Section 2.14, be
exchanged for a new stock certificate, of like tenor and aggregate number of
shares, which shall not bear the Restricted Stock Legend required by this
Section 2.1(e).

                  (f) Each Global Note, whether or not a Transfer Restricted
Note, shall bear the following legend:

                  "THIS SECURITY IS A GLOBAL SECURITY WITHIN THE MEANING OF THE
                  INDENTURE HEREINAFTER REFERRED TO AND IS REGISTERED IN THE
                  NAME OF THE DEPOSITORY TRUST COMPANY, A NEW YORK CORPORATION
                  ("DEPOSITARY"), OR A NOMINEE OF THE DEPOSITARY, WHICH MAY BE
                  TREATED BY THE COMPANY, THE TRUSTEE AND ANY AGENT THEREOF AS
                  THE OWNER AND HOLDER OF THIS SECURITY FOR ALL PURPOSES. UNLESS
                  THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE
                  OF THE DEPOSITARY TO THE COMPANY OR ITS AGENT FOR REGISTRATION
                  OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY CERTIFICATE ISSUED
                  IS REGISTERED IN THE NAME OF CEDE & CO. OR IN SUCH OTHER NAME
                  AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF THE
                  DEPOSITARY (AND ANY PAYMENT IS MADE TO CEDE & CO. OR TO SUCH
                  OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE
                  OF THE DEPOSITARY), ANY TRANSFER, PLEDGE OR OTHER USE HEREOF
                  FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL
                  INASMUCH AS THE REGISTERED OWNER HEREOF, CEDE & CO., HAS AN
                  INTEREST HEREIN.

                                       16
<PAGE>

                  TRANSFERS OF THIS GLOBAL SECURITY SHALL BE LIMITED TO
                  TRANSFERS IN WHOLE, BUT NOT IN PART, BY THE DEPOSITARY TO A
                  NOMINEE OF THE DEPOSITARY OR BY A NOMINEE OF THE DEPOSITARY TO
                  THE DEPOSITARY OR ANOTHER NOMINEE OF THE DEPOSITARY OR BY THE
                  DEPOSITARY OR ANY SUCH NOMINEE TO A SUCCESSOR DEPOSITARY OR A
                  NOMINEE OF SUCH SUCCESSOR DEPOSITARY, AND TRANSFERS OF
                  PORTIONS OF THIS GLOBAL SECURITY SHALL BE LIMITED TO TRANSFERS
                  MADE IN ACCORDANCE WITH THE RESTRICTIONS SET FORTH IN THE
                  INDENTURE REFERRED TO ON THE REVERSE HEREOF."

                  (g) The following book-entry provisions shall apply to Global
Notes deposited with the Notes Custodian:

                  (i) Each Global Note initially shall (x) be registered in the
         name of the Depositary for such Global Note or the nominee of such
         Depositary and (y) be delivered to the Notes Custodian.

                  (ii) Except as provided herein, members of, or participants
         in, the Depositary ("Agent Members") shall have no rights under this
         Indenture with respect to any Global Note held on their behalf by the
         Depositary or by the Notes Custodian or under such Global Note, and the
         Depositary may be treated by the Company, the Trustee, the Notes
         Custodian and any agent of the Company or the Trustee as the absolute
         owner of such Global Note for all purposes whatsoever. Notwithstanding
         the foregoing, nothing herein shall prevent the Company, the Trustee or
         any agent of the Company or the Trustee from giving effect to any
         written certification, proxy or other authorization furnished by the
         Depositary or impair, as between the Depositary and its Agent Members,
         the operation of customary practices of the Depositary governing the
         exercise of the rights of a beneficial owner of an interest in any
         Global Note.

                  (iii) The registered Holder of a Global Note may grant proxies
         and otherwise authorize any Person, including Agent Members and Persons
         that may hold interests through Agent Members, to take any action that
         a Holder is entitled to take under this Indenture or the Notes.

                  (iv) In connection with the transfer of an entire Global Note
         to beneficial owners pursuant to Section 2.1(h), such Global Note shall
         be deemed to be surrendered to the Trustee for cancellation, and the
         Company shall execute, and the Trustee shall authenticate and deliver,
         to each beneficial owner identified by the Depositary in exchange for
         its beneficial interest in such Global Note, an equal aggregate
         principal amount of Definitive Notes of authorized denominations.

                                       17
<PAGE>

                  (v) Any Holder of a Global Note shall, by acceptance of such
         Global Note, agree that transfers of beneficial interests in such
         Global Note may be effected only through a book-entry system maintained
         by (a) the Holder of such Global Note (or its agent) or (b) any Holder
         of a beneficial interest in such Global Note, and that ownership of a
         beneficial interest in such Global Note shall be required to be
         reflected in a book entry.

                  (h) Owners of beneficial interests in Global Notes will not be
entitled to receive Definitive Notes; provided, however, Definitive Notes shall
be transferred to all beneficial owners in exchange for their beneficial
interests in a Global Note if the Depositary notifies the Company that it is
unwilling or unable to continue as depositary for such Global Note or the
Depositary ceases to be a clearing agency registered under the Exchange Act, at
a time when the Depositary is required to be so registered in order to act as
Depositary, and in each case a successor depositary is not appointed by the
Company within 90 days of such notice.

                  (i) Any Definitive Note delivered in exchange for an interest
in a Global Note pursuant to Section 2.1(g)(iv) shall, except as otherwise
provided by Section 2.6, bear the Restricted Note Legend applicable to the
Definitive Note set forth in Section 2.1(d).

                  (j) Notwithstanding any other provision of this Indenture, so
long as a series of Notes is represented by a Global Note, the parties hereto
will be bound at all times by the Applicable Procedures of the Depositary with
respect to such series.

                  SECTION 2.2. Execution and Authentication. An Officer shall
sign the Notes for the Company by manual or facsimile signature. If an Officer
whose signature is on a Note no longer holds that office at the time the Trustee
authenticates the Note, the Note shall be valid nevertheless.

                  A Note shall not be valid until an authorized signatory of the
Trustee manually authenticates the Note. The signature of the Trustee on a Note
shall be conclusive evidence that such Note has been duly and validly
authenticated and issued under this Indenture.

                  The Trustee will, upon receipt of a written order of the
Company signed by an Officer of the Company (a "Company Order"), authenticate
Notes, including any Additional Notes, in an unlimited aggregate principal
amount, subject to the provisions of this Indenture. Each Authentication Order
will specify the amount of Notes to be authenticated, the date on which the
Notes are to be authenticated and, in the case of Additional Notes, the issue
price of such Notes.

                  The Trustee may appoint an agent (the "Authenticating Agent")
reasonably acceptable to the Company to authenticate the Notes. Unless limited
by the terms of such appointment, any such Authenticating Agent may authenticate
Notes whenever the Trustee may do so. Each reference in this Indenture to
authentication by the Trustee includes authentication by such Authenticating
Agent.

                                       18
<PAGE>

                  In case the Company pursuant to Article IV shall be
consolidated or merged with or into any other Person or shall convey, transfer,
lease or otherwise dispose of its properties and assets substantially as an
entirety to any Person, and the successor Person resulting from such
consolidation, or surviving such merger, or into which the Company shall have
been merged, or the Person that shall have received a conveyance, transfer,
lease or other disposition as aforesaid, shall have executed an indenture
supplemental hereto with the Trustee pursuant to Article IV; any of the Notes
authenticated or delivered prior to such consolidation, merger, conveyance,
transfer, lease or other disposition may, from time to time, at the request of
the successor Person, be exchanged for other Notes executed in the name of the
successor Person with such changes in phraseology and form as may be
appropriate, but otherwise in substance of like tenor as the Notes surrendered
for such exchange and of like principal amount; and the Trustee, upon Company
Order of the successor Person, shall authenticate and deliver Notes as specified
in such order for the purpose of such exchange. If Notes shall at any time be
authenticated and delivered in any new name of a successor Person pursuant to
this Section 2.2 in exchange or substitution for or upon registration of
transfer of any Notes, such successor Person, at the option of the Holders but
without expense to them, shall provide for the exchange of all Notes at the time
outstanding for Notes authenticated and delivered in such new name.

                  SECTION 2.3. Registrar, Conversion Agent and Paying Agent. The
Trustee shall initially serve as the Registrar, Conversion Agent and Paying
Agent for the Notes. The Registrar, the Conversion Agent and the Paying Agent
shall each maintain an office or agency in the Borough of Manhattan, The City of
New York. As of the date hereof, such office is located at: Wilmington Trust
FSB, 520 Madison Avenue, 332d Floor, New York, NY 10022, Attention: Corporate
Trust Division (Enzon Pharmaceuticals, Inc., 4% Convertible Senior Notes due
2013). The Registrar shall keep a register of the Notes and of their transfer
and exchange (the "Note Register"). The Company may have one or more
co-registrars and one or more additional conversion agents and paying agents.
The term Paying Agent includes any additional paying agents, the term Conversion
Agent includes any additional conversion agents and the term Registrar includes
any co-registrar. The Company may appoint and change any Paying Agent,
Conversion Agent or Registrar without prior notice to any Holder.

                  The Company shall enter into an appropriate agency agreement
with any Registrar, Conversion Agent or Paying Agent not a party to this
Indenture, which shall incorporate the terms of the TIA. The agreement shall
implement the provisions of this Indenture that relate to such agent. The
Company shall notify the Trustee in writing of the name and address of each such
agent. If the Company fails to maintain a Registrar, Conversion Agent or Paying
Agent, the Trustee shall act as such and shall be entitled to appropriate
compensation therefor pursuant to Section 8.7. The Company or any of its
domestically incorporated Subsidiaries may act as Paying Agent, Conversion Agent
or Registrar.

                  The Company may remove any Registrar, Conversion Agent or
Paying Agent upon written notice to such Registrar, Conversion Agent or Paying
Agent and to the Trustee; provided, however, that no such removal shall become
effective until (i) acceptance of any appointment by a successor as evidenced by
an appropriate agreement entered into by the Company and such successor
Registrar, Conversion Agent or Paying Agent, as the case may be, and such
agreement is delivered to the Trustee or (ii) notification to the Trustee that
the Trustee shall serve as Registrar, Conversion Agent or Paying Agent until the
appointment of a successor in accordance with clause (i) above. The Registrar,
Conversion Agent or Paying Agent may resign at any time upon written notice to
the Company and the Trustee.

                                       19
<PAGE>

                  SECTION 2.4. Paying Agent To Hold Money and Securities in
Trust. Except as otherwise provided herein, on or prior to 10:00 a.m. (New York
City time) on each due date of payment in respect of any Note, the Company shall
deposit with the Paying Agent a sum of money (in immediately available funds)
sufficient to make such payments when due. The Company shall require each Paying
Agent (other than the Trustee) to agree in writing that such Paying Agent shall
hold in trust for the benefit of Holders or the Trustee all money held by such
Paying Agent for the payment of principal of, interest on, and other payments in
respect of the Notes, and shall notify the Trustee in writing of any default by
the Company in making any such payment. If the Company or a Subsidiary acts as
Paying Agent, it shall segregate the money held by it as Paying Agent and hold
it as a separate trust fund for the benefit of the Holders of the Notes. The
Company at any time may require a Paying Agent (other than the Trustee) to pay
all money held by it to the Trustee and to account for any funds disbursed by
such Paying Agent.

Upon complying with this Section 2.4, the Paying Agent (if other than the
Company or a Subsidiary) shall have no further liability for the money delivered
to the Trustee. Upon any bankruptcy, reorganization or similar proceeding with
respect to the Company, the Trustee shall serve as Paying Agent for the Notes.

                  SECTION 2.5. Holder Lists. The Trustee shall preserve in as
current a form as is reasonably practicable the most recent list available to it
of the names and addresses of Holders and shall otherwise comply with TIA ss.
312(a). If the Trustee is not the Registrar or to the extent otherwise required
under the TIA, the Company, on its own behalf, shall furnish to the Trustee, in
writing at least seven Business Days before each Interest Payment Date and at
such other times as the Trustee may reasonably request in writing within 15
days, a list in such form and as of such date as the Trustee may reasonably
require of the names and addresses of Holders and the Company shall otherwise
comply with TIA ss. 312(a).

                  SECTION 2.6. Transfer and Exchange.

                  (a) The following provisions shall apply with respect to any
proposed transfer of a Note prior to the date which is two years after the later
of the date of its original issue and the last date on which the Company or any
Affiliate of the Company was the owner of such Notes (or any predecessor
thereto) (the "Resale Restriction Termination Date"):

                  (i) a transfer of a Note or a beneficial interest therein to a
         QIB shall be made upon receipt by the Trustee or its agent of a
         certificate substantially in the form of the Form of Certificate to be
         Delivered Upon Exchange or Registration of Transfer of Securities set
         forth on the reverse of the Note that the transferee is purchasing the
         Note for its own account or an account with respect to which it
         exercises sole investment discretion and that it and any such account
         is a "qualified institutional buyer" within the meaning of Rule 144A,
         and is aware that the sale to it is being made in reliance on Rule 144A
         and acknowledges that it has received such information regarding the
         Company as it has requested pursuant to Rule 144A or has determined not
         to request such information and that it is aware that the transferor is
         relying upon its foregoing representations in order to claim the
         exemption from registration provided by Rule 144A;

                                       20
<PAGE>

                           (ii) a transfer of a Note or a beneficial interest
                  therein pursuant to an exemption from registration under the
                  Securities Act provided by Rule 144 thereunder, shall be made
                  upon receipt by the Registrar of such opinions of counsel,
                  certificates and/or other information reasonably required by
                  and satisfactory to it in order to ensure compliance with the
                  Securities Act; and

                           (iii) a transfer of a Note or a beneficial interest
                  therein to an IAI shall be made upon receipt by the Trustee or
                  its agent of a certificate substantially in the form set forth
                  in Section 2.7 from the proposed transferee and the delivery
                  of an Opinion of Counsel, certification and/or other
                  information satisfactory to each of them.

                  (b) Upon the transfer, exchange or replacement of Notes not
bearing a Restricted Note Legend, the Registrar shall deliver Notes that do not
bear a Restricted Note Legend. Upon the transfer, exchange or replacement of
Notes bearing a Restricted Note Legend, the Registrar shall deliver only Notes
that bear such Restricted Note Legend unless (i) a Note is being transferred
pursuant to an effective registration statement or (ii) if requested by the
Company or Registrar, there is delivered to the Company and the Registrar an
Opinion of Counsel to the effect that neither such legend nor the related
restrictions on transfer are required in order to maintain compliance with the
provisions of the Securities Act.

                  (c) The Registrar shall retain copies of all letters, notices
and other written communications received pursuant to Section 2.1 or this
Section 2.6 until the Notes have matured and been paid in full. The Company
shall have the right to inspect and make copies of all such letters, notices or
other written communications at any reasonable time upon the giving of
reasonable written notice to the Registrar.

                  (d) The following obligations with respect to transfers and
exchanges of Notes shall apply:

                  (i) To permit registrations of transfers and exchanges, the
         Company shall, subject to the other terms and conditions of this
         Article II, execute and the Trustee shall upon receipt of a Company
         Order, authenticate Definitive Notes and Global Notes at the
         Registrar's request.

                  (ii) No service charge shall be made to a Holder for any
         registration of transfer or exchange, but the Company or Trustee may
         require payment of a sum sufficient to cover any transfer tax,
         assessments or similar governmental charge payable in connection
         therewith (other than any such transfer taxes, assessments or similar
         governmental charges payable upon exchange or transfer pursuant to
         Section 3.9, 3.10 or Article V).

                  (iii) The Registrar shall not be required to register the
         transfer of or exchange of any Note (A) for a period beginning at the
         opening of business 15 days before any selection of Notes for
         redemption or repurchase and ending at the close of business on the day
         notice of such redemption or repurchase is deemed to have been given to
         all Holders of Notes to be so redeemed or repurchased or (B) selected
         for redemption or repurchase in whole or in part, except for the
         transfer of the unredeemed portion of any Note being redeemed in part.

                                       21
<PAGE>

                  (iv) Except as provided herein, prior to the due presentation
         for registration of transfer of any Note, the Company, the Trustee,
         Paying Agent, the Conversion Agent or the Registrar may deem and treat
         the Person in whose name a Note is registered as the absolute owner of
         such Note for the purpose of receiving payment of principal of and
         interest (including Additional Interest, if any) on such Note and for
         all other purposes whatsoever, whether or not such Note is overdue, and
         none of the Company, the Trustee, the Paying Agent, the Conversion
         Agent or the Registrar shall be affected by notice to the contrary.

                  (v) All Notes issued upon any transfer or exchange pursuant to
         the terms of this Indenture shall evidence the same debt and shall be
         entitled to the same benefits under this Indenture as the Notes
         surrendered upon such transfer or exchange.

                  SECTION 2.7. Form of Certificate To Be Delivered in Connection
with Transfers to Institutional Accredited Investors.

                                                                          [Date]
Enzon Pharmaceuticals, Inc.
c/o Wilmington Trust Company
1100 North Market Street
Rodney Square North
Wilmington, Delaware 19890

Attention:  Corporate Trust Administration

Ladies and Gentlemen:

This certificate is delivered to request a transfer of $__________ principal
amount of the 4% Convertible Senior Notes due 2013 (the "Notes") of Enzon
Pharmaceuticals, Inc. (the "Company").

Upon transfer, the Notes would be registered in the name of the new beneficial
owner as follows:

Name:  _________________________________________________________________________

Address:  ______________________________________________________________________

Taxpayer ID Number:  ___________________________________________________________

The undersigned represents and warrants to you that:

                  1. We are an institutional accredited investor (as defined in
         Rule 501(a)(1), (2), (3) or (7) under the Securities Act of 1933, as
         amended (the "Securities Act")) purchasing for our own account or for
         the account of such an institutional accredited investor at least
         $250,000 principal amount of the Notes, and we are acquiring the Notes
         not with a view to, or for offer or sale in connection with, any
         distribution in violation of the Securities Act. We have such knowledge
         and experience in financial and business matters as to be capable of
         evaluating the merits and risk of our investment in the Notes and we
         invest in or purchase securities similar to the Notes in the normal
         course of our business. We and any accounts for which we are acting are
         each able to bear the economic risk of the complete loss of our or its
         investment.

                                       22
<PAGE>

                  2. We understand that the Notes have not been registered under
         the Securities Act and, unless so registered, may not be sold except as
         permitted in the following sentence. We agree on our own behalf and on
         behalf of any investor account for which we are purchasing Notes to
         offer, sell or otherwise transfer such Notes prior to the date that is
         two years after the later of the date of original issue and the last
         date on which the Company or any affiliate of the Company was the owner
         of such Notes (or any predecessor thereto) (the "Resale Restriction
         Termination Date") only (a) to the Company, (b) pursuant to a
         registration statement which has been declared effective under the
         Securities Act, (c) in a transaction complying with the requirements of
         Rule 144A under the Securities Act ("Rule 144A"), to a Person we
         reasonably believe is a qualified institutional buyer under Rule 144A
         (a "QIB") that purchases for its own account or for the account of a
         QIB and to whom notice is given that the transfer is being made in
         reliance on Rule 144A or (d) to an institutional accredited investor
         within the meaning of Rule 501(a)(1), (2), (3) or (7) under the
         Securities Act that is purchasing for its own account or for the
         account of such an institutional accredited investor, in each case in a
         minimum principal amount of Notes of $250,000 or, subject in each of
         the foregoing cases to compliance with any applicable state securities
         laws. The foregoing restrictions on resale will not apply subsequent to
         the Resale Restriction Termination Date. If any resale or other
         transfer of the Notes is proposed to be made pursuant to clause (d)
         above prior to the Resale Restriction Termination Date, the transferor
         shall deliver a letter from the transferee substantially in the form of
         this letter to the Company and the Trustee, which shall provide, among
         other things, that the transferee is an institutional accredited
         investor (within the meaning of Rule 501(a)(1), (2), (3) or (7) under
         the Securities Act) and that it is acquiring such Notes for investment
         purposes and not for distribution in violation of the Securities Act.
         Each purchaser acknowledges that the Company and the Trustee reserve
         the right prior to any offer, sale or other transfer prior to the
         Resale Termination Date of the Notes pursuant to clauses (c) or (d)
         above to require the delivery of an opinion of counsel, certifications
         and/or other information satisfactory to the Company and the Trustee.

                                          TRANSFEREE:  _________________________

                                          BY:  _________________________________

                                       23
<PAGE>

                  SECTION 2.8. Mutilated, Destroyed, Lost or Stolen Notes. If a
mutilated Note is surrendered to the Registrar or if the Holder of a Note claims
that the Note has been lost, destroyed or stolen, subject to compliance with the
provisions of the next two sentences of this Section 2.8, the Company shall
issue and the Trustee, upon Company Order, shall authenticate a replacement Note
at the expense of the Holder if the requirements of Section 8-405 of the Uniform
Commercial Code are met (such that the Holder (a) notifies the Company and the
Trustee within a reasonable time after such Holder has notice of such loss,
destruction or theft and the Registrar has not registered a transfer prior to
receiving such notification, (b) makes such request to the Company prior to the
Company having notice that the Note has been acquired by a protected purchaser
as defined in Section 8-303 of the Uniform Commercial Code (a "protected
purchaser") and (c) satisfies any other reasonable requirements of the Company
and the Trustee). Such Holder shall furnish indemnity sufficient in the judgment
of the Company and the Trustee to protect the Company, the Trustee, the Paying
Agent, the Conversion Agent and the Registrar from any loss which any of them
may suffer if a Note is replaced. The Company shall execute and upon Company
Order the Trustee shall authenticate and deliver, in exchange for any such
mutilated Note or in lieu of any such destroyed, lost or stolen Note, a new Note
of like tenor and principal amount, bearing a number not contemporaneously
outstanding, only in the absence of notice to the Company, the Trustee, Paying
Agent, Conversion Agent or Registrar that such Note has been acquired by a
protected purchaser.

                  In case any such mutilated, destroyed, lost or stolen Note has
become or is about to become due and payable, the Company in its discretion, but
subject to any conversion rights, may, instead of issuing a new Note, pay such
Note upon satisfaction of the conditions set forth in the preceding paragraph.

                  Upon the issuance of any new Note under this Section, the
Company or the Trustee may require the payment of a sum sufficient to cover any
tax or other governmental charge that may be imposed in relation thereto and any
other expenses (including attorneys' fees and expenses and the fees and expenses
of the Trustee) in connection therewith.

                  Every new Note issued pursuant to this Section in lieu of any
mutilated, destroyed, lost or stolen Note shall constitute an original
additional contractual obligation of the Company and any other obligor upon the
Notes, whether or not the mutilated, destroyed, lost or stolen Note shall be at
any time enforceable by anyone, and shall be entitled to all benefits of this
Indenture equally and proportionately with any and all other Notes duly issued
hereunder.

                  The provisions of this Section are exclusive and shall
preclude (to the extent lawful) all other rights and remedies with respect to
the replacement or payment of mutilated, destroyed, lost or stolen Notes.

                  SECTION 2.9. Cancellation. The Company at any time may deliver
Notes to the Trustee for cancellation. The Registrar and the Paying Agent shall
forward to the Trustee any Notes surrendered to them for registration of
transfer, exchange or final payment. The Trustee and no one else shall cancel
and dispose of them in accordance with its customary procedures and upon written
request of the Company shall return to the Company all Notes surrendered for
registration of transfer, exchange, final payment, redemption, purchase,
conversion or cancellation. All Notes so delivered to the Trustee shall be
cancelled promptly by the Trustee. The Company may not issue new Notes to
replace Notes it has paid or delivered to the Trustee for cancellation.

                                       24
<PAGE>

                  At such time as all beneficial interests in a Global Note have
either been exchanged for Definitive Notes, transferred, paid, redeemed,
repurchased, converted or canceled, such Global Note shall be returned by the
Depositary or the Notes Custodian to the Trustee for cancellation or retained
and canceled by the Trustee. At any time prior to such cancellation, if any
beneficial interest in a Global Note is exchanged for Definitive Notes,
transferred in exchange for an interest in another Global Note, paid, redeemed,
repurchased, converted or canceled, the principal amount of Notes represented by
such Global Note shall be reduced and an adjustment shall be made on the Global
Note and on the books and records of the Trustee (if it is then the Notes
Custodian for such Global Note) with respect to such Global Note, by the Trustee
or the Notes Custodian, to reflect such reduction.

                  SECTION 2.10. Payment of Interest; Defaulted Interest.
Interest on any Note that is payable, and is punctually paid or duly provided
for, on any Interest Payment Date shall be paid to the Person in whose name such
Note (or one or more predecessor Notes) is registered at the close of business
on the Regular Record Date for such interest at the office or agency maintained
for such purpose pursuant to Section 2.3.

                  Any interest on any Note that is payable, but is not paid when
the same becomes due and payable and such nonpayment continues for a period of
30 days shall forthwith cease to be payable to the Holder on the Regular Record
Date, and such defaulted interest and (to the extent lawful) interest on such
defaulted interest at the rate borne by the Notes (such defaulted interest and
interest thereon herein collectively called "Defaulted Interest") shall be paid
by the Company, at its election, as provided in clause (a) or (b) below:

                  (a) The Company may elect to make payment of any Defaulted
Interest to the Persons in whose names the Notes (or their respective
predecessor Notes) are registered at the close of business on a Special Record
Date (as defined below) for the payment of such Defaulted Interest, which shall
be fixed in the following manner. The Company shall notify the Trustee in
writing of the amount of Defaulted Interest proposed to be paid on each Note and
the date (not less than 30 days after such notice) of the proposed payment (the
"Special Interest Payment Date"), and the Company shall make arrangements
reasonably satisfactory to the Trustee to deposit with the Trustee an amount of
money equal to the aggregate amount proposed to be paid in respect of such
Defaulted Interest on or prior to the date of the proposed payment, such money
when deposited to be held in trust for the benefit of the Persons entitled to
such Defaulted Interest as in this clause provided. Thereupon the Trustee shall
fix a record date (the "Special Record Date") for the payment of such Defaulted
Interest which shall be not more than 15 days and not less than 10 days prior to
the Special Interest Payment Date and not less than 10 days after the receipt by
the Trustee of the notice of the proposed payment. The Trustee shall promptly
notify the Company of such Special Record Date, and in the name and at the
expense of the Company, shall cause notice of the proposed payment of such
Defaulted Interest and the Special Record Date and Special Interest Payment Date
therefor to be given in the manner provided for in Section 11.2, not less than
10 days prior to such Special Record Date. Notice of the proposed payment of
such Defaulted Interest and the Special Record Date and Special Interest Payment
Date therefor having been so given, such Defaulted Interest shall be paid on the
Special Interest Payment Date to the Persons in whose names the Notes are
registered at the close of business on such Special Record Date and shall no
longer be payable pursuant to the following clause (b).

                                       25
<PAGE>

                  (b) The Company may make payment of any Defaulted Interest in
any other lawful manner not inconsistent with the requirements of any securities
exchange on which the Notes may be listed, and upon such notice as may be
required by such exchange, if, after notice given by the Company to the Trustee
of the proposed payment pursuant to this clause, such manner of payment shall be
deemed practicable by the Trustee.

                  Subject to the foregoing provisions of this Section, each Note
delivered under this Indenture upon registration of transfer of, or in exchange
for, or in lieu of any other Note shall carry the rights to interest accrued and
unpaid which were carried by such other Note.

                  SECTION 2.11. Computation of Interest. Interest on the Notes
shall be computed on the basis of a 360-day year comprised of twelve 30-day
months.

                  SECTION 2.12. CUSIP Numbers. The Company in issuing the Notes
and Common Stock upon conversion of the Notes may use CUSIP numbers (if then
generally in use). The Trustee shall not be responsible for the use of CUSIP
numbers, and the Trustee makes no representation as to their correctness as
printed on any Note, certificate of Common Stock or notice to Holders and that
reliance may be placed only on the other identification numbers printed on the
Notes, and any redemption shall not be affected by any defect in or omission of
such CUSIP numbers. The Company shall promptly notify the Trustee in writing of
any change in the CUSIP numbers.

                  SECTION 2.13. Calculations in Respect of the Notes. The
Company shall be responsible for making all calculations called for under the
Notes. These calculations include, but are not limited to, determinations of the
Closing Sale Price of the Common Stock, any accrued interest payable on the
Notes and the Conversion Rate of the Notes. The Company shall make these
calculations in good faith and, absent manifest error, such calculations will be
final and binding on Holders of the Notes. The Company shall provide to the
Trustee a schedule of its calculations, and the Trustee, subject to Sections 8.1
and 8.2, shall be entitled to rely upon the accuracy of such calculations
without independent verification. The Trustee shall forward the Company's
calculations to any Holder of the Notes upon the request of such Holder.

                  SECTION 2.14. Issuance, Transfer and Exchange of Common Stock
Issuable Upon Conversion of the Notes.

                  Shares of Common Stock to be issued upon conversion of Notes
prior to the effectiveness of a Shelf Registration Statement shall be physically
delivered in certificated form to the Holders converting such Notes and the
certificate representing such shares of Common Stock shall bear the Restricted
Stock Legend unless removed in accordance with Section 2.1(e).

                  If (i) shares of Common Stock to be issued upon conversion of
Notes prior to the effectiveness of a Shelf Registration Statement are to be
registered in a name other than that of the Holder of such Notes or (ii) shares
of Common Stock represented by a certificate bearing the Restricted Stock Legend
are transferred subsequently by such Holder, then, unless the Shelf Registration
Statement has become effective and such shares are being transferred pursuant to
the Shelf Registration Statement, the Holder must deliver to the transfer agent
for the Common Stock and to the Company a certificate in substantially the form
of Exhibit C as to compliance with the restrictions on transfer applicable to
such shares of Common Stock and neither the transfer agent nor the registrar for
the Common Stock shall be required to register any transfer of such Common Stock
not so accompanied by a properly completed certificate.

                                       26
<PAGE>

                  Except in connection with a Shelf Registration Statement, if
certificates representing shares of Common Stock are issued upon the
registration of transfer, exchange or replacement of any other certificate
representing shares of Common Stock bearing the Restricted Stock Legend, or if a
request is made to remove such Restricted Stock Legend from certificates
representing shares of Common Stock, the certificates so issued shall bear the
Restricted Stock Legend, or the Restricted Stock Legend shall not be removed, as
the case may be, unless there is delivered to the Company such reasonably
satisfactory evidence, which, in the case of a transfer made pursuant to Rule
144 under the Securities Act, may include a written opinion from legal counsel,
as may be reasonably required by the Company, that neither the legend nor the
restrictions on transfer set forth therein are required to ensure that transfers
thereof comply with the Securities Act and that such shares of Common Stock are
securities that are not "restricted" within the meaning of Rule 144 under the
Securities Act. Upon provision to the Company of such reasonably satisfactory
evidence, the Company shall cause the transfer agent for the Common Stock to
countersign and deliver certificates representing shares of Common Stock that do
not bear the Restricted Stock Legend.

                                  ARTICLE III

                                    COVENANTS

                  SECTION 3.1. Payment of Notes.

                  The Company will pay or cause to be paid the principal of and
interest, if any, on the Notes on the dates and in the manner provided in the
Notes. Principal and interest, if any, will be considered paid on the date due
if the Paying Agent, if other than the Company or a Subsidiary thereof, holds as
of 11:00 a.m. New York City time on the due date money deposited by the Company
in immediately available funds and designated for and sufficient to pay all
principal and interest then due.

                  The Company will pay interest on overdue principal at the then
applicable interest rate on the Notes to the extent lawful; it will pay interest
on overdue installments of interest (without regard to any applicable grace
period) at the same rate to the extent lawful.

                  SECTION 3.2. Maintenance of Office or Agency.

                  The Company will maintain in the Borough of Manhattan, the
City of New York, an office or agency (which may be an office of the Trustee or
an affiliate of the Trustee, Registrar or co-registrar) where Notes may be
surrendered for registration of transfer or for exchange or conversion and where
notices and demands to or upon the Company in respect of the Notes and this
Indenture may be served. The Company hereby designates the office of the Trustee
located at: Wilmington Trust FSB, 520 Madison Avenue, 332d Floor, New York, NY
10022, Attention: Corporate Trust Division (Enzon Pharmaceuticals, Inc., 4%
Convertible Senior Notes due 2013) for such purposes. The Company will give
prompt written notice to the Trustee of the location, and any change in the
location, of such office or agency. If at any time the Company fails to maintain
any such required office or agency or fails to furnish the Trustee with the
address thereof, such presentations, surrenders, notices and demands may be made
or served at the Corporate Trust Office of the Trustee.

                                       27
<PAGE>

                  The Company may also from time to time designate one or more
other offices or agencies where the Notes may be presented or surrendered for
any or all such purposes and may from time to time rescind such designations;
provided, however, that no such designation or rescission will in any manner
relieve the Company of its obligation to maintain an office or agency in the
Borough of Manhattan, the City of New York, for such purposes. The Company will
give prompt written notice to the Trustee of any such designation or rescission
and of any change in the location of any such other office or agency.

                  The Company hereby designates the Corporate Trust Office of
the Trustee as one such office or agency of the Company.

                  SECTION 3.3. Compliance Certificate.

                  The Company shall deliver to the Trustee within 120 days after
the end of each fiscal year an Officers' Certificate, one of the signatories of
which shall be the chief executive officer, chief financial officer or chief
accounting officer of the Company, stating that in the course of the performance
by the signer of his or her duties as an Officer of the Company, he or she would
normally have knowledge of any Default and whether or not such signer knows of
any Default that occurred during such period. If such signer does have such
knowledge, the certificate shall describe the Default, its status and what
action the Company is taking or proposes to take with respect thereto. The
Company also shall comply with Section 314(a)(4) of the TIA.

                  The Company shall deliver to the Trustee, as soon as possible
and in any event within five Business Days after the Company becomes aware of
the occurrence of any Event of Default or an event that, with notice or the
lapse of time or both, would constitute an Event of Default, an Officers'
Certificate setting forth the details of such Event of Default or Default and
the action that the Company is taking or proposes to take with respect thereto.

                  SECTION 3.4. Reservation of Common Stock.

                  The Company shall at all times reserve and keep available,
free from preemptive rights, out of its authorized but unissued Common Stock or
shares held in treasury by the Company, for the purpose of effecting the
conversion of Notes, the full number of shares of Common Stock then issuable
upon the conversion of all outstanding Notes.

                  SECTION 3.5. Issuance of Shares.

                  All shares of Common Stock delivered upon conversion of the
Notes shall be newly issued shares or shares held in treasury by the Company,
shall have been duly authorized and validly issued and shall be fully paid and
nonassessable, and shall be free from preemptive rights and free of any lien or
adverse claim.

                                       28
<PAGE>

                  SECTION 3.6. Additional Interest Notices.

                  In the event that the Company is required to pay additional
interest to Holders of Notes pursuant to the Registration Rights Agreement
("Additional Interest"), the Company will provide a direction or order in the
form of a written notice ("Additional Interest Notice") to the Trustee (and if
the Trustee is not the Paying Agent, the Paying Agent) of the Company's
obligation to pay Additional Interest no later than five Business Days prior to
the proposed payment date set for the payment of Additional Interest, and the
Additional Interest Notice shall set forth the amount of Additional Interest to
be paid by the Company on such payment date and direct the Trustee (or, if the
Trustee is not the Paying Agent, the Paying Agent) to make payment to the extent
it receives funds from the Company to do so.

                  SECTION 3.7. SEC Reports.

                  The Company will file with the Commission (so long as the
Commission will accept any such filings) and the Trustee the annual reports,
quarterly reports and other documents required to be filed with the Commission
pursuant to Sections 13 and 15 of the Exchange Act, whether or not the Company
has a class of securities registered under the Exchange Act, provided reports
filed via EDGAR (and electronically or otherwise noticed to the Trustee) are
deemed to be filed with the Trustee. The Company will also comply with the other
provisions of Section 314(a) of the Trust Indenture Act.

                  SECTION 3.8. Rule 144A Information Requirements.

                  Within the period prior to the expiration of the holding
period applicable to sales of the Notes under Rule 144(k) under the Securities
Act (or any successor provision), the Company covenants and agrees that it
shall, during any period in which it is not subject to Section 13 or 15(d) under
the Exchange Act, upon the request of any Holder or beneficial holder of the
Notes or any Common Stock issued upon conversion thereof bearing a Restricted
Note Legend or Restricted Sock Legend, as the case may be, make available to
such Holder or beneficial holder of such Notes or any Common Stock issued upon
conversion thereof in connection with any sale thereof and any prospective
purchaser of Notes or such Common Stock designated by such Holder or beneficial
holder, the information required pursuant to Rule 144A(d)(4) under the
Securities Act and it will take such further action as any Holder or beneficial
holder of such Notes or such Common Stock may reasonably request, all to the
extent required from time to time to enable such Holder or beneficial holder to
sell its Notes or Common Stock without registration under the Securities Act
within the limitation of the exemption provided by Rule 144A, as such Rule may
be amended from time to time. Upon the request of any Holder or any beneficial
holder of the Notes or such Common Stock, the Company will deliver to such
Holder a written statement as to whether such Holder and prospective purchaser
have complied with such requirements.

                  SECTION 3.9. Transfer Taxes.

                  If a Holder converts Notes for shares of Common Stock, the
Company will pay any and all documentary, stamp or similar issue or transfer tax
due on the issue of shares of Common Stock upon the conversion. The Company
shall not, however, be required to pay any tax or duty that may be payable in
respect of any transfer involved in the issue and delivery of shares of Common
Stock in a name other than that of the Holder of the Note or Notes to be
converted, and no such issue or delivery shall be made unless and until the
Person requesting such issue has paid to the Company the amount of any such tax
or duty, or has established to the satisfaction of the Company that such tax or
duty has been paid.

                                       29
<PAGE>

                  SECTION 3.10. Offer To Repurchase upon a Fundamental Change.

                  (a) Subject to Section 3.10(d) hereof, upon the occurrence of
a Fundamental Change at any time prior to Stated Maturity, each Holder may
require the Company to repurchase the Notes on a date chosen by the Company in
its sole discretion that is no less than 20 Business Days and no more than 35
Business Days (subject to extension to comply with applicable law) after the
Company sends the Fundamental Change Repurchase Right Notice (the "Fundamental
Change Repurchase Date"), and the Company shall repurchase on the Fundamental
Change Repurchase Date, any or all Notes submitted for repurchase for cash, or
any portion of the initial principal amount thereof that is equal to $1,000 or
an integral multiple of $1,000 at a price equal to 100% of the aggregate
principal amount thereof plus accrued and unpaid interest, if any, to but not
including the Fundamental Change Repurchase Date, unless such Fundamental Change
Repurchase Date falls after a Regular Record Date and on or prior to the
corresponding Interest Payment Date, in which case the Company shall pay the
full amount of accrued and unpaid interest payable on such Interest Payment Date
to the Holder of record at the close of business on the corresponding Regular
Record Date. At least 20 Business Days prior to the anticipated Effective Date
of the Fundamental Change (or if the Company does not have actual notice of a
Fundamental Change 20 Business Days prior to the Effective Date, as soon as the
Company has actual notice of such Fundamental Change), the Company will provide
to all Holders of the Notes, the Trustee, the Paying Agent and the Conversion
Agent a notice (the "Fundamental Change Notice") stating:

                  (1) if applicable, whether the Company will adjust the
         Conversion Rate pursuant to Section 6.5(e) hereof;

                  (2) the anticipated Effective Date of the Fundamental Change;
         and

                  (3) whether the Company expects that Holders will have the
         right to require the Company to repurchase their Notes as described in
         this Section 3.10.

                  (b) On or before the 20th Trading Day after the Effective Date
of a Fundamental Change, the Company will provide to all Holders of the Notes
and the Trustee and Paying Agent and Conversion Agent a notice of the occurrence
of the Fundamental Change and of the resulting repurchase right (the
"Fundamental Change Repurchase Right Notice"). Each Fundamental Change
Repurchase Right Notice shall state:

                  (1) the events causing the Fundamental Change;

                  (2) if the Company is required to adjust the Conversion Rate
         and related conversion obligation as described in Section 6.5(e) hereof
         pursuant to a Fundamental Change that falls under clause (2) or (3) of
         the definition of Fundamental Change, the Conversion Rate and any
         adjustments to the Conversion Rate;

                                       30
<PAGE>

                  (3) the Effective Date, if applicable;

                  (4) the last date on which a Holder may exercise such
         repurchase right;

                  (5) the Fundamental Change repurchase price;

                  (6) the Fundamental Change Repurchase Date;

                  (7) the name and address of the Paying Agent and the
         Conversion Agent;

                  (8) that the Notes with respect to which the Fundamental
         Change Repurchase Right Notice has been given may be converted only if
         the Holder thereof withdraws any Fundamental Change Repurchase Notice
         previously delivered by such Holder in accordance with the terms of
         this Indenture; and

                  (9) the procedures that Holders must follow to require the
         Company to repurchase their Notes.

                  (c) A Holder may exercise its right specified in Section
3.10(a) upon delivery of a notice of repurchase (a "Fundamental Change
Repurchase Notice") in the form required by the Fundamental Change Repurchase
Right Notice delivered to the Paying Agent at any time prior to 5:00 p.m., New
York City time, on the second Business Day immediately preceding the Fundamental
Change Repurchase Date, stating:

                  (1) the information required under the Applicable Procedures
         or, if such Holder holds Definitive Notes, the certificate numbers of
         the Notes which the Holder will deliver to be repurchased;

                  (2) the portion of the principal amount of the Notes which the
         Holder will deliver to be repurchased, which portion must be in a
         principal amount of $1,000 or an integral multiple of $1,000; and

                  (3) that such Notes are to be purchased by the Company as of
         the Fundamental Change Repurchase Date pursuant to the terms and
         conditions specified in the Notes and in this Indenture.

                  If the Notes are not in certificated form, the Fundamental
Change Repurchase Notice must comply with the Applicable Procedures.

                  The delivery of such Notes (either through the surrender of
Definitive Notes or through the delivery of beneficial interests in a Global
Note in accordance with the Applicable Procedures) to the Paying Agent with, or
at any time after delivery of, the Fundamental Change Repurchase Notice prior to
5:00 p.m., New York City time, on the second Business Day immediately preceding
the Fundamental Change Repurchase Date (together with all necessary
endorsements) at the offices of the Paying Agent shall be a condition to the
receipt by the Holder of payment therefor; provided, however, that such payment
shall be so paid pursuant to this Section 3.10 only if the Notes so delivered to
the Paying Agent shall conform in all respects to the description thereof in the
related Fundamental Change Repurchase Notice. Any repurchase by the Company
pursuant to the provisions of this Section 3.10 shall be consummated by the
delivery of the consideration to be received by the Holder promptly following
the later of the Fundamental Change Repurchase Date and the time of delivery of
the Notes.

                                       31
<PAGE>

                  Provided that the Company or a Subsidiary thereof is not
serving as the Paying Agent and the Paying Agent holds money or securities
sufficient to pay the repurchase price of such Notes on the Business Day
following the Fundamental Change Repurchase Date, such Notes will cease to be
outstanding and interest, if any, shall cease to accrue on the Notes or portions
thereof delivered for repurchase on the Fundamental Change Repurchase Date
(whether or not book-entry transfer of the Notes is made or whether or not the
Notes are delivered to the Paying Agent) and all other rights of the Holders of
the Notes to be repurchased pursuant to this Section 3.10 shall terminate (other
than the right to receive payment upon delivery or transfer of the Notes).

                  (d) The Company will comply with the requirements of Rule
13e-4 and Rule 14e-1 under the Exchange Act, including the filing of a Schedule
TO if required, and will comply with the requirements of any other federal and
state securities laws and regulations thereunder to the extent those laws and
regulations are applicable in connection with the repurchase of the Notes by the
Company as a result of a Fundamental Change. To the extent that the provisions
of any securities laws or regulations conflict with the provisions of this
Section 3.10, the Company will comply with the applicable securities laws and
regulations and will not be deemed to have breached its obligations under this
Section 3.10 by virtue of such conflict.

                  (e) On or before the Fundamental Change Repurchase Date, the
Company will, to the extent lawful:

                  (1) accept for payment all Notes or portions thereof properly
         tendered;

                  (2) deposit with the Paying Agent an amount equal to the
         payment in respect of all Notes or portions of Notes properly tendered;
         and

                  (3) deliver or cause to be delivered to the Trustee the Notes
         so accepted together with an Officers' Certificate stating the
         aggregate principal amount of Notes or portions of Notes being
         purchased by the Company in accordance with the terms of this Section
         3.10.

                  The Paying Agent will promptly mail to each Holder of Notes
properly tendered the payment for such Notes, and the Trustee will promptly
authenticate (upon receipt of a Company Order) and mail (or cause to be
transferred by book entry) to each Holder a new Note equal in principal amount
to any unpurchased portion of the Notes surrendered, if any; provided that each
new Note will be in a principal amount of $1,000 and integral multiples of
$1,000.

                  (f) Notwithstanding anything contained herein to the contrary,
Holders of the Notes will not have the right to require the Company to
repurchase any Notes pursuant to the occurrence of any of the events identified
in clauses (2), (3) or (4) of the definition of Fundamental Change (and the
Company will not be required to deliver the Fundamental Change Repurchase Right
Notice incidental thereto), if either:

                                       32
<PAGE>

                  (1) the Closing Sale Price of the Common Stock for any five
         Trading Days within the period of ten consecutive Trading Days ending
         (A) on and including the later of the date of the occurrence of the
         Fundamental Change or the public announcement of the Fundamental Change
         in the case of a Fundamental Change under clause (2) of the definition
         of Fundamental Change; or (B) immediately before the Fundamental Change
         in the case of a Fundamental Change under clauses (3) or (4) of the
         definition of Fundamental Change, equals or exceeds 105% of the
         Applicable Conversion Price of the Notes in effect on each of those
         five Trading Days; or

                  (2) at least 90% of the consideration paid for the Common
         Stock (excluding cash payments for fractional shares and cash payments
         made pursuant to dissenters' appraisal rights and cash dividends) in a
         merger or consolidation or a conveyance, sale, transfer or lease
         otherwise constituting a Fundamental Change under clause (2) and/or
         clause (3) of the definition of Fundamental Change consists of shares
         of common stock traded on the NASDAQ, the NYSE or another U.S. national
         securities exchange or quoted on an established automated
         over-the-counter trading market in the United States (or will be so
         traded or quoted immediately following the merger or consolidation)
         and, as a result of the merger or consolidation, the Notes become
         convertible into such shares of such common stock.

                  (g) Upon receipt by the Paying Agent of a Fundamental Change
Repurchase Notice specified in Section 3.10(c) hereof, the Holder of the Notes
in respect of which such Fundamental Change Repurchase Notice was given shall
(unless such Fundamental Change Repurchase Notice is withdrawn as specified in
Section 3.10(h) hereof) thereafter be entitled to receive solely the payment
described in Section 3.10(a) hereof with respect to such Notes. Such payment
shall be paid to such Holder, subject to the Paying Agent holding money or
securities sufficient to make such payment on the Business Day following the
Fundamental Change Repurchase Date, promptly following the later of (a) the
Fundamental Change Repurchase Date (provided the conditions in Section 3.10(c)
have been satisfied) and (b) the time of book-entry transfer or the delivery of
such Notes to the Paying Agent by the Holder thereof in the manner required by
Section 3.10(c). Notes in respect of which a Fundamental Change Repurchase
Notice has been given by the Holder thereof and the right to be repurchased
under this Section 3.10 has otherwise been exercised may not be surrendered for
conversion pursuant to Article VI on or after the date of the delivery of such
Fundamental Change Repurchase Notice unless such Fundamental Change Repurchase
Notice has first been validly withdrawn as specified in Section 3.10(h) hereof.

                  (h) Notwithstanding anything contained herein to the contrary,
any Holder that has delivered to the Paying Agent the Fundamental Change
Repurchase Notice contemplated by Section 3.10(c) hereof shall have the right to
withdraw such Fundamental Change Repurchase Notice, in whole or in part, by
means of a written notice of withdrawal delivered to the Paying Agent at any
time prior to 5:00 p.m., New York City time, on the second Business Day
immediately preceding the Fundamental Change Repurchase Date, specifying:

                  (1) the principal amount of the Notes with respect to which
         such notice of withdrawal is being submitted;

                                       33
<PAGE>

                  (2) the certificate numbers of the Definitive Notes, if any,
         in respect of which such notice of withdrawal is being submitted; and

                  (3) the principal amount, if any, of such Notes that remain
         subject to the original Fundamental Change Repurchase Notice and which
         have been or will be delivered for repurchase by the Company.

                  If the Notes with respect to which the notice of withdrawal is
being submitted are not in certificated form, the notice of withdrawal must
comply with the Applicable Procedures.

                  (i) The Trustee shall be under no obligation to ascertain the
occurrence of a Fundamental Change or to give notice with respect thereto. The
Trustee may conclusively assume, in the absence of written notice to the
contrary from the Company, that no Fundamental Change has occurred.

                                   ARTICLE IV

                                   SUCCESSORS

                  SECTION 4.1. Merger, Consolidation, or Sale of Assets.

                  The Company shall not, directly or indirectly, consolidate or
merge with or into any other Person in a transaction in which the Company is not
the surviving corporation or convey, transfer or lease the properties and assets
of the Company substantially as an entirety to any successor Person, unless:

                  (1) the successor Person, if any, is:

                           (a) a corporation organized and existing under the
                  laws of the United States, any state of the United States, or
                  the District of Columbia, and

                           (b) such Person assumes the Company's obligations on
                  the Notes and under this Indenture pursuant to agreements
                  reasonably satisfactory in form and substance to the Trustee;

                  (2) immediately after giving effect to the transaction, no
         Default or Event of Default will have occurred and be continuing; and

                  (3) the Company shall have delivered to the Trustee an
         Officers' Certificate and an Opinion of Counsel, each stating that such
         consolidation, merger, conveyance, transfer or lease and, if a
         supplemental indenture is required in connection with such transaction,
         such supplemental indenture, comply with this Article IV and that all
         conditions precedent herein provided for relating to such transaction
         have been satisfied.

                  This Section 4.1 will not apply to a merger of the Company
with an Affiliate solely for the purpose of reincorporating the Company under
the laws of another state of the United States or the District of Columbia.

                                       34
<PAGE>

                  SECTION 4.2. Successor Corporation Substituted.

                  Upon any consolidation or merger, or any sale, assignment,
transfer, lease, conveyance or other disposition of all or substantially all of
the properties or assets of the Company in a transaction that is subject to, and
that complies with the provisions of, Section 4.1 hereof, the successor Person
formed by such consolidation with or into which the Company is merged or to
which such sale, assignment, transfer, lease, conveyance or other disposition is
made shall succeed to, and be substituted for (so that from and after the date
of such consolidation, merger, sale, assignment, transfer, lease, conveyance or
other disposition, the provisions of this Indenture referring to the "Company"
shall refer instead to the successor Person and not to the Company), and may
exercise every right and power of the Company under this Indenture with the same
effect as if such successor Person had been named as the Company herein;
provided, however, that the predecessor Company shall not be relieved from the
obligation to pay the principal of and interest on the Notes except in the case
of a sale of all of the Company's assets in a transaction that is subject to,
and that complies with the provisions of, Section 4.1 hereof.

                                   ARTICLE V

                               REDEMPTION OF NOTES

                  SECTION 5.1. Optional Redemption.

                  The Notes are subject to redemption, at the option of the
Company, on or after June 1, 2009, in whole or in part, but only if the Closing
Sale Price of the Common Stock for at least 20 Trading Days in the 30
consecutive Trading Day period ending on the date one Trading Day prior to the
day the Company gives a notice of redemption is greater than 140% of the
Applicable Conversion Price on the date of such notice, at a redemption price in
cash equal to 100% of the principal amount of the Notes to be redeemed, plus
accrued and unpaid interest, if any, on the principal amount of the Notes
redeemed to the date of redemption.

                  SECTION 5.2. Selection and Notice of Redemption.

                  (a) If less than all of the Notes are to be redeemed pursuant
to Section 5.1, the Trustee will select Notes for redemption in compliance with
the requirements of the principal national securities exchange on which the
Notes are listed, or if such notes are not then listed on a national securities
exchange, on a pro rata basis, by lot or by such method as the Trustee shall
deem fair and appropriate, except if otherwise required by law.

                  In the event of redemption by lot, the particular Notes to be
redeemed will be selected, unless otherwise provided herein, not less than 15
nor more than 60 days prior to the Redemption Date by the Trustee from the
outstanding Notes not previously called for redemption.

                  The Trustee will promptly notify the Company in writing of the
Notes selected for redemption and, in the case of any Note selected for partial
redemption, the principal amount thereof to be redeemed. Notes and portions of
Notes selected will be in amounts of $1,000 or integral multiples of $1,000;
except that if all of the Notes of a Holder are to be redeemed, the entire
outstanding amount of Notes held by such Holder, even if not a multiple of
$1,000, shall be redeemed. Except as provided in the preceding sentence,
provisions of this Indenture that apply to Notes called for redemption also
apply to portions of Notes called for redemption.

                                       35
<PAGE>

                  (b) Notice of redemption will be sent by the Company or by the
Trustee at the Company's request by first class mail, electronically or by other
means approved by the Trustee not less than 15 nor more than 60 days before the
Redemption Date to each Holder of Notes to be redeemed at its registered
address. Such notice shall specify the date fixed for redemption. If any Note is
to be redeemed in part only, the notice of redemption that relates to that Note
will state the portion of the principal amount of the Note to be redeemed.
Subject to Section 5.5, a Note in a principal amount equal to the unredeemed
portion of the Note will be issued in the name of the Holder of the note upon
cancellation of the original Note. On and after the Redemption Date, interest
will cease to accrue on Notes or portions thereof called for redemption so long
as the Company has deposited with the Paying Agent for the Notes, if other than
the Company or a Subsidiary thereof, funds in satisfaction of the redemption
price (including accrued and unpaid interest, if any, on the Notes to be
redeemed) pursuant to this Indenture.

                  SECTION 5.3. Effect of Notice of Redemption.

                  Once notice of redemption is sent in accordance with Section
5.2 hereof, Notes called for redemption shall become irrevocably due and payable
on the Redemption Date. A notice of redemption shall not be conditional.

                  SECTION 5.4. Deposit of Redemption Price.

                  Prior to 11:00 a.m., New York City time, on any Redemption
Date, if not previously deposited, the Company will deposit with the Trustee or
with the Paying Agent, if other than the Company or a Subsidiary thereof, money
sufficient to pay the redemption price of and accrued interest, if any, on all
Notes to be redeemed on that date. The Trustee or the Paying Agent will promptly
return to the Company any money deposited with the Trustee or the Paying Agent
by the Company in excess of the amounts necessary to pay the redemption price
of, and accrued interest, if any, on, all Notes to be redeemed.

                  SECTION 5.5. Notes Redeemed in Part.

                  Upon surrender of a Note that is redeemed in part, the Company
will issue and, upon receipt of a Company Order, the Trustee will authenticate
for the Holder at the expense of the Company a new Note equal in principal
amount to the unredeemed portion of the Note surrendered.

                                       36
<PAGE>

                                   ARTICLE VI

                               CONVERSION OF NOTES

                  SECTION 6.1. Conversion Right and Conversion Rate.

                  (a) Subject to and upon compliance with the provisions of this
Article VI, at the option of the Holder thereof, at any time prior to Maturity,
unless earlier repurchased or redeemed, any portion of the principal amount of
any Note that is an integral multiple of $1,000 may be converted into fully paid
and non-assessable shares of Common Stock at the Conversion Rate, determined as
hereinafter provided, in effect at the time of conversion (provided that the
principal amount of any such Notes to remain outstanding after such conversion
is equal to $1,000 or any integral multiple of $1,000 in excess thereof).

                  (b) If any Holder has submitted Notes for repurchase upon a
Fundamental Change in accordance with Section 3.7 hereof, such Notes submitted
for repurchase may be converted only if such Holder withdraws the election for
repurchase in accordance with Section 3.7 hereof.

                  (c) Each $1,000 principal amount of Notes converted into
shares of Common Stock shall initially be converted at a Conversion Price of
$9.55 per share. The rate at which shares of Common Stock shall be delivered
upon conversion (herein called the "Conversion Rate") shall be initially
104.7120 shares of Common Stock for each $1,000 principal amount of Notes. The
Conversion Rate will be adjusted under the circumstances provided in Section
6.5. All calculations under this Article shall be made to the nearest 1/10th
cent or to the nearest 1/10,000ths of a share, as the case may be.

                  SECTION 6.2. Conversion Consideration.

                  (a) Upon surrendering any Notes for conversion, the Holder of
such Notes shall receive, in respect of each $1,000 principal amount of Notes, a
number of shares of Common Stock equal to the Applicable Conversion Rate.

                  (b) When a Holder receives Common Stock upon conversion of
Notes, such Holder will also receive the associated rights under the Company's
Rights Agreement dated May 17, 2002 and any stockholder rights plan that the
Company may subsequently adopt, whether or not the rights have separated from
the Common Stock at the time of conversion unless, prior to conversion, the
rights have expired, terminated or been exchanged.

                  SECTION 6.3. Exercise of Conversion Right.

                  (a) In order to exercise the conversion right:

                  (1) the Holder of any Definitive Note to be converted must:
         (i) complete and manually sign a notice of conversion substantially in
         the form of Exhibit B hereto (the "Conversion Notice"); (ii) deliver
         the Conversion Notice and the Definitive Note to the Conversion Agent;
         and (iii) if required, furnish appropriate endorsements and transfer
         documents; or

                  (2) the holder of beneficial interests in any Global Note to
         be converted must, to the extent required, deliver irrevocable notice
         of conversion and otherwise comply with the Applicable Procedures to
         cause the beneficial interests in such Global Note to be delivered to
         the Conversion Agent,

and in either case, the Holder of a Definitive Note or holder of beneficial
interests in a Global Note will, if required, pay all transfer or similar taxes
that the Company is not otherwise required to pay pursuant to Section 3.9 hereof
and, if required pursuant to Section 6.3(b) hereof, pay funds equal to the
interest payable on the next Interest Payment Date.

                                       37
<PAGE>

                  The date on which a Holder of a Definitive Note or holder of a
beneficial interest in a Global Note completes the requirements of this Section
6.3(a) shall be deemed to be the date of conversion (the "Conversion Date") for
purposes of this Article VI. On and after the Conversion Date, the conversion by
such Holder or holder, as set forth in the Conversion Notice, shall become
irrevocable.

                  The Company shall deliver shares of Common Stock (and any cash
in lieu of fractional shares) deliverable upon conversion to the Conversion
Agent no later than the third Business Day following the Conversion Date.

                  (b) Each Definitive Note surrendered (in whole or in part), or
beneficial interest in any Global Note surrendered to the Conversion Agent, for
conversion during a Record Date Period shall be accompanied by payment by the
Holder in same-day funds or other funds acceptable to the Company of an amount
equal to the interest payable on the applicable Interest Payment Date on the
principal amount of such Note (or part thereof, as the case may be) being
surrendered for conversion; provided, however, that no such payment by the
Holder need be made in the case of any Note or portion thereof that (x) has been
delivered for repurchase following a Fundamental Change on a Fundamental Change
Repurchase Date or (y) which has been called for redemption on a Redemption
Date, in each case, occurring during the Record Date Period. The interest
payable by the Company on such Interest Payment Date with respect to any Note
(or portion thereof, if applicable) that is surrendered for conversion during a
Record Date Period shall be paid to the Holder of such Note as of such Regular
Record Date in an amount equal to the interest that would have been payable on
such Note if such Note had been converted as of the close of business on the
applicable Interest Payment Date.

                  Except as provided in this Section 6.3(b), no cash payment or
adjustment shall be made upon any conversion on account of any interest accrued
from the Interest Payment Date immediately prior to the Conversion Date, in
respect of any Note (or part thereof, as the case may be) surrendered for
conversion, or on account of any dividends on the Common Stock issued upon
conversion. The Company's delivery to the Holder of the number of shares of
Common Stock (and cash in lieu of fractions thereof in accordance with Section
6.4 hereof) into which a Note is convertible will be deemed to satisfy all of
the Company's obligations to pay the principal of and interest, if any, on the
Note. Accordingly, accrued but unpaid interest, if any, will be deemed to be
paid in full rather than canceled, extinguished or forfeited.

                  (c) Notes shall be deemed to have been converted immediately
prior to the close of business on the Conversion Date, and at such time the
rights of the Holders of such Notes as Holders shall cease, and the Person or
Persons entitled to receive the shares of Common Stock issuable upon conversion
shall be treated for all purposes as the record holder or holders of such Common
Stock at such time. Following any Conversion Date, the Company shall satisfy its
obligations with respect to such conversion by either:

                                       38
<PAGE>

                  (1) delivering to the Trustee, for delivery to the Holder (or
         such other Person as may be named in the relevant Conversion Notice),
         certificates representing the number of shares of Common Stock issuable
         upon such conversion; or

                  (2) delivering to such Holder (or such other Person as may be
         named in the relevant Conversion Notice) such number of shares of
         Common Stock issuable upon such conversion in accordance with the
         Applicable Procedures,

in each case, together with payment in lieu of any fractional shares, if any, as
provided in Section 6.4 (such delivery of shares and cash payment, if any, the
"Settlement"); provided that shares of Common Stock only will be deliverable in
certificated form if (i) the Notes being converted are required to bear the
Restricted Note Legend, (ii) the Holder exercising such conversion has
specifically requested in writing that delivery be in certificates or (iii) the
Company determines that delivery is required in certificated shares either
because (A) delivery to the Holder (or such other Person named in the relevant
Conversion Notice) is not practicable in accordance with the Applicable
Procedures or (B) in the opinion of legal counsel, delivery is required in
certificated form in order to comply with the requirements of applicable
securities laws. Settlement shall occur promptly (but in no event more than
three Business Days) following the Conversion Date.

                  (d) In the case of any Note that is converted in part only,
upon such conversion the Company shall execute and the Trustee shall
authenticate (upon receipt of a Company Order) and deliver to the Holder
thereof, at the expense of the Company, a new Note or Notes of authorized
denominations in an aggregate principal amount equal to the unconverted portion
of the principal amount of such Note.

                  SECTION 6.4. Fractions of Shares.

                  No fractional shares of Common Stock shall be issued upon
conversion of any Note or Notes. If more than one Note shall be surrendered for
conversion at one time by the same Holder, the number of full shares that shall
be issuable upon conversion thereof shall be computed on the basis of the
aggregate principal amount of the Notes (or specified portions thereof) so
surrendered. The number of fractional shares to be paid, if any, will be valued
by the Closing Sale Price of the Common Stock on Trading Day immediately
preceding the Conversion Date. Instead of any fractional share of Common Stock
that would otherwise be issuable upon conversion of any Note or Notes (or
specified portions thereof), the Company shall calculate and pay a cash
adjustment for the fractional amount (calculated to the nearest 1/10,000th of a
share) based upon the Closing Sale Price on the Trading Day immediately
preceding the Conversion Date.

                  SECTION 6.5. Adjustment of Conversion Rate.

                  (a) The Applicable Conversion Rate shall be subject to
adjustment, without duplication, from time to time upon the occurrence of any of
the following:

                                       39
<PAGE>

                  (1) Stock Dividends in Common Stock. In case the Company shall
         pay or make a dividend or other distribution on shares of Common Stock
         payable exclusively in shares of Common Stock, the Applicable
         Conversion Rate in effect at the opening of business on the Ex-Dividend
         Trading Day for such dividend or distribution, or the effective date
         shall be increased by dividing such Conversion Rate by an adjustment
         factor equal to a fraction of which the numerator shall be the number
         of shares of Common Stock outstanding at the close of business on the
         effective date of such dividend or distribution and the denominator
         shall be the sum of such number of shares and the total number of
         shares constituting such dividend or other distribution, such increase
         to become effective immediately after the opening of business on the
         day following the effective date of such dividend or distribution. If,
         after any date fixed for determination of stockholders entitled to
         receive such dividend or distribution, any dividend or distribution is
         not in fact paid, the Applicable Conversion Rate shall be immediately
         readjusted, effective as of the date the Company's Board of Directors
         determines not to pay such dividend or distribution, to the Applicable
         Conversion Rate that would have been in effect if such determination
         date had not been fixed. For the purposes of this clause (1), the
         number of shares of Common Stock at any time outstanding shall not
         include shares held in the treasury of the Company. The Company will
         not pay any dividend or make any distribution on shares of Common Stock
         held in the treasury of the Company.

                  (2) Issuance of Rights or Warrants. In case the Company shall
         issue rights or warrants to all or substantially all holders of its
         Common Stock entitling them for a period expiring within 60 days from
         the date of issuance of the rights or warrants to subscribe for or
         purchase shares of Common Stock at a price per share less than the
         Current Market Price per share of Common Stock on the date fixed for
         the determination of stockholders entitled to receive such rights or
         warrants (other than any rights or warrants that (x) by their terms
         will also be issued to any Holder upon conversion of a Note into shares
         of Common Stock without any action required by the Company or any other
         Person or (y) are distributed to shareholders of the Company upon a
         merger or consolidation in compliance with Section 6.8 hereof and
         taking into consideration in determining the price per share any
         consideration received by the Company for such rights or warrants and
         any amount payable on exercise or conversion thereof, with the value of
         such consideration, if other than cash, to be determined by the
         Company), then the Applicable Conversion Rate in effect at the opening
         of business on the Ex-Dividend Trading Day for such distribution shall
         be increased by dividing such Applicable Conversion Rate by an
         adjustment factor equal to a fraction:

                      (A) the numerator of which shall be the number of shares
                   of Common Stock outstanding at the close of business on the
                   effective date of such dividend or distribution plus the
                   number of shares of Common Stock that the aggregate of the
                   offering price of the total number of shares of Common Stock
                   so offered for subscription or purchase would purchase at
                   such Current Market Price; and

                      (B) the denominator of which shall be the number of shares
                   of Common Stock outstanding at the close of business on the
                   effective date of such dividend or distribution plus the
                   number of shares of Common Stock so offered for subscription
                   or purchase,

such increase to become effective immediately after the opening of business on
the day following the Ex-Dividend Trading Day for such distribution. If, after
any date fixed for determination of stockholders entitled to received such
rights and warrants, any such rights or warrants are not in fact issued, or are
not exercised prior to the expiration thereof, the Conversion Rate shall be
immediately readjusted, effective as of the date such rights or warrants expire,
or the date the Company's Board of Directors determines not to issue such rights
or warrants, to the Applicable Conversion Rate that would have been in effect if
the unexercised rights or warrants had never been granted or such determination
date had not been fixed, as the case may be, and as a result no additional
shares are delivered or issued pursuant to such rights or warrants. For the
purposes of this clause (2), the number of shares of Common Stock at any time
outstanding shall not include shares held in the treasury of the Company. The
Company will not issue any rights or warrants in respect of shares of Common
Stock held in the treasury of the Company.

                                       40
<PAGE>

                  (3) Stock Splits and Combinations. In case outstanding shares
         of Common Stock shall be subdivided or split into a greater number of
         shares of Common Stock, then the Applicable Conversion Rate in effect
         at the opening of business on the day following the day upon which such
         subdivision or split becomes effective shall be proportionately
         increased; in case outstanding shares of Common Stock shall be combined
         or reclassified into a smaller number of shares of Common Stock, then
         the Applicable Conversion Rate in effect at the opening of business on
         the day following the day upon which such combination or
         reclassification becomes effective shall be proportionately reduced;
         and in case the Company issues any shares of its Capital Stock in a
         reclassification of the outstanding shares of Common Stock, then the
         Applicable Conversion Rate in effect at the opening of business on the
         day following the day upon which such reclassification becomes
         effective shall be proportionately applied to the new class of shares
         of Capital Stock of the Company into which the Common Stock was
         reclassified; in each case, such increase, reduction or
         reclassification, as the case may be, to become effective immediately
         after the opening of business on the Business Day following the day
         upon which such subdivision, combination or reclassification becomes
         effective.

                  (4) Distribution of Indebtedness, Securities or Assets. In
         case the Company shall, by dividend or otherwise, distribute to all or
         substantially all holders of its Common Stock evidences of its
         indebtedness, securities, assets or rights, options or warrants to
         purchase the Company's securities (provided that if these rights are
         only exercisable upon the occurrence of specified triggering events,
         then the conversion rate will not be adjusted until the triggering
         events occur), but excluding

                      (i) any dividends or distributions referred to in clause
                      (1) of this Section 6.5(a),

                      (ii) any rights or warrants referred to in clause (2) of
                      this Section 6.5(a),

                      (iii) any dividends or distributions paid exclusively in
                      cash described in clause (6), (7) or (8) of this Section
                      6.5(a)

                      (the "Distributed Assets"), then (other than in the case
                      as described in clause (5) of this Section 6.5(a)) the
                      Applicable Conversion Rate shall be adjusted so that the
                      same shall equal the rate determined by multiplying the
                      Applicable Conversion Rate in effect immediately prior to
                      the close of business on the Trading Day prior to the
                      Ex-Dividend Trading Day for such distribution by an
                      adjustment factor equal to a fraction:

                                       41
<PAGE>

                            (A) the numerator of which shall be the Current
                      Market Price per share of Common Stock; and

                            (B) the denominator of which shall be the Current
                      Market Price per share of Common Stock on the date fixed
                      for such determination minus the Fair Market Value, as
                      determined by the Company's Board of Directors, whose
                      determination in good faith shall be conclusive and
                      described in a Board Resolution filed with the Trustee, of
                      the portion of those Distributed Assets applicable to one
                      share of Common Stock, such adjustment to become effective
                      on the Ex-Dividend Trading Day for such distribution.

If after any date fixed for determination of stockholders entitled to receive
such distribution, any such distribution is not in fact made, the Applicable
Conversion Rate shall be immediately readjusted, effective as of the date the
Company's Board of Directors determines not to make such distribution, to the
Applicable Conversion Rate that would have been in effect if such determination
date had not been fixed.

                  Notwithstanding the foregoing, in cases where (i) the Fair
Market Value per share of the Distributed Assets equals or exceeds the Current
Market Price of the Common Stock, or (ii) the Current Market Price of the Common
Stock exceeds the Fair Market Value per share of the Distributed Assets by less
than $1.00, in lieu of the adjustment set forth in this Section 6.5(a)(4),
Holders will receive upon conversion, in addition to shares of Common Stock, if
any, the amount and type of Distributed Assets such Holders would have received
upon conversion of such Holders' Notes if they had been converted immediately
prior to the record date for such distribution.

                      (5) Spin-Offs. In case the Company shall distribute to all
                   or substantially all holders of its Common Stock shares of
                   Capital Stock of any class or series, or similar Equity
                   Interests, of or relating to a Subsidiary or other business
                   unit, which Capital Stock is or Equity Interests are traded
                   on NASDAQ, the NYSE or another U.S. national securities
                   exchange or quoted on an established automated
                   over-the-counter trading market in the United States (a
                   "Spin-off"), then the Applicable Conversion Rate shall be
                   adjusted so that the same shall equal the rate determined by
                   multiplying the Conversion Rate in effect immediately prior
                   to the close of business on the Trading Day prior to the
                   Ex-Dividend Trading Day for such distribution by an
                   adjustment factor equal to the sum of the Daily Adjustments
                   for each of the 10 consecutive Trading Days beginning on the
                   effective date of the Spin-off, such adjustment to become
                   effective on the 10th Trading Day from, and including, the
                   effective date of the Spin-off.

                      (6) Cash Distributions. In case the Company shall, by
                   dividend or otherwise, distribute to all or substantially all
                   holders of outstanding shares of Common Stock distributions
                   consisting exclusively of cash, then the Applicable
                   Conversion Rate shall be adjusted so that the same shall
                   equal the rate determined by multiplying the Conversion Rate
                   in effect immediately prior to the close of business on the
                   Trading Day prior to the Ex-Dividend Trading Day for such
                   distribution by an adjustment factor equal to a fraction:

                                       42
<PAGE>

                            (A) the numerator of which shall be equal to the
                      Current Market Price per share of Common Stock on the date
                      fixed for such determination; and

                            (B) the denominator of which shall be equal to the
                      Current Market Price per share of Common Stock on such
                      date fixed for determination minus the amount per share of
                      such distribution, such adjustment to become effective
                      immediately after the Trading Day prior to the Ex-Dividend
                      Trading Day for such dividend or distribution.

                  Notwithstanding the foregoing, in cases where (i) the per
share amount of such distribution equals or exceeds the Current Market Price of
the Common Stock, or (ii) the Current Market Price of the Common Stock exceeds
the per share amount of such distribution by less than $1.00, in lieu of the
adjustment set forth in this Section 6.5(a)(6), Holders will receive upon
conversion, in addition to shares of Common Stock, if any, such distribution
such Holders would have received upon conversion of such Holders' Notes if they
had been converted immediately prior to the record date for such distribution.

                      (7) Tender or Exchange Offers. In case the Company or any
                   Subsidiary shall make a payment in respect of a tender offer
                   or exchange offer for any portion of the Common Stock, in
                   which event, to the extent the cash and value of any other
                   consideration included in the payment per share of Common
                   Stock exceeds the Closing Sale Price of the Common Stock on
                   the Trading Day immediately following the last date on which
                   tenders or exchanges may be made pursuant to such tender
                   offer or exchange offer (the "Expiration Date"), as the case
                   may be, then the Applicable Conversion Rate shall be adjusted
                   so that the same shall equal the rate determined by
                   multiplying the Applicable Conversion Rate immediately prior
                   to close of business on the Expiration Date by an adjustment
                   factor equal to a fraction:

                            (A) the numerator of which shall be equal to the sum
                      of (a) the Fair Market Value, as determined by the Board
                      of Directors of the Company, of the aggregate
                      consideration payable for all shares of Common Stock
                      purchased by the Company in the tender or exchange offer
                      and (b) the product of (i) the number of shares of Common
                      Stock outstanding less any such purchased shares and (ii)
                      the Closing Sale Price of the Common Stock on the Trading
                      Day immediately following the Expiration Date; and

                            (B) the denominator of which shall be equal to the
                      product of (a) the number of shares of Common Stock
                      outstanding, including any such purchased shares, and (b)
                      the Closing Sale Price of the Common Stock on the Trading
                      Day immediately following the Expiration Date.

                                       43
<PAGE>

                  The adjustment pursuant to this clause (7) will become
effective immediately after the opening of business on the second Trading Day
immediately following the Expiration Date.

                      (8) Repurchases. In case the Company or any of its
                   Subsidiaries shall make a payment in respect of a repurchase
                   of Common Stock the consideration for which exceeds the
                   average of the Closing Sale Prices of the Common Stock for
                   the five consecutive Trading Days ending on the relevant
                   repurchase date (such amount, the "Repurchase Premium"), and
                   that repurchase, together with any other repurchases of
                   Common Stock by the Company or any of its Subsidiaries
                   involving a Repurchase Premium concluded within the preceding
                   12 months not triggering an adjustment to the Applicable
                   Conversion Rate, results in the payment by the Company of an
                   aggregate consideration exceeding an amount equal to 10% of
                   the Market Capitalization of the Common Stock, then the
                   Conversion Rate shall be adjusted so that the same shall
                   equal the rate determined by multiplying the Conversion Rate
                   immediately prior to the close of business on the Trading Day
                   prior to the Ex-Dividend Trading Day for such distribution by
                   adjustment factor equal to a fraction:

                            (A) the numerator of which shall be equal to the
                      Current Market Price of the Common Stock; and

                            (B) the denominator of which shall be equal to (a)
                      the Current Market Price of the Common Stock minus (b) the
                      quotient of (i) the aggregate amount of all the Repurchase
                      Premiums paid in connection with such repurchases and (ii)
                      the number of shares of Common Stock outstanding on the
                      day immediately following the date of the repurchase
                      triggering the adjustment, as determined by the Board of
                      Directors of the Company;

provided that no adjustment to the Conversion Rate shall be made to the extent
the Conversion Rate is not increased as a result of the above calculation; and
provided, further, that the repurchases of Common Stock effected by the Company
or its agent in conformity with Rule 10b-18 under the Exchange Act will not be
included in any adjustment to the Conversion Rate made pursuant to this Section
6.5(a)(8).

                  If a payment by the Company shall cause an adjustment to the
Conversion Rate under both clause (7) and clause (8) of this Section 6.5(a), the
provisions of Section 6.5(a)(8) shall control.

                   (b) No Adjustment. For the avoidance of doubt, no adjustment
in the Conversion Rate shall be required:

                   (1) upon the issuance of (A) any shares of Common Stock or
         (B) options, warrants or other rights to acquire Common Stock
         (including the issuance of Common Stock pursuant to such options,
         warrants or other rights), in any transaction resulting in an exchange
         for Fair Market Value, including in connection with a reduction of
         indebtedness or liabilities of the Company or its Subsidiaries
         including, without limitation, upon the conversion of convertible
         securities of the Company outstanding on the date the Notes were issued
         or pursuant to settlements with respect to claims related to any
         governmental or private litigation, dispute, investigation, proceeding
         or other similar action or pursuant to a strategic partnership or
         licensing agreement;

                                       44
<PAGE>

                   (2) upon the issuance of any shares of Common Stock pursuant
         to any present or future plan or similar arrangement providing for the
         reinvestment of dividends or interest payable on the Company's
         securities and the investment of additional optional amounts in shares
         of Common Stock under any such plan or arrangement in each case, at the
         market price at the time of such investment in Common Stock;

                   (3) upon the issuance of any shares of Common Stock or
         options or rights to purchase such shares pursuant to any present or
         future employee, director or consultant benefit plan or program,
         compensation agreement, or similar arrangement of, or assumed by, the
         Company or any of its Subsidiaries;

                   (4) upon the issuance of any shares of Common Stock pursuant
         to any option, warrant, right or exercisable, exchangeable or
         convertible security not described in clause (3) of this Section 6.5(b)
         and outstanding as of the date the Notes were first issued;

                   (5) for a change in the par value of the Common Stock; or

                   (6) for accrued and unpaid interest, if any.

                  In addition, the Company will not be required to make an
adjustment in the Conversion Rate unless the adjustment would require a change
of at least 1% in the Conversion Rate. The Company shall carry forward any
adjustment that is less than 1% of the Conversion Rate, take such
carried-forward adjustments into account in any subsequent adjustments, and make
such carried-forward adjustments, regardless of whether the aggregate adjustment
is less than 1%, (a) annually on the anniversary of the first date of issue of
the Notes and (b) otherwise (1) five Business Days prior to the Stated Maturity
of the Notes or (2) prior to any Redemption Date or Fundamental Change
Repurchase Date, unless such adjustment has already been made.

                  No adjustment will be made to the Conversion Rate or a
Holder's ability to convert the Notes if such Holder otherwise participates in a
distribution without conversion.

                   (c) Increase in Conversion Rate due to Taxes. The Company may
make such increases in the Conversion Rate, for the remaining term of the Notes
or any shorter term, in addition to those required by clause (a) of this Section
6.5, as the Board of Directors of the Company considers to be advisable in order
to avoid or diminish any income tax to any holders of shares of Common Stock or
rights to purchase Common Stock resulting from any dividend or distribution of
stock or issuance of rights or warrants to purchase or subscribe for stock or
from any event treated as such for income tax purposes. The Company shall have
the power to resolve any ambiguity or correct any error in this clause (c) and
its actions in so doing shall, absent manifest error, be final and conclusive.

                   (d) Temporary Increase in Conversion Rate. To the extent
permitted by applicable law, the Company from time to time may increase the
Conversion Rate by any amount for any period of time if the period is at least
twenty Business Days, the increase is irrevocable during such period, and the
Company's Board of Directors shall have made a determination that such increase
would be in the best interests of the Company, which determination shall be
conclusive; provided, however, that no such increase shall be taken into account
for purposes of determining whether the closing price of the Common Stock equals
or exceeds 105% of the Conversion Price in connection with an event which would
otherwise be a Fundamental Change. Whenever the Conversion Rate is increased
pursuant to the preceding sentence, the Company shall give notice of the
increase to the Holders in the manner provided in Section 11.2, with a copy to
the Trustee and Conversion Agent, at least fifteen (15) days prior to the date
the increased Conversion Rate takes effect, and such notice shall state the
increased Conversion Rate and the period during which it will be in effect.

                                       45
<PAGE>

                   (e) Fundamental Change Make-Whole Adjustment. In case of a
Fundamental Change as specified in clauses (2) or (3) of the definition thereof,
solely upon receipt by the Conversion Agent of any Holder's Conversion Notice on
or after the Effective Date of the Fundamental Change and prior to the 45th day
following such Effective Date (or, if earlier and to the extent applicable, the
close of business on the second Business Day immediately preceding the
Fundamental Change Repurchase Date (as specified in the Fundamental Change
Repurchase Right Notice)), the Company shall increase the Conversion Rate for
the Notes surrendered for conversion by such Holder by the number of Additional
Shares determined in accordance with this Section 6.5(e); provided, however,
that no increase shall be made in the case of a Fundamental Change if at least
90% of the consideration paid for the Common Stock (excluding cash payments for
fractional shares and cash payments made pursuant to dissenters' appraisal
rights) in such Fundamental Change transaction consists of shares of Capital
Stock traded on NASDAQ, the NYSE or another U.S. national securities exchange or
quoted on an established automated over-the-counter trading market in the United
States (or that will be so traded or quoted immediately following the
transaction) and as a result of such transaction or transactions the Notes
become convertible solely into such common stock. The number of Additional
Shares will be determined by reference to the table below.

                  The following table sets forth the number of Additional Shares
issuable per $1,000 initial principal amount of Notes as a result of a
Fundamental Change that occurs in the corresponding period:

<TABLE>
<CAPTION>
------------------------------------------------------------------------------------------------------------------------
                                                       STOCK PRICE
------------------------------------------------------------------------------------------------------------------------
 EFFECTIVE DATE OF    $7.64  $8.00  $8.50  $9.00  $9.50  $10.00  $10.50  $11.00  $11.50  $12.00  $15.00  $20.00  $25.00
 FUNDAMENTAL CHANGE
------------------------------------------------------------------------------------------------------------------------
<S>                    <C>    <C>    <C>    <C>    <C>     <C>     <C>     <C>     <C>     <C>      <C>     <C>     <C>
    MAY 23, 2006       26.2   23.8   21.0   18.6   16.6    15.0    13.5    12.3    11.3    10.4     6.9     4.5     3.4
------------------------------------------------------------------------------------------------------------------------
    JUNE 1, 2007       25.2   22.6   19.5   17.0   14.9    13.1    11.6    10.3     9.2     8.3     5.1     3.1     2.3
------------------------------------------------------------------------------------------------------------------------
    JUNE 1, 2008       24.6   21.9   18.6   15.7   13.4    11.4     9.7     8.3     7.1     6.1     2.9     1.6     1.2
------------------------------------------------------------------------------------------------------------------------
    JUNE 1, 2009       24.4   21.5   18.1   15.2   12.7    10.5     8.5     6.9     5.3     4.0     0.1     0.0     0.0
------------------------------------------------------------------------------------------------------------------------
    JUNE 1, 2010       24.1   21.0   17.5   14.5   12.0     9.9     8.0     6.4     5.0     3.7     0.1     0.0     0.0
------------------------------------------------------------------------------------------------------------------------
    JUNE 1, 2011       23.6   20.2   16.4   13.3   10.8     8.8     7.0     5.6     4.3     3.2     0.1     0.0     0.0
------------------------------------------------------------------------------------------------------------------------
    JUNE 1, 2012       23.2   19.1   14.5   11.0    8.4     6.4     4.9     3.8     2.8     2.0     0.0     0.0     0.0
------------------------------------------------------------------------------------------------------------------------
    JUNE 1, 2013        0.0    0.0    0.0    0.0    0.0     0.0     0.0     0.0     0.0     0.0     0.0     0.0     0.0
------------------------------------------------------------------------------------------------------------------------
</TABLE>

The Stock Prices and Additional Share amounts set forth above are based upon a
closing sale price of $7.64 on May 17, 2006 and an initial Conversion Rate of
104.7120 share of Common Sock per $1,000 in principal amount of Notes, which is
equal to an initial Conversion Price of $9.55. The Stock Prices set forth in the
first row of the table above shall be adjusted as of any date on which the
Conversion Rate of the Notes is adjusted in accordance with Section 6.5 hereof.
The adjusted Stock Prices shall equal the Stock Prices applicable immediately
prior to such adjustment, multiplied by an adjustment factor equal to a
fraction, the numerator of which is the Conversion Rate immediately prior to the
adjustment giving rise to the Stock Price adjustment and the denominator of
which is the Conversion Rate as so adjusted. The number of Additional Shares
shall be adjusted in the same manner and for the same events as the Conversion
Rate as set forth in Section 6.5 hereof.

                                       46
<PAGE>

The exact Stock Price and Conversion Dates may not be set forth on the table; in
which case, if:

                   (A) the Stock Price is between two Stock Price amounts on the
         table or the Conversion Date is between two dates on the table, the
         number of Additional Shares will be determined by straight-line
         interpolation between the number of Additional Shares set forth for the
         higher and lower stock price amounts and the two dates, as applicable,
         based on a 365-day year;

                   (B) the Stock Price is more than $25.00 per share (subject to
         adjustment), no further adjustment will be made to the Conversion Rate
         as a result of the Fundamental Change; and

                   (C) the Stock Price is less than $7.64 per share (subject to
         adjustment), no further adjustment will be made to the Conversion Rate
         as a result of the Fundamental Change.

         Notwithstanding the foregoing, in no event shall the total number of
shares of Common Stock issuable upon conversion of a Note exceed 130.8901 per
$1,000 initial principal amount of the Notes, subject to proportional adjustment
in the same manner as the Conversion Rate as set forth in Section 6.5(a) hereof.

         SECTION 6.6. Notice of Adjustments of Conversion Rate.

         Whenever the Conversion Rate is adjusted pursuant to Section 6.5
hereof:

         (a) the Company shall compute the adjusted Conversion Rate in
accordance with Section 6.5 hereof and shall prepare an Officer's Certificate
setting forth (1) the adjusted Conversion Rate, (2) the clause of Section 6.5
pursuant to which such adjustment has been made, showing in reasonable detail
the facts upon which such adjustment is based, (3) the calculation of such
adjustment and (4) the date as of which such adjustment is effective, and such
certificate shall promptly be filed with the Trustee and with each Conversion
Agent (which such certificates shall be conclusive absent manifest error); and

         (b) upon each such adjustment, a notice stating that the Conversion
Rate has been adjusted and setting forth the adjusted Conversion Rate shall be
required, and as soon as practicable after it is required, such notice shall be
provided by the Company to all Holders in accordance with Section 11.2.

                                       47
<PAGE>

         Neither the Trustee nor any Conversion Agent shall be under any duty or
responsibility with respect to any such certificate or the information and
calculations contained therein, except to exhibit the same to any Holder of
Notes desiring inspection thereof at its office during normal business hours.

         SECTION 6.7. Cancellation of Converted Notes.

         All Definitive Notes delivered for conversion shall be delivered to the
Trustee or its agent to be canceled by or at the direction of the Trustee, which
shall dispose of the same as provided in this Indenture. Upon conversions of
beneficial interests in any Global Note, the Trustee or the Notes Custodian, at
the direction of the Trustee, shall reduce the aggregate principal amount of
outstanding Notes represented by such Global Note to reflect the conversion
pursuant to Section 2.1(b).

         SECTION 6.8. Provision in Case of Consolidation, Merger or Sale of
Assets.

         In the case of any consolidation or merger of the Company with or into
any other Person, any merger of another Person with or into the Company (other
than a merger that does not result in any reclassification, conversion, exchange
or cancellation of outstanding shares of Common Stock of the Company) or any
conveyance, sale or transfer of all or substantially all of the assets of the
Company or other transaction that causes the Common Stock to be converted into
the right to receive other securities, cash or property, the Person formed by
such consolidation or resulting from such merger or which acquires such assets,
as the case may be, shall execute and deliver to the Trustee a supplemental
indenture providing that the Holder of each Note then outstanding shall have the
right thereafter, during the period such Note shall be convertible as specified
in Section 6.1 to convert such Note only into the kind and amount of securities,
cash and other property receivable upon such consolidation, merger, conveyance,
sale or transfer by a holder of the number of shares of Common Stock of the
Company into which such Note might have been converted immediately prior to such
consolidation, merger, conveyance, sale or transfer. For purposes of this
Section 6.8, the kind and amount of consideration that a Holder would have been
entitled to receive as a Holder of the Common Stock in the case of
consolidations, mergers, conveyances, sales or transfers of assets or other
transactions that cause the Common Stock to be converted into the right to
receive more than a single type of consideration (determined based in part upon
any form of stockholder election) will be deemed to be the weighted average of
the kind and amount of consideration received by the Holders of the Common Stock
that affirmatively make such an election. The above provisions of this Section
6.8 shall similarly apply to successive consolidations, mergers, conveyances,
sales, transfers or leases. Notice of the execution of such a supplemental
indenture shall be given by the Company to the Holder of each Note as provided
in Section 11.2 promptly upon such execution.

         Neither the Trustee nor any Conversion Agent shall be under any
responsibility to determine the correctness of any provisions contained in any
such supplemental indenture relating either to the kind or amount of shares of
stock or other securities or property or cash receivable by Holders of Notes
upon the conversion of their Notes after any such consolidation, merger,
conveyance, transfer, sale or lease or to any such adjustment, but may accept as
conclusive evidence of the correctness of any such provisions, and shall be
protected in relying upon, an Officers' Certificate and an Opinion of Counsel
with respect thereto, which the Company shall cause to be furnished to the
Trustee.

                                       48
<PAGE>

         SECTION 6.9. Rights Issued in Respect of Common Stock.

         Rights or warrants distributed by the Company to all holders of Common
Stock entitling the holders thereof to subscribe for or purchase shares of the
Company's Capital Stock (either initially or under certain circumstances), which
rights or warrants, until the occurrence of a specified event or events
("Trigger Event"):

         (1) are deemed to be transferred with such shares of Common Stock;

         (2) are not exercisable; and

         (3) are also issued in respect of future issuances of Common Stock,

shall not be deemed distributed for purposes of Section 6.5(a) until the
occurrence of the earliest Trigger Event. In addition, in the event of any
distribution of rights or warrants, or any Trigger Event with respect thereto,
that shall have resulted in an adjustment to the Conversion Rate under Section
6.5(a), (A) in the case of any such rights or warrants that shall all have been
redeemed or repurchased without exercise by any holders thereof, the Conversion
Rate shall be readjusted upon such final redemption or repurchase to give effect
to such distribution or Trigger Event, as the case may be, as though it were a
cash distribution, equal to the per share redemption or repurchase price
received by a holder of Common Stock with respect to such rights or warrants
(assuming such holder had retained such rights or warrants), made to all holders
of Common Stock as of the date of such redemption or repurchase, and (B) in the
case of any such rights or warrants all of which shall have expired without
exercise by any holder thereof, the Conversion Rate shall be readjusted as if
such issuance had not occurred.

         SECTION 6.10. Responsibility of Trustee and Conversion Agent for
Conversion Provisions.

                  The Trustee and any Conversion Agent shall not at any time be
under any duty or responsibility to any Holder of Notes to determine whether any
facts exist which may require any adjustment of the Conversion Rate, or with
respect to the nature or extent of any such adjustment when made, or with
respect to the method employed, herein or in any supplemental indenture provided
to be employed, in making the same, or whether a supplemental indenture need be
entered into. Neither the Trustee nor any Conversion Agent shall be accountable
with respect to the validity or value (or the kind or amount) of any Common
Stock, or of any other securities or property or cash, which may at any time be
issued or delivered upon the conversion of any Note; and it or they do not make
any representation with respect thereto. Neither the Trustee nor any Conversion
Agent shall be responsible for any failure of the Company to make or calculate
any cash payment or to issue, transfer or deliver any shares of Common Stock or
share certificates or other securities or property or cash upon the surrender of
any Note for the purpose of conversion; and the Trustee and any Conversion Agent
shall not be responsible for any failure of the Company to comply with any of
the covenants of the Company contained in this Article VI.

                                       49
<PAGE>

                                  ARTICLE VII

                              DEFAULTS AND REMEDIES

                  SECTION 7.1. Events of Default.

                  Each of the following is an "Event of Default":

                  (1) a default in the payment of any installment of interest
         upon any of the Notes as and when the same shall become due and
         payable, and continuance of such default for a period of 30 days;

                  (2) a default in the payment of all or any part of the
         principal of any of the Notes as and when the same shall become due and
         payable;

                  (3) a default on the part of the Company in the performance,
         or breach by the Company, of any other covenant or agreement on the
         part of the Company set forth in the Notes or in this Indenture (other
         than a covenant or agreement in respect of which a default or breach by
         the Company is specifically dealt with in this Section 7.1), and
         continuance of such default or breach without cure or waiver for a
         period of 60 days after there has been given, by registered or
         certified mail, to the Company by the Trustee, or to the Company and
         the Trustee by the Holders of at least 25% in principal amount of the
         Notes at the time Outstanding, a written notice specifying such failure
         and requiring the same to be remedied;

                  (4) the Company fails to pay the purchase price of any Note
         when due (including, without limitation, on any Fundamental Change
         Repurchase Date);

                  (5) the Company fails to deliver shares of Common Stock or any
         cash in lieu of fractional shares upon conversion of Notes within the
         time period required by this Indenture and this failure continues for 5
         business days;

                  (6) the Company fails to timely provide the Fundamental Change
         Repurchase Right Notice, if required by this Indenture and such failure
         continues for 30 days;

                  (7) any indebtedness for money borrowed by the Company or one
         of its Significant Subsidiaries in an aggregate outstanding principal
         amount in excess of $25.0 million is not paid at final maturity or upon
         acceleration and such indebtedness is not discharged, or such
         acceleration is not cured or rescinded, within 10 days after written
         notice specifying such failure;

                  (8) a failure by the Company or any of its Significant
         Subsidiaries to pay final and non-appealable judgments entered by a
         court or courts of competent jurisdiction, the aggregate uninsured or
         unbonded portion of which is at least $25.0 million, if the judgments
         are not paid, discharged or stayed within 60 days;

                  (9) the Company or any of its Significant Subsidiaries
         pursuant to or within the meaning of Bankruptcy Law:

                                       50
<PAGE>

                      (A) commences a voluntary case,

                      (B) consents to the entry of an order for relief against
                   it in an involuntary case,

                      (C) consents to the appointment of a custodian of it or
                   for all or substantially all of its property, or

                      (D) makes a general assignment for the benefit of its
                   creditors; and

                   (10) a court of competent jurisdiction enters an order or
decree under any Bankruptcy Law that:

                      (A) is for relief against the Company or any of its
                   Significant Subsidiaries in an involuntary case;

                      (B) appoints a custodian of the Company or any of its
                   Significant Subsidiaries or for all or substantially all of
                   the property of the Company or any of its Significant
                   Subsidiaries; or

                      (C) orders the liquidation of the Company or any of its
                   Significant Subsidiaries and the order or decree remains
                   unstayed and in effect for 90 consecutive days.

                   SECTION 7.2. Acceleration.

                  (1) In the case of an Event of Default specified in clause (9)
or (10) of Section 7.1 hereof with respect to the Company, then the principal
of, and accrued interest on, all outstanding Notes will become due and payable
immediately without further action or notice. If any other Event of Default
occurs and is continuing, the Trustee or the Holders of at least 25% in
aggregate principal amount of the then outstanding Notes may declare all the
Notes to be due and payable immediately. Upon any such declaration, the Notes
shall become due and payable immediately.

                  (2) Notwithstanding the foregoing, if an Event of Default
specified in clause (7) of Section 7.1 occurs resulting in a declaration of
acceleration of the Notes, such declaration of acceleration shall be
automatically annulled if such Event of Default triggering such declaration of
acceleration pursuant to clause (7) of Section 7.1 shall have been remedied or
cured by the Company or any of its Subsidiaries or waived by the holders of the
relevant indebtedness within 60 days of the declaration of acceleration with
respect thereto and if (i) the annulment of the acceleration of the Notes would
not conflict with any judgment or decree of a court of competent jurisdiction
and (ii) all existing Events of Default, except nonpayment of principal or
interest on the Notes that became due and payable solely because of the
acceleration of the Notes, have been cured or waived.

                  (3) At any time after a declaration of acceleration with
respect to the Notes as described in Section 7.1, the Holders of a majority in
aggregate principal amount of the outstanding Notes may rescind and annul such
declaration and its consequences: (i) if the rescission would not conflict with
any judgment or decree of a court of competent jurisdiction; (ii) if all
existing Events of Default have been cured or waived except nonpayment of
principal or interest that has become due solely because of the acceleration;
(iii) to the extent the payment of such interest is lawful, interest on overdue
installments of interest and overdue principal, which has become due otherwise
than by such declaration of acceleration, has been paid; and (iv) if the Company
has paid the Trustee its reasonable compensation and reimbursed the Trustee for
its expenses, disbursements and advances. No such rescission shall affect any
subsequent Default or impair any right consequent thereto.

                                       51
<PAGE>

                   SECTION 7.3. Other Remedies.

                  If an Event of Default occurs and is continuing, the Trustee
may pursue any available remedy to collect the payment of principal and interest
on the Notes or to enforce the performance of any provision of the Notes or this
Indenture.

                  The Trustee may maintain a proceeding even if it does not
possess any of the Notes or does not produce any of them in the proceeding. A
delay or omission by the Trustee or any Holder of a Note in exercising any right
or remedy accruing upon an Event of Default shall not impair the right or remedy
or constitute a waiver of or acquiescence in the Event of Default. All remedies
are cumulative to the extent permitted by law.

                   SECTION 7.4. Control by Majority.

                  Holders of a majority in aggregate principal amount of the
then outstanding Notes may direct the time, method and place of conducting any
proceeding for exercising any remedy available to the Trustee or exercising any
trust or power conferred on it. However, the Trustee may refuse to follow any
direction (and the Holders shall have no right to give any direction) that
conflicts with law or this Indenture, that the Trustee determines may be unduly
prejudicial to the rights of other Holders of Notes, or that may involve the
Trustee in personal liability or affect its indemnification.

                   SECTION 7.5. Limitation on Suits.

                  No Holder will have any right to institute any proceeding
under the Indenture or for the appointment of a receiver or a trustee, or for
any other remedy under this Indenture or the Notes unless:

                   (a) such Holder has previously given to the Trustee written
notice that an Event of Default is continuing;

                   (b) Holders of at least 25% in aggregate principal amount of
the then outstanding Notes make a written request to the Trustee to pursue the
remedy as Trustee;

                   (c) such Holders of 25% in aggregate principal amount of the
outstanding Notes have offered and, if requested, provided to the Trustee
security or indemnity reasonably satisfactory to the Trustee against any loss,
liability or expense to institute such proceeding or seek the appointment of a
receiver or trustee;

                                       52
<PAGE>

                   (d) the Trustee has failed to institute such proceeding
within 60 days after receipt of the notice, request and offer of security or
indemnity; and

                   (e) during such 60-day period, Holders of a majority in
aggregate principal amount of the then outstanding Notes do not give the Trustee
a direction inconsistent with such request.

                  A Holder of a Note may not use this Indenture to prejudice the
rights of another Holder of a Note or to obtain a preference or priority over
another Holder of a Note.

                   SECTION 7.6. Rights of Holders of Notes To Receive Payment or
Effect Conversion.

                  Notwithstanding any other provision of this Indenture, the
right of any Holder of a Note to receive payment of principal and interest on
the Note, on or after the respective due dates expressed in the Note (including
in connection with an offer to purchase), or to bring suit for the enforcement
of any such payment on or after such respective dates or the right to convert
Notes in accordance with Article VI of this Indenture, shall not be impaired or
affected without the consent of such Holder or limited by Section 7.5 of this
Indenture.

                   SECTION 7.7. Collection Suit by Trustee.

                  If an Event of Default specified in Section 7.1 hereof occurs
and is continuing, the Trustee is authorized to recover judgment in its own name
and as trustee of an express trust against the Company for the whole amount of
principal of and interest remaining unpaid on the Notes, interest on overdue
principal and, to the extent lawful, interest and such further amount as shall
be sufficient to cover the costs and expenses of collection, including the
reasonable compensation, expenses, disbursements and advances of the Trustee,
its agents and counsel.

                   SECTION 7.8. Trustee May File Proofs of Claim.

                  The Trustee is authorized to file such proofs of claim and
other papers or documents as may be necessary or advisable in order to have the
claims of the Trustee (including any claim for the reasonable compensation,
expenses, disbursements and advances of the Trustee, its agents and counsel) and
the Holders of the Notes allowed in any judicial proceedings relative to the
Company (or any other obligor upon the Notes), its creditors or its property and
shall be entitled and empowered to collect, receive and distribute any money or
other property payable or deliverable on any such claims and any custodian in
any such judicial proceeding is hereby authorized by each Holder to make such
payments to the Trustee, and in the event that the Trustee shall consent to the
making of such payments directly to the Holders, to pay to the Trustee any
amount due to it for the reasonable compensation, expenses, disbursements and
advances of the Trustee, its agents and counsel, and any other amounts due the
Trustee under Section 8.7. To the extent that the payment of any such
compensation, expenses, disbursements and advances of the Trustee, its agents
and counsel, and any other amounts due the Trustee under Section 8.7 out of the
estate in any such proceeding, shall be denied for any reason, payment of the
same shall be secured by a lien on, and shall be paid out of, any and all
distributions, dividends, money, securities and other properties that the
Holders may be entitled to receive in such proceeding whether in liquidation or
under any plan of reorganization or arrangement or otherwise. Nothing contained
in this Section 7.8 shall be deemed to authorize the Trustee to authorize or
consent to or accept or adopt on behalf of any Holder any plan of
reorganization, arrangement, adjustment or composition affecting the Notes or
the rights of any Holder, or to authorize the Trustee to vote in respect of the
claim of any Holder in any such proceeding.

                                       53
<PAGE>

                   SECTION 7.9. Priorities.

                  If the Trustee collects any money after exercise of any remedy
available to it pursuant to this Article VII, it shall pay out the money in the
following order:

                  First: to the Trustee, its agents and attorneys for amounts
due under Section 8.7, including payment of all compensation, expenses and
liabilities incurred, and all advances made, by the Trustee and the costs and
expenses of collection;

                   Second: to Holders of Notes for amounts due and unpaid on the
Notes for principal and interest, ratably, without preference or priority of any
kind, according to the amounts due and payable on the Notes for principal and
interest, respectively; and

                   Third: to the Company or such party as a court of competent
jurisdiction shall direct.

                  The Trustee may fix a record date and payment date for any
payment to Holders of Notes pursuant to this Section 7.9. If a record date is
fixed, the Trustee shall send, by first class mail, electronically or by any
other means approved by the Trustee to the Holders of the Notes of record a
notice at least 30 days but not more than 60 days before the payment date. Such
notice shall state: (1) that a payment is being made pursuant to this Section
7.9, (2) the relevant Default and the circumstances giving rise to the
collection of money pursuant to this Section 7.9, (3) the payment date and (4)
the amount of such payment per $1,000 of Notes.

                   SECTION 7.10. Undertaking for Costs.

                  In any suit for the enforcement of any right or remedy under
this Indenture or in any suit against the Trustee for any action taken or
omitted by it as a Trustee, a court in its discretion may require the filing by
any party litigant in the suit of an undertaking to pay the costs of the suit,
and the court in its discretion may assess reasonable costs, including
reasonable attorneys' fees, against any party litigant in the suit, having due
regard to the merits and good faith of the claims or defenses made by the party
litigant. This Section 7.10 does not apply to a suit by the Trustee, a suit by a
Holder of a Note pursuant to Section 7.6 hereof, or a suit by Holders of more
than 10% in aggregate principal amount of the then outstanding Notes.

                                  ARTICLE VIII

                                     TRUSTEE

                   SECTION 8.1. Duties of Trustee.

                   (a) If an Event of Default has occurred and is continuing,
the Trustee shall exercise the rights and powers vested in it by this Indenture
and use the same degree of care and skill in its exercise as a prudent Person
would exercise or use under the circumstances in the conduct of such Person's
own affairs; provided, unless expressly prohibited by the TIA, that if an Event
of Default occurs and is continuing, the Trustee will be under no obligation to
exercise any of the rights or powers under this Indenture at the request or
direction of any of the Holders unless such Holders have provided the Trustee
indemnity or security reasonably satisfactory to the Trustee against loss,
liability or expense.

                                       54
<PAGE>

                   (b) Except during the continuance of an Event of Default:

                       (i) the Trustee undertakes to perform such duties and
                   only such duties as are specifically set forth in this
                   Indenture and no implied covenants or obligations shall be
                   read into this Indenture against the Trustee; and

                       (ii) in the absence of bad faith on its part, the Trustee
                   may conclusively rely, as to the truth of the statements and
                   the correctness of the opinions expressed therein, upon
                   certificates, directions, notices or opinions furnished to
                   the Trustee. However, in the case of any such certificates,
                   directions, notices or opinions which by any provisions
                   hereof are specifically required to be furnished to the
                   Trustee, the Trustee shall examine such certificates and
                   opinions to determine whether or not they conform to the
                   requirements of this Indenture (but need not confirm or
                   investigate the accuracy of mathematical calculations or
                   other facts stated therein).

                   (c) The Trustee may not be relieved from liability for its
own negligent action, its own negligent failure to act or its own willful
misconduct, except that:

                       (i) this paragraph does not limit the effect of paragraph
                   (b) of this Section;

                       (ii) the Trustee shall not be liable for any error of
                   judgment made in good faith by a Responsible Officer unless
                   it is proved that the Trustee was negligent in ascertaining
                   the pertinent facts; and

                       (iii) the Trustee shall not be liable with respect to any
                   action it takes or omits to take in good faith in accordance
                   with a direction received by it pursuant to Section 7.4.

                   (d) The Trustee shall not be liable for interest on any money
received by it except as the Trustee may agree in writing with the Company.

                   (e) Money held in trust by the Trustee need not be segregated
from other funds except to the extent required by law.

                   (f) No provision of this Indenture shall require the Trustee
to expend or risk its own funds or otherwise incur any financial liability in
the performance of any of its duties hereunder or in the exercise of any of its
rights or powers, if it shall have reasonable grounds to believe that repayment
of such funds or adequate indemnity against such risk or liability is not
reasonably assured to it.

                                       55
<PAGE>

                   (g) Every provision of this Indenture relating to the conduct
or affecting the liability of or affording protection to the Trustee shall be
subject to the provisions of this Section 8.1 and to the provisions of the TIA.

                   (h) The Trustee shall be under no obligation to exercise any
of the rights or powers vested in it by this Indenture at the request or
direction of any of the Holders unless such Holders shall have provided to the
Trustee security or indemnity reasonably satisfactory to it against the costs,
expenses (including reasonable attorneys' fees and expenses) and liabilities
that might be incurred by it in compliance with such request or direction.

                   SECTION 8.2. Rights of Trustee.

                   (a) The Trustee may conclusively rely and shall be protected
in acting or refraining from acting upon any paper or document believed by it to
be genuine and to have been signed or presented by the proper Person or Persons.
The Trustee need not investigate any fact or matter stated in any such document.

                   (b) Before the Trustee acts or refrains from acting, it may
require an Officers' Certificate or an Opinion of Counsel. The Trustee shall not
be liable for any action it takes or omits to take in good faith in reliance on
the Officers' Certificate or Opinion of Counsel.

                   (c) The Trustee may act through its attorneys and agents and
shall not be responsible for the misconduct or negligence of any attorney or
agent appointed with due care.

                   (d) The Trustee shall not be liable for any action it takes
or omits to take in good faith which it believes to be authorized or within its
rights or powers; provided, however, that the Trustee's conduct does not
constitute willful misconduct or negligence.

                   (e) The Trustee may consult with counsel of its selection,
and the advice or opinion of such counsel appointed with due care with respect
to legal matters relating to this Indenture and the Notes shall be full and
complete authorization and protection from liability in respect to any action
taken, omitted or suffered by it hereunder in good faith and in accordance with
the advice or opinion of such counsel.

                   (f) The Trustee shall not be bound to make any investigation
into the facts or matters stated in any resolution, certificate, statement,
instrument, opinion, notice, request, direction, consent, order, bond or other
paper or document; but the Trustee, in its discretion, may make such further
inquiry or investigation into such facts or matters as it may see fit and, if
the Trustee shall determine to make such further inquiry or investigation, it
shall be entitled to examine the books, records and premises of the Company at
reasonable times, in a reasonable manner and upon reasonable advance notice,
personally or by agent or attorney at the sole cost of the Company and shall
incur no liability or additional liability of any kind by reason of such inquiry
or investigation.

                   (g) The Trustee shall not be deemed to have knowledge of any
Default or Event of Default except, (i) during any period it is serving as
Registrar and Paying Agent for the Notes, any Event of Default occurring
pursuant to Sections 7.1(1), 7.1(2), 7.1(4) or 7.1(5) or (ii) any Default or
Event of Default of which a Responsible Officer shall have received written
notification or obtained actual knowledge. The term "actual knowledge" shall
mean the actual fact or statement of knowing by a Responsible Officer without
independent investigation with respect thereto.

                                       56
<PAGE>

                   (h) Delivery of the reports, information and documents to the
Trustee is for informational purposes only and the Trustee's receipt of such
shall not constitute constructive notice of any information contained therein or
determinable from information contained therein, including the Company's
compliance with any of its covenants hereunder (as to which the Trustee is
entitled to rely exclusively on Officers' Certificates).

                   (i) In no event shall the Trustee be responsible or liable
for special, indirect, or consequential loss or damage of any kind whatsoever
(including, but not limited to, loss of profit) irrespective of whether the
Trustee has been advised of the likelihood of such loss or damage and regardless
of the form of action.

                   (j) The rights, privileges, protections, immunities and
benefits given to the Trustee, including its right to be indemnified, are
extended to, and shall be enforceable by, the Trustee in each of its capacities
hereunder, and each agent, custodian and other Person employed to act hereunder.

                   (k) The Trustee may request that the Company deliver an
Officers' Certificate setting forth the names of individuals and/or titles of
officers authorized at such time to take specified actions pursuant to this
Indenture, which Officers' Certificate may be signed by any Person authorized to
sign an Officers' Certificate, including any Person specified as so authorized
in any such certificate previously delivered and not superseded.

                   SECTION 8.3. Individual Rights of Trustee. The Trustee in its
individual or any other capacity may become the owner or pledgee of Notes and
may otherwise deal with the Company or its Affiliates with the same rights it
would have if it were not Trustee. Any Paying Agent, Registrar, co-registrar or
co-paying agent may do the same with like rights. However, the Trustee must
comply with Sections 8.10 and 8.11. In addition, the Trustee shall be permitted
to engage in transactions with the Company; provided, however, that if the
Trustee acquires any conflicting interest (as such term is defined in Section
310(b) of the TIA) the Trustee must (i) eliminate such conflict within 90 days
of acquiring such conflicting interest, (ii) apply to the Commission for
permission to continue acting as Trustee or (iii) resign as Trustee hereunder.

                   SECTION 8.4. Trustee's Disclaimer. The Trustee shall not be
responsible for and makes no representation as to the validity or adequacy of
this Indenture or the Notes, it shall not be accountable for the Company's use
of the Notes or the proceeds from the Notes, and it shall not be responsible for
any statement of the Company in this Indenture or in any document issued or
offering circular (or similar document) used in connection with the sale of the
Notes or in the Notes other than the Trustee's certificate of authentication or
for the use or application of any funds received by any Paying Agent other than
the Trustee.

                   SECTION 8.5. Notice of Defaults. If a Default or Event of
Default occurs and is continuing and if a Responsible Officer has actual
knowledge thereof, the Trustee shall mail to each Holder notice of the Default
or Event of Default within 90 days after it occurs. Except in the case of a
Default or Event of Default in payment of principal of, or interest on any Note
(including payments pursuant to the required repurchase provisions of such Note,
if any), the Trustee may withhold the notice if and so long as its board of
directors, a committee of its board of directors or a committee of its
Responsible Officers and/or a Responsible Officer in good faith determines that
withholding the notice is in the interests of Holders.

                                       57
<PAGE>

                   SECTION 8.6. Reports by Trustee to Holders. As promptly as
practicable after each March 15 beginning with the March 15 following the date
of this Indenture, and in any event prior to December 15 in each year, the
Trustee shall mail to each Holder a brief report dated as of such March 15 that
complies with TIA ss. 313(a), if and to the extent such report may be required
by the TIA. The Trustee also shall comply with TIA ss. 313(b). The Trustee shall
also transmit by mail all reports required by TIA ss. 313(c).

                  A copy of each report at the time of its mailing to Holders
shall be filed with the Commission and each stock exchange (if any) on which the
Notes are listed. The Company agrees to notify promptly the Trustee in writing
whenever the Notes become listed on any stock exchange and of any delisting
thereof.

                   SECTION 8.7. Compensation and Indemnity. The Company
covenants and agrees: (a) to pay to the Trustee from time to time, and the
Trustee shall be entitled to such compensation for all services rendered by it
hereunder as shall be agreed by the Company and the Trustee in writing (which
shall not be limited by any provision of law in regard to the compensation of a
trustee of an express trust); (b) to reimburse the Trustee and each predecessor
Trustee upon its request for all reasonable expenses, fees, disbursements and
advances incurred or made by or on behalf of it in accordance with any of the
provisions of this Indenture (including the reasonable compensation, fees, and
the expenses and disbursements of its counsel and of all agents and other
Persons not regularly in its employ), except any such expense, disbursement or
advance as may arise from its negligence or bad faith; and (c) to indemnify the
Trustee and each predecessor Trustee for, and to hold it harmless against, any
loss, liability, damage, claim or expense, including taxes, if any (other than
taxes based upon, determined by or measured by the income of the Trustee),
incurred without negligence or bad faith on its part, arising out of or in
connection with the acceptance or administration of this Indenture or the trusts
hereunder and its duties hereunder, including enforcement of this Section 8.7.
The obligations of the Company under this Section to compensate and indemnify
the Trustee and each predecessor Trustee and to pay or reimburse the Trustee and
each predecessor Trustee for expenses, fees, disbursements and advances shall
constitute an additional obligation hereunder and shall survive the satisfaction
and discharge of this Indenture, the resignation or removal of the Trustee or
the termination of this Indenture. To secure the obligations of the Company to
the Trustee under this Section 8.7, the Trustee shall have a prior lien upon all
property and funds held or collected by the Trustee as such, except funds and
property paid by the Company and held in trust for the benefit of the Holders of
particular Notes.

                   SECTION 8.8. Replacement of Trustee. The Trustee may resign
at any time by so notifying the Company. The Holders of a majority in principal
amount of the Notes may remove the Trustee by so notifying the Company and the
Trustee in writing and the Company may appoint a successor Trustee. The Company
shall remove the Trustee if:

                                       58
<PAGE>

                       (i) the Trustee fails to comply with Section 8.10;

                       (ii) the Trustee is adjudged bankrupt or insolvent;

                       (iii) a receiver or other public officer takes charge of
                   the Trustee or its property; or

                       (iv) the Trustee otherwise becomes incapable of acting.

                  If the Trustee resigns or is removed by the Company or by the
Holders of a majority in principal amount of the Notes and the Company does not
reasonably promptly appoint a successor Trustee, or if a vacancy exists in the
office of Trustee for any reason (the Trustee in such event being referred to
herein as the retiring Trustee), the Holders of a majority in aggregate
principal amount of the Notes may appoint a successor Trustee.

                  A successor Trustee shall deliver a written acceptance of its
appointment to the retiring Trustee and to the Company. Thereupon the
resignation or removal of the retiring Trustee shall become effective, and the
successor Trustee shall have all the rights, powers and duties of the Trustee
under this Indenture. The successor Trustee shall mail a notice of its
succession to Holders. The retiring Trustee shall promptly transfer all property
held by it as Trustee to the successor Trustee, subject to the lien provided for
in Section 8.7.

                  If the Company has not appointed a successor Trustee within 60
days after the retiring Trustee resigns or is removed, the retiring Trustee or
the Holders of 10% in principal amount of the Notes may petition, at the expense
of the Company, any court of competent jurisdiction for the appointment of a
successor Trustee.

                  If the Trustee fails to comply with Section 8.10, unless the
Trustee's duty to resign is stayed as provided in TIA ss. 310(b), any Holder may
petition any court of competent jurisdiction for the removal of the Trustee and
the appointment of a successor Trustee.

                  Notwithstanding the replacement of the Trustee pursuant to
this Section 8.8, the Company's obligations under Section 8.7 shall continue for
the benefit of the retiring Trustee.

                   SECTION 8.9. Successor Trustee by Merger. If the Trustee
consolidates with, merges or converts into, or transfers all or substantially
all its corporate trust business or assets to, another corporation or banking
association, the resulting, surviving or transferee corporation without any
further act shall be the successor Trustee.

                  In case at the time such successor or successors by merger,
conversion or consolidation to the Trustee shall succeed to the trusts created
by this Indenture, any of the Notes shall have been authenticated but not
delivered, any such successor to the Trustee may adopt the certificate of
authentication of any predecessor trustee, and deliver such Notes so
authenticated; and in case at that time any of the Notes shall not have been
authenticated, any successor to the Trustee may authenticate such Notes either
in the name of any predecessor hereunder or in the name of the successor to the
Trustee; and in all such cases such certificates shall have the full force which
it is anywhere in the Notes or in this Indenture provided that the certificate
of the Trustee shall have.

                                       59
<PAGE>

                   SECTION 8.10. Eligibility; Disqualification. There shall at
all times be a Trustee hereunder which shall be eligible to act as Trustee under
Trust Indenture Act Sections 310(a)(1) and (2) and which shall have a combined
capital and surplus of at least $100,000,000, and have a an office in the
Borough of Manhattan in The City of New York, State of New York. If such
corporation publishes reports of condition at least annually, pursuant to law or
to the requirements of any federal, state, territorial or District of Columbia
supervising or examining authority, then for the purposes of this Section, the
combined capital and surplus of such corporation shall be deemed to be its
combined capital and surplus as set forth in its most recent report of condition
so published. If at any time the Trustee shall cease to be eligible in
accordance with the provisions of this Section, the Trustee shall resign
immediately in the manner and with the effect hereinafter specified in this
Article.

                   SECTION 8.11. Preferential Collection of Claims Against
Company. If and when the Trustee shall be or become a creditor of the Company,
the Trustee shall comply with TIA ss. 311(a), excluding any creditor
relationship listed in TIA ss. 311(b). A Trustee who has resigned or been
removed shall be subject to TIA ss. 311(a) to the extent indicated.

                                   ARTICLE IX

                    SATISFACTION AND DISCHARGE OF INDENTURE;
                                UNCLAIMED MONEYS

                   SECTION 9.1. Satisfaction and Discharge of Indenture. If at
any time (a) the Company shall have paid or caused to be paid the principal of
and interest on all the Notes outstanding (other than Notes which have been
destroyed, lost or stolen and which have been replaced or paid as provided in
Section 2.8) as and when the same shall have become due and payable, or (b) the
Company shall have delivered to the Trustee for cancellation all Notes
theretofore authenticated (other than Notes which have been destroyed, lost or
stolen and which have been replaced or paid as provided in Section 2.8); and if,
in any such case, the Company shall also pay or cause to be paid all other sums
payable hereunder by the Company, then this Indenture shall cease to be of
further effect, and the Trustee, on demand of the Company accompanied by an
Officers' Certificate and an Opinion of Counsel, each stating that all
conditions precedent relating to the satisfaction and discharge contemplated by
this provision have been complied with, and at the cost and expense of the
Company, shall execute proper instruments acknowledging such satisfaction and
discharging this Indenture. The Company agrees to reimburse the Trustee for any
costs or expenses thereafter reasonably and properly incurred, and to compensate
the Trustee for any services thereafter reasonably and properly rendered, by the
Trustee in connection with this Indenture or the Notes.

                                       60
<PAGE>

                  If at any time the exact amount described in clause (ii) below
can be determined at the time of making the deposit referred to in such clause
(ii), (i) all of the Notes not theretofore delivered to the Trustee for
cancellation shall have become due and payable, or are by their terms to become
due and payable within one year or are subject to redemption following the
Company's delivery of a Notice of Redemption under arrangements satisfactory to
the Trustee for the giving of notice of redemption, and (ii) (a) the Company
shall have irrevocably deposited or caused to be deposited with the Trustee as
funds in trust dedicated solely to the benefit of the Holders of the Notes, cash
in an amount or Government Securities, maturing as to principal and interest, if
any, at such times and in such amounts as will insure the availability of cash
or securities sufficient in the opinion of a nationally recognized firm of
independent public accountants expressed in a written certification thereof
delivered to the Trustee, to pay the principal of and interest, if any, on all
of the Notes on each date that such principal or interest, if any, is due and
payable in accordance with the terms of this Indenture and the Notes, and (b)
the Company has paid or caused to be paid all other sums payable hereunder by
the Company; then the Company shall be deemed to have paid and discharged the
entire indebtedness on all the Notes on the date of the deposit referred to in
this clause (ii), and the provisions of this Indenture with respect to the Notes
shall no longer be in effect (except as to (i) rights of registration of
transfer and exchange of Notes, (ii) substitution of mutilated, defaced,
destroyed, lost or stolen Notes, (iii) rights of Holders of Notes to receive
payments of principal thereof and interest, if any, thereon upon the original
stated due dates therefor (but not upon acceleration), (iv) the rights,
obligations, duties and immunities of the Trustee hereunder, (v) the rights of
the Holders of Notes as beneficiaries hereof with respect to the property so
deposited with the Trustee payable to all or any of them, (vi) rights of Holders
of Notes to convert the Notes pursuant to Article VI and (vii) the obligations
of the Company under Section 9.2 with respect to the Notes), and the Trustee, on
demand of the Company accompanied by an Officers' Certificate and an Opinion of
Counsel, each stating that all conditions precedent contemplated by this
provision have been complied with, and at the cost and expense of the Company,
shall execute proper instruments acknowledging such satisfaction and discharging
such indebtedness.

                   SECTION 9.2. Application by Trustee of Funds Deposited for
Payment of Notes. All moneys deposited with the Trustee or any Paying Agent
shall be held in trust and applied by it to the payment, either directly or
through any Paying Agent (other than the Company or any Subsidiary thereof), to
the Holders of the Notes for the payment or redemption of which such moneys have
been deposited with the Trustee, of all sums due and to become due thereon for
principal and interest, if any, but such money need not be segregated from other
funds except to the extent required by law.

                   SECTION 9.3. Repayment of Moneys Held by Paying Agent. In
connection with the satisfaction and discharge of this Indenture with respect to
the Notes, all moneys then held by any Paying Agent under the provisions of this
Indenture with respect to the Notes shall, upon demand of the Company, be repaid
to it and thereupon such Paying Agent shall be released from all further
liability with respect to such moneys.

                                       61
<PAGE>

                   SECTION 9.4. Return of Moneys Held by Trustee and Paying
Agent Unclaimed for Two Years. Any moneys deposited with or paid to the Trustee
or any Paying Agent for the payment of the principal of or interest, if any, on
the Notes and not applied but remaining unclaimed for two years after the date
upon which such principal or interest, if any, shall have become due and
payable, shall, upon the written request of the Company and unless otherwise
required by mandatory provisions of applicable escheat or abandoned or unclaimed
property law, be repaid to the Company by the Trustee or such Paying Agent, and
the Holder of the Notes shall, unless otherwise required by mandatory provisions
of applicable escheat or abandoned or unclaimed property laws, thereafter look
only to the Company for any payment which such Holder may be entitled to
collect, and all liability of the Trustee or any Paying Agent with respect to
such moneys shall thereupon cease; provided, however, that the Trustee or such
Paying Agent, before being required to make any such repayment with respect to
moneys deposited with it for any payment in respect of the Notes, shall, at the
expense of the Company, mail by first-class mail to Holders of the Notes at
their addresses as they shall appear on the Note register notice that such
moneys remain and that, after a date specified therein, which shall not be less
than 30 days from the date of such mailing or publication, any unclaimed balance
of such money then remaining will be repaid to the Company.

                   SECTION 9.5. Indemnity for U.S. Government Obligations. The
Company agrees to pay and indemnify the Trustee against any tax, fee or other
charge imposed on or assessed against the Government Securities deposited
pursuant to Section 9.1 or the principal or interest received in respect of such
obligations.

                                   ARTICLE X

                     SUPPLEMENTAL INDENTURES AND AMENDMENTS

                   SECTION 10.1. Without Consent of Holders. Without the consent
of any Holders, the Company, when authorized by a Board Resolution of the
Company, and the Trustee, at any time and from time to time, may amend, waive,
modify or supplement this Indenture or the Notes for any of the following
purposes:

                   (a) to cure any ambiguity, omission, defect or inconsistency;

                   (b) to provide for the assumption of the Company's
obligations under this Indenture and the Notes in accordance with Article IV;

                   (c) to secure the Notes or to provide guarantees of the
Notes;

                   (d) to comply with any requirements to effect or maintain the
qualification of this Indenture under the TIA;

                   (e) to add covenants that would benefit the Holders of the
Notes or to surrender any rights of the Company under this Indenture;

                   (f) to add Events of Default with respect to the Notes;

                   (g) to make any change that does not adversely affect any
outstanding Notes in any material respect;

                   (h) to evidence and provide for the acceptance of the
appointment of a successor Trustee hereunder; or

                   (i) to provide for the issuance of Additional Notes in
accordance with the limitations set forth in this Indenture as of the date
hereof.

                                       62
<PAGE>

                   SECTION 10.2. With Consent of Holders. With the written
consent of the Holders of not less than a majority in aggregate principal amount
of the Outstanding Notes (including, without limitation, Additional Notes, if
any) delivered to the Company and the Trustee, the Company when authorized by a
Board Resolution, together with the Trustee, may amend, waive (without notices
to Holders), modify or supplement any other provision of this Indenture or the
Notes; provided, however, that no such amendment, waiver, modification or
supplement may, without the written consent of the Holder of each Outstanding
Note:

                   (a) change the Stated Maturity or reduce the principal amount
of or interest on any Note;

                   (b) change the place or currency of payment of principal of
or interest on any Note;

                   (c) reduce the price or change the time at which Notes are
redeemed pursuant to Article V hereof;

                   (d) impair the right to institute suit for the enforcement of
any payment on any Note;

                   (e) modify the provisions with respect to a holder's rights
and the Company's obligation to repurchase Notes upon a Fundamental Change in a
manner adverse to Holders, including the Company's obligations to repurchase the
Notes following a Fundamental Change;

                   (f) adversely affect the right of Holders under the
conversion provisions of Article VI of this Indenture or the Notes;

                   (g) reduce the percentage in principal amount of outstanding
notes necessary for waiver of compliance with the provisions of this Indenture
under Section 10.2;

                   (h) modify provisions with respect to modification and waiver
(including waiver of Events of Default) that require each Holder's consent under
Section 10.2 of this Indenture;

                   (i) waive a Default or Event of Default in the payment of
principal or interest on the Notes, except as provided in this Indenture; or

                   (j) modify the ranking or priority of any Note in any manner
adverse to the Holders of the Notes.

                  Upon the written request of the Company accompanied by a copy
of a Board Resolution authorizing the execution of any such supplemental
indenture or other agreement, instrument or waiver, and upon the filing with the
Trustee of evidence of the consent of Holders as aforesaid, the Trustee shall
join with the Company in the execution of such supplemental indenture or other
agreement, instrument or waiver.

                  It shall not be necessary for any act of Holders under this
Section to approve the particular form of any proposed supplemental indenture or
other agreement, instrument or waiver, but it shall be sufficient if such act
shall approve the substance thereof.

                                       63
<PAGE>

                   SECTION 10.3. Execution of Supplemental Indentures,
Agreements and Waivers. In executing any supplemental indenture, agreement,
instrument or waiver permitted by this Article X or the modifications thereby of
the Indenture, the Trustee shall be entitled to receive, and (subject to Section
8.1 hereof) shall be fully protected in relying upon, an Opinion of Counsel and
an Officers' Certificate from each obligor under the Notes entering into such
supplemental indenture, agreement, instrument or waiver, each stating that the
execution of such supplemental indenture, agreement, instrument or waiver (a) is
authorized or permitted by this Indenture and (b) does not violate the
provisions of any agreement or instrument evidencing any other Indebtedness of
the Company, or any Subsidiary of the Company. Notwithstanding anything to the
contrary set forth in this Agreement, the Trustee may, but shall not be
obligated to, enter into any such supplemental indenture, agreement, instrument
or waiver which affects the Trustee's own rights, duties or immunities under
this Indenture, the Notes or otherwise.

                   SECTION 10.4. Effect of Supplemental Indentures. Upon the
execution of any supplemental indenture under this Article X, this Indenture and
the Notes, if applicable, shall be modified in accordance therewith, and such
supplemental indenture shall form a part of this Indenture and the Notes, if
applicable, as the case may be, for all purposes; and every Holder of Notes
theretofore or thereafter authenticated and delivered hereunder shall be bound
thereby.

                   SECTION 10.5. Compliance with Trust Indenture Act. Every
supplemental indenture or amendment to this Indenture or the Notes shall comply
with the TIA as then in effect.

                   SECTION 10.6. Reference in Notes to Supplemental Indentures.
Notes authenticated and delivered after the execution of any supplemental
indenture pursuant to this Article may, and shall if required by the Trustee,
bear a notation in a form approved by the Trustee as to any matter provided for
in such supplemental indenture. If the Company shall so determine, new Notes so
modified as to conform, in the opinion of the Trustee and the Board of Directors
of the Company, to any such supplemental indenture may be prepared and executed
by the Company and authenticated and delivered by the Trustee upon a Company
Order in exchange for Outstanding Notes.

                   SECTION 10.7. Revocation and Effect of Consents and Waivers.
A consent to an amendment or a waiver by a Holder of a Note shall bind the
Holder and every subsequent Holder of that Note or portion of the Note that
evidences the same debt as the consenting Holder's Note, even if notation of the
consent or waiver is not made on the Note. However, any such Holder or
subsequent Holder may revoke the consent or waiver as to such Holder's Note or
portion of the Note if the Trustee receives the notice of revocation before the
date the amendment or waiver becomes effective. After an amendment or waiver
becomes effective, it shall bind every Holder. An amendment or waiver made
pursuant to Section 10.2 shall become effective upon receipt by the Trustee of
the requisite number of written consents and, if applicable, execution by the
Trustee of such amendment or waiver.

                                       64
<PAGE>

                  The Company may, but shall not be obligated to, fix a record
date for the purpose of determining the Holders entitled to give their consent
or take any other action described above or required or permitted to be taken
pursuant to this Indenture. If a record date is fixed, then notwithstanding the
immediately preceding paragraph, those Persons who were Holders at such record
date (or their duly designated proxies), and only those Persons, shall be
entitled to give such consent or to revoke any consent previously given or to
take any such action, whether or not such Persons continue to be Holders after
such record date. No such consent shall become valid or effective more than 120
days after such record date.

                   SECTION 10.8. Notation on or Exchange of Notes. If an
amendment changes the terms of a Note, the Trustee may require the Holder of the
Note to deliver it to the Trustee. The Trustee may place an appropriate notation
on the Note regarding the changed terms and return it to the Holder.
Alternatively, if the Company or the Trustee so determines, the Company in
exchange for the Note shall issue and the Trustee shall authenticate a new Note
that reflects the changed terms. Failure to make the appropriate notation or to
issue a new Note shall not affect the validity of such amendment.

                                   ARTICLE XI

                                  MISCELLANEOUS

                   SECTION 11.1. Trust Indenture Act Controls. If any provision
of this Indenture limits, qualifies or conflicts with another provision which is
required to be included in this Indenture by the TIA, the provision required by
the TIA shall control.

                   SECTION 11.2. Notices. Any notice or communication shall be
in writing and delivered in person, by courier or facsimile or mailed by
first-class mail addressed as follows:

          If to the Company:

                  Enzon Pharmaceuticals, Inc.
                  685 Route 202/206
                  Bridgewater, New Jersey 08807
                  Attn:  Chief Financial Officer, with a copy to General Counsel
                  Facsimile: 908-575-9457 (Chief Financial Officer)
                             908-541-8838 (General Counsel)

          With copies to:

                  Weil, Gotshal & Manges LLP
                  767 Fifth Avenue
                  New York, NY 10153
                  Attn: Todd R. Chandler
                  Facsimile: 212-310-8007

     If to the Trustee:

                  Wilmington Trust Company
                  1100 North Market Street
                  Rodney Square North
                  Wilmington, Delaware 19890
                  Attention: Corporate Trust Administration

                                       65
<PAGE>

                  The Company on one hand or the Trustee on the other hand by
notice to the other may designate additional or different addresses for
subsequent notices or communications.

                  Any notice or communication mailed to a Holder shall be mailed
to the Holder at the Holder's address as it appears on the Note Register and
shall be sufficiently given if so mailed within the time prescribed. Notices
shall be deemed to have been given as of the date of mailing.

                  Failure to mail a notice or communication to a Holder or any
defect in it shall not affect its sufficiency with respect to other Holders. If
a notice or communication is mailed in the manner provided above, it is duly
given, whether or not the addressee receives it.

                   SECTION 11.3. Communication by Holders with Other Holders.
Holders may communicate pursuant to TIA ss. 312(b) with other Holders with
respect to their rights under this Indenture or the Notes. The Trustee shall
comply with TIA ss. 312(b). The Company, the Trustee, the Registrar and anyone
else shall have the protection of TIA ss. 312(c).

                   SECTION 11.4. Certificate and Opinion as to Conditions
Precedent. Upon any request or application by the Company to the Trustee to take
or refrain from taking any action under this Indenture, the Company shall
furnish to the Trustee such certificates and opinions as may be required under
the TIA. Each such certificate or opinion shall be given in the form of one or
more Officers' Certificates, if to be given by an Officer, or an Opinion of
Counsel, if to be given by counsel, and shall comply with the requirements of
the TIA and any other requirements set forth in this Indenture. Notwithstanding
the foregoing, in the case of any such request or application as to which the
furnishing of any Officers' Certificate or Opinion of Counsel is specifically
required by any provision of this Indenture relating to such particular request
or application, no additional certificate or opinion need be furnished.

                   SECTION 11.5. Statements Required in Certificate or Opinion.
Each certificate or opinion with respect to compliance with a covenant or
condition provided for in this Indenture shall include:

                   (1) a statement that the individual making such certificate
         or opinion has read such covenant or condition;

                   (2) a brief statement as to the nature and scope of the
         examination or investigation upon which the statements or opinions
         contained in such certificate or opinion are based;

                   (3) a statement that, in the opinion of such individual, he
         has made such examination or investigation as is necessary to enable
         him to express an informed opinion as to whether or not such covenant
         or condition has been complied with; and

                   (4) a statement as to whether or not, in the opinion of such
         individual, such covenant or condition has been complied with.

                                       66
<PAGE>

                  In giving an Opinion of Counsel, counsel may rely as to
factual matters on an Officers' Certificate or such other certificates of
Officer(s) as it may deem appropriate and on certificates of public officials.

                   SECTION 11.6. When Notes Disregarded. In determining whether
the Holders of the required principal amount of Notes have concurred in any
direction, waiver or consent, Notes owned by the Company or by any Person
directly or indirectly controlling or controlled by or under direct or indirect
common control with the Company shall be disregarded and deemed not to be
outstanding, except that, for the purpose of determining whether the Trustee
shall be protected in relying on any such direction, waiver or consent, only
Notes which a Responsible Officer of the Trustee actually knows are so owned
shall be so disregarded. Also, subject to the foregoing, only Notes outstanding
at the time shall be considered in any such determination.

                   SECTION 11.7. Rules by Trustee, Paying Agent and Registrar.
The Trustee may make reasonable rules for action by, or a meeting of, Holders.
The Registrar and the Paying Agent may make reasonable rules for their
functions.

                   SECTION 11.8. Governing Law. This Indenture and the Notes
shall be governed by, and construed in accordance with, the laws of the State of
New York.

                   SECTION 11.9. No Recourse Against Others. A director,
officer, employee, incorporator or stockholder of the Company, as such, will not
have any liability for any obligations of the Company under the Notes or the
Indenture or for any claim based on, in respect of, or by reason of, such
obligations or their creation. Each Holder by accepting a Note waives and
releases all such liability. The waiver and release are part of the
consideration for the issuance of the Notes.

                   SECTION 11.10. Successors. All agreements of the Company in
this Indenture and the Notes shall bind its successors. All agreements of the
Trustee in this Indenture shall bind its successors.

                   SECTION 11.11. Multiple Originals. The parties may sign any
number of copies of this Indenture. Each signed copy shall be an original, but
all of them together represent the same agreement. One signed copy is enough to
prove this Indenture.

                   SECTION 11.12. Qualification of Indenture. The Company shall
qualify this Indenture under the TIA in accordance with the terms and conditions
of the Registration Rights Agreement and shall pay all reasonable costs and
expenses (including attorneys' fees and expenses for the Company and the
Trustee) incurred in connection therewith, including, but not limited to, costs
and expenses of qualification of the Indenture and the Notes and printing this
Indenture and the Notes. The Trustee shall be entitled to receive from the
Company any such Officers' Certificates, Opinions of Counsel or other
documentation as it may reasonably request in connection with any such
qualification of this Indenture under the TIA.

                  [Remainder of Page Intentionally Left Blank]

                                       67
<PAGE>

                  IN WITNESS WHEREOF, the parties hereto have caused this
Indenture to be duly executed, all as of the date first written above.

                                           ENZON PHARMACEUTICALS, INC.

                                           By:        /S/ JEFFREY H. BUCHALTER
                                              ----------------------------------

                                                Name: Jeffrey H. Buchalter
                                                Title: Chairman, President & CEO

                                           WILMINGTON TRUST COMPANY, as Trustee

                                           By:        /S/ CHRISTOPHER MONIGLE
                                              ----------------------------------

                                                Name: Christopher Monigle
                                                Title: Assistant Vice President

                                      S-1

<PAGE>

                                                                      EXHIBIT A

                           [FORM OF FACE OF SECURITY]

         THIS NOTE AND ANY COMMON STOCK ISSUABLE UPON THE CONVERSION OF THIS
         NOTE HAVE NOT BEEN REGISTERED UNDER THE U.S. SECURITIES ACT OF 1933, AS
         AMENDED (THE "SECURITIES ACT"), AND MAY NOT BE SOLD OR OTHERWISE
         TRANSFERRED IN THE ABSENCE OF SUCH REGISTRATION OR AN APPLICABLE
         EXEMPTION THEREFROM. EACH PURCHASER OF THIS NOTE IS HEREBY NOTIFIED
         THAT THE SELLER OF THIS NOTE MAY BE RELYING ON THE EXEMPTION FROM THE
         PROVISIONS OF SECTION 5 OF THE SECURITIES ACT PROVIDED BY RULE 144A
         THEREUNDER.

         THIS NOTE AND ANY COMMON STOCK ISSUABLE UPON THE CONVERSION OF THIS
         NOTE MAY NOT BE OFFERED, SOLD, PLEDGED OR OTHERWISE TRANSFERRED EXCEPT
         (A) (1) TO A PERSON WHO THE TRANSFEROR REASONABLY BELIEVES IS A
         QUALIFIED INSTITUTIONAL BUYER WITHIN THE MEANING OF RULE 144A UNDER THE
         SECURITIES ACT ACQUIRING FOR ITS OWN ACCOUNT OR FOR THE ACCOUNT OF A
         QUALIFIED INSTITUTIONAL BUYER IN A TRANSACTION MEETING THE REQUIREMENTS
         OF RULE 144A, (2) PURSUANT TO AN EXEMPTION FROM REGISTRATION UNDER THE
         SECURITIES ACT PROVIDED BY RULE 144 THEREUNDER (IF AVAILABLE), (3) TO
         AN INSTITUTIONAL INVESTOR THAT IS AN ACCREDITED INVESTOR WITHIN THE
         MEANING OF RULE 501(a)(1), (2), (3) OR (7) OF REGULATION D UNDER THE
         SECURITIES ACT PURSUANT TO AN EXEMPTION FROM REGISTRATION UNDER THE
         SECURITIES ACT (IF AVAILABLE) OR (4) PURSUANT TO AN EFFECTIVE
         REGISTRATION STATEMENT UNDER THE SECURITIES ACT, AND (B) IN ACCORDANCE
         WITH ALL APPLICABLE SECURITIES LAWS OF THE STATES OF THE UNITED STATES
         AND OTHER JURISDICTIONS.

         THE HOLDER OF THIS NOTE WILL, AND EACH SUBSEQUENT HOLDER IS REQUIRED
         TO, NOTIFY ANY PURCHASER OF THE NOTE FROM IT OF THE RESALE RESTRICTIONS
         REFERRED TO ABOVE.

         THIS NOTE, ANY SHARES OF COMMON STOCK ISSUABLE UPON ITS CONVERSION AND
         ANY RELATED DOCUMENTATION MAY BE AMENDED OR SUPPLEMENTED FROM TIME TO
         TIME TO MODIFY THE RESTRICTIONS ON RESALES AND OTHER TRANSFERS OF THIS
         NOTE AND ANY SUCH SHARES TO REFLECT ANY CHANGE IN APPLICABLE LAW OR
         REGULATION (OR THE INTERPRETATION THEREOF) OR IN PRACTICES RELATING TO
         THE RESALE OR TRANSFER OF RESTRICTED SECURITIES GENERALLY. THE HOLDER
         OF THIS NOTE AND SUCH SHARES OF COMMON STOCK SHALL BE DEEMED BY THE
         ACCEPTANCE OF THIS NOTE AND ANY SUCH SHARES TO HAVE AGREED TO ANY SUCH
         AMENDMENT OR SUPPLEMENT.

                                      A-1
<PAGE>

         THIS SECURITY IS A GLOBAL SECURITY WITHIN THE MEANING OF THE INDENTURE
         HEREINAFTER REFERRED TO AND IS REGISTERED IN THE NAME OF THE DEPOSITORY
         TRUST COMPANY, A NEW YORK CORPORATION ("DEPOSITARY"), OR A NOMINEE OF
         THE DEPOSITARY, WHICH MAY BE TREATED BY THE COMPANY, THE TRUSTEE AND
         ANY AGENT THEREOF AS THE OWNER AND HOLDER OF THIS SECURITY FOR ALL
         PURPOSES. UNLESS THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED
         REPRESENTATIVE OF THE DEPOSITARY TO THE COMPANY OR ITS AGENT FOR
         REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY CERTIFICATE
         ISSUED IS REGISTERED IN THE NAME OF CEDE & CO. OR IN SUCH OTHER NAME AS
         IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITARY (AND ANY
         PAYMENT IS MADE TO CEDE & CO. OR TO SUCH OTHER ENTITY AS IS REQUESTED
         BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITARY), ANY TRANSFER,
         PLEDGE, OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON
         IS WRONGFUL INASMUCH AS THE REGISTERED OWNER HEREOF, CEDE & CO., HAS AN
         INTEREST HEREIN.

         TRANSFERS OF THIS GLOBAL SECURITY SHALL BE LIMITED TO TRANSFERS IN
         WHOLE, BUT NOT IN PART, BY THE DEPOSITARY TO A NOMINEE OF THE
         DEPOSITARY OR BY A NOMINEE OF THE DEPOSITARY TO THE DEPOSITARY OR
         ANOTHER NOMINEE OF THE DEPOSITARY OR BY THE DEPOSITARY OR ANY SUCH
         NOMINEE TO A SUCCESSOR DEPOSITARY OR A NOMINEE OF SUCH SUCCESSOR
         DEPOSITARY, AND TRANSFERS OF PORTIONS OF THIS GLOBAL SECURITY SHALL BE
         LIMITED TO TRANSFERS MADE IN ACCORDANCE WITH THE RESTRICTIONS SET FORTH
         IN THE INDENTURE REFERRED TO ON THE REVERSE HEREOF.

                                      A-2
<PAGE>

No. 1                                            Principal Amount $225,000,000,
                                        as revised by the Schedule of Increases
                               and Decreases in the Global Note attached hereto

                                                          CUSIP NO. 293904 AD 0

                           Enzon Pharmaceuticals, Inc.

                      4% Convertible Senior Notes due 2013

Enzon Pharmaceuticals, Inc., a Delaware corporation, promises to pay to Cede &
Co., or registered assigns, the principal sum of $225,000,000 Dollars, as
revised by the Schedule of Increases and Decreases in the Global Note attached
hereto, on June 1, 2013.

Interest Payment Dates: June 1 and December 1.

Regular Record Dates:  May 15 and November 15.

Additional provisions of this Note are set forth on the other side of this Note.

                                        ENZON PHARMACEUTICALS, INC.

                                        By: _________________________________

TRUSTEE'S CERTIFICATE OF
    AUTHENTICATION

Dated:

Wilmington Trust Company,
    as Trustee, certifies that this is one of
    the Notes referred to in the within-mentioned Indenture.

By:  _____________________________
        Authorized Signatory

                                      A-3
<PAGE>

                                 [Back of Note]
                      4% Convertible Senior Notes due 2013

                  Capitalized terms used herein have the meanings assigned to
them in the Indenture referred to below unless otherwise indicated.

1. Interest.

                  Enzon Pharmaceuticals, Inc., a Delaware corporation (the
"Company"), promises to pay interest on the principal amount of this Note at 4%
per annum from May 23, 2006 until Maturity. The Company will pay interest, if
any, semi-annually in arrears on June 1 and December 1 of each year (subject to
limited exceptions if the Note is converted or purchased prior to such date), or
if any such day is not a Business Day, on the next Business Day (each, an
"Interest Payment Date"). Interest on the Notes will accrue from the most recent
date to which interest has been paid or, if no interest has been paid, from May
23, 2006; provided that if there is no existing Default in the payment of
interest, and if this Note is authenticated between a Record Date referred to on
the face hereof and the next succeeding Interest Payment Date, interest shall
accrue from such next succeeding Interest Payment Date; provided, further, that
the first Interest Payment Date shall be December 1, 2006. The Company will pay
interest on overdue principal from time to time on demand at the rate then in
effect to the extent lawful; it will pay interest on overdue installments of
interest, if any (without regard to any applicable grace periods), from time to
time on demand at the same rate to the extent lawful. Interest will be computed
on the basis of a 360-day year of twelve 30-day months.

2. Method of payment.

                  The Company will pay interest on the Notes, if any, to the
Persons who are registered Holders of Notes at the close of business on the May
15 or November 15 next preceding the Interest Payment Date (each a "Regular
Record Date"), even if such Notes are canceled after such record date and on or
before such Interest Payment Date. The Notes will be payable as to principal, if
any, and interest at the office or agency of the Company maintained for such
purpose within or without the City and State of New York, or, at the option of
the Company, payment of interest, if any, may be made by check mailed to the
Holders at their addresses set forth in the register of Holders; provided that
payment will be made by wire transfer of immediately available funds with
respect to principal of and interest, if any, on, all Global Notes and all other
Notes with an aggregate principal amount in excess of $2 million for which the
Holders have provided wire transfer instructions at least 10 Business Days prior
to the Interest Payment Date to the Company or the Paying Agent. Such payment
will be in such coin or currency of the United States of America as at the time
of payment is legal tender for payment of public and private debts.

3. Paying agent, registrar and conversion agent.

                  Initially, Wilmington Trust Company, the Trustee under the
Indenture, will act as Paying Agent, Registrar and Conversion Agent. The Company
may change any Paying Agent, Registrar or Conversion Agent without notice to any
Holder. The Company or any of its Subsidiaries may act in any such capacity.

                                      A-4
<PAGE>

4. Indenture.

                  The Company issued the Notes under the Indenture dated as of
May 23, 2006 (the "Indenture") between the Company and the Trustee. The terms of
the Notes include those stated in the Indenture and those made part of the
Indenture by reference to the TIA. The Notes are subject to all such terms, and
Holders are referred to the Indenture and the TIA for a statement of such terms.
To the extent any provision of this Note conflicts with the express provisions
of the Indenture, the provisions of the Indenture shall govern and be
controlling. The Notes are unsecured obligations of the Company.

5. Optional redemption.

                  The Notes are not redeemable by the Company prior to June 1,
2009. At any time on or after June 1, 2009, if the Closing Sale Price of the
Common Stock for at least 20 Trading Days in the 30 consecutive Trading Day
period ending on the date one Trading Day prior to the day the Company gives a
notice of redemption is greater than 140% of the Applicable Conversion Price on
the date of such notice, the Company may redeem the Notes in whole or in part at
a redemption price in cash equal to 100% of the principal amount of the Notes to
be redeemed, plus accrued and unpaid interest, if any, on the principal amount
of the Notes redeemed to the Redemption Date.

6. Repurchase at the option of holder upon a fundamental change.

                  Subject to Section 3.10(d) of the Indenture, upon the
occurrence of a Fundamental Change at any time prior to Stated Maturity, each
Holder may require the Company to repurchase the Notes on a date chosen by the
Company in its sole discretion that is no less than 20 Business Days and no more
than 35 Business Days after the mailing of the Fundamental Change Repurchase
Right Notice (the "Fundamental Change Repurchase Date"), and the Company shall
repurchase on the Fundamental Change Repurchase Date, any or all Notes submitted
for repurchase for cash or any portion of the initial principal amount thereof
equal to $1,000 or an integral multiple of $1,000, at a price equal to 100% of
the aggregate principal amount thereof plus accrued and unpaid interest, if any,
to but not including the Fundamental Change Repurchase Date (the "Fundamental
Change Payment"), unless such Fundamental Change Repurchase Date falls after a
Regular Record Date and on or prior to the corresponding Interest Payment Date,
in which case the Company shall pay the full amount of accrued and unpaid
interest payable on such Interest Payment Date to the Holder of record at the
close of business on the corresponding Regular Record Date. At least 20 Business
Days prior to the anticipated Effective Date of a Fundamental Change (or, if the
Company does not have actual notice of a Fundamental Change 20 Business Days
prior to the Effective Date, as soon as the Company has actual notice of such
Fundamental Change), the Company will provide to all Holders, the Trustee, the
Paying Agent and the Conversion Agent a Fundamental Change Notice as required by
the Indenture.

                                      A-5
<PAGE>

7. Conversion.

                  Subject to Article VI of the Indenture, at any time prior to
Maturity, unless earlier repurchased or redeemed, Holders of the Notes may
surrender any portion of the principal amount of any Note that is an integral
multiple of $1,000 for conversion into fully paid and non-assessable shares of
Common Stock at the Conversion Rate, determined as provided in the Indenture, in
effect at the time of conversion.

8. Denominations, transfer, exchange.

                  The Notes are in registered form without coupons in
denominations of $1,000 and integral multiples of $1,000. The transfer of Notes
may be registered and Notes may be exchanged as provided in the Indenture. The
Registrar and the Trustee may require a Holder, among other things, to furnish
appropriate endorsements and transfer documents and the Company may require a
Holder to pay any taxes and fees required by law or permitted by the Indenture.
The Company need not exchange or register the transfer of any Note or portion of
a Note selected for conversion or repurchase, except for the unconverted or
unrepurchased portion of any Note being converted or repurchased in part. Also,
the Company need not exchange or register the transfer of any Notes during the
period between a Regular Record Date and the corresponding Interest Payment
Date.

9. Persons deemed owners.

                  The registered Holder of a Note may be treated as its owner
for all purposes.

10. Amendment, supplement and waiver.

                  Subject to certain exceptions, the Indenture and the Notes may
be amended or supplemented with the consent of the Holders of not less than a
majority in aggregate principal amount of the then Outstanding Notes, including
Additional Notes, if any, and any existing Default or compliance with any
provision of the Indenture and the Notes may be waived with the consent of the
Holders of not less than a majority in aggregate principal amount of the then
Outstanding Notes, including Additional Notes, if any, voting as a single class.
Without the consent of any Holder of a Note, the Indenture and the Notes may be
amended or supplemented to cure any ambiguity, omission, defect or
inconsistency, to provide for the assumption of the Company's obligations under
the Indenture or the Notes in accordance with Article IV in the Indenture, to
comply with requirements to effect or maintain the qualification of the
Indenture under the TIA, to secure the Notes or provide guarantees of the Notes,
to add covenants that would benefit the Holders of the Notes or to surrender any
rights of the Company under the Indenture, to add Events of Default with respect
to the Notes, to make any change that does not adversely affect any outstanding
Notes in any material respect, or to evidence and provide for the acceptance of
the appointment of a successor Trustee under the Indenture.

                                      A-6
<PAGE>

11. Events of default.

                  Each of the following is an "Event of Default":

                  (1) a default in the payment of any installment of interest
         upon this Note as and when the same shall become due and payable, and
         continuance of such default for a period of 30 days;

                  (2) default in the payment of all or any part of the principal
         of this Note as and when the same shall become due and payable;

                  (3) default on the part of the Company in the performance, or
         breach by the Company, of any other covenant or agreement on the part
         of the Company set forth in this Note or in the Indenture (other than a
         covenant or agreement in respect of which a default or breach by the
         Company is specifically dealt with in Section 7.1 of the Indenture),
         and continuance of such default or breach without cure or waiver for a
         period of 60 days after there has been given, by registered or
         certified mail, to the Company by the Trustee, or to the Company and
         the Trustee by the Holders of at least 25% in principal amount of the
         Notes at the time Outstanding, a written notice specifying such failure
         and requiring the same to be remedied;

                  (4) the Company fails to pay the purchase price of any Note
         when due (including, without limitation, on any Fundamental Change
         Repurchase Date;

                  (5) The Company fails to deliver shares of Common Stock or any
         cash in lieu of fractional shares upon conversion within the time
         period required by the Indenture and this failure continues for 5
         business days;

                  (6) the Company fails to provide a timely Fundamental
         Repurchase Right Notice, if required by the Indenture and such failure
         continues for 30 days;

                  (7) any indebtedness for money borrowed by the Company or one
         of its Significant Subsidiaries in an aggregate outstanding principal
         amount in excess of $25.0 million is not paid at final maturity or upon
         acceleration and such indebtedness is not discharged, or such
         acceleration is not cured or rescinded, within 10 days after written
         notice specifying such failure;

                  (8) failure by the Company or any of its Significant
         Subsidiaries to pay final and non-appealable judgments entered by a
         court or courts of competent jurisdiction, the aggregate uninsured or
         unbonded portion of which is at least $25.0 million, if the judgments
         are not paid, discharged or stayed within 60 days;

                  (9) the Company or any of its Significant Subsidiaries
         pursuant to or within the meaning of Bankruptcy Law:

                           (A) commences a voluntary case,

                           (B) consents to the entry of an order for relief
                  against it in an involuntary case,

                           (C) consents to the appointment of a custodian of it
                  or for all or substantially all of its property, or

                                      A-7
<PAGE>

                           (D) makes a general assignment for the benefit of its
                  creditors; and

                  (10) a court of competent jurisdiction enters an order or
         decree under any Bankruptcy Law that:

                           (A) is for relief against the Company or any of its
                  Significant Subsidiaries in an involuntary case;

                           (B) appoints a custodian of the Company or any of its
                  Significant Subsidiaries or for all or substantially all of
                  the property of the Company or any of its Subsidiaries; or

                           (C) orders the liquidation of the Company or any of
                  its Significant Subsidiaries; and the order or decree remains
                  unstayed and in effect for 90 consecutive days.

12. Trustee dealings with company.

                  The Trustee, in its individual or any other capacity, may make
loans to, accept deposits from, and perform services for the Company or its
Affiliates, and may otherwise deal with the Company or its Affiliates, as if it
were not the Trustee.

13. No recourse against others.

                  A director, officer, employee, incorporator or stockholder of
the Company, as such, will not have any liability for any obligations of the
Company under the Notes or the Indenture or for any claim based on, in respect
of, or by reason of, such obligations or their creation. Each Holder by
accepting a Note waives and releases all such liability. The waiver and release
are part of the consideration for the issuance of the Notes.

14. Open market purchases.

                  The Company may, to the extent permitted by applicable law, at
any time, and from time to time, purchase Notes at any price in the open market
or otherwise.

15. Authentication.

                  This Note will not be valid until authenticated by the manual
signature of the Trustee or an authenticating agent.

16. Abbreviations.

                  Customary abbreviations may be used in the name of a Holder or
an assignee, such as: TEN COM (= tenants in common), TEN ENT (= tenants by the
entireties), JT TEN (= joint tenants with right of survivorship and not as
tenants in common), CUST (= Custodian), and U/G/M/A (= Uniform Gifts to Minors
Act).

                                      A-8
<PAGE>

17. CUSIP numbers.

                  Pursuant to a recommendation promulgated by the Committee on
Uniform Security Identification Procedures, the Company has caused CUSIP numbers
to be printed on the Notes, and the Trustee may use CUSIP numbers in notices of
repurchase or conversion as a convenience to Holders. No representation is made
as to the accuracy of such numbers either as printed on the Notes or as
contained in any notice of repurchase or conversion, and reliance may be placed
only on the other identification numbers placed thereon.

18. Governing law.

                  THE INTERNAL LAW OF THE STATE OF NEW YORK WILL GOVERN AND BE
USED TO CONSTRUE THE INDENTURE AND THIS NOTE WITHOUT GIVING EFFECT TO APPLICABLE
PRINCIPLES OF CONFLICTS OF LAW TO THE EXTENT THAT THE APPLICATION OF THE LAWS OF
ANOTHER JURISDICTION WOULD BE REQUIRED THEREBY.

                                      A-9
<PAGE>

                                 ASSIGNMENT FORM

To assign this Note, fill in the form below:

(I) or (we) assign and transfer this Note to ___________________________________
                                                (Insert assignee's legal name)

________________________________________________________________________________
                  (Insert assignee's soc. sec. or tax I.D. No.)

________________________________________________________________________________

              (Print or type assignee's name, address and zip code)

and irrevocably appoint                              to transfer this Note on
the books of the Company. The agent may substitute another to act for him.

Date:__________________

                              Your Signature:___________________________________
                                             (Sign exactly as your name appears
                                             on the face of this Note)

Signature Guarantee*: ______________________

____________________________________________
*Participant in a recognized Signature Guarantee Medallion Program (or other
signature guarantor acceptable to the Trustee).

                                      A-10
<PAGE>

              SCHEDULE OF EXCHANGES OF INTERESTS IN THE GLOBAL NOTE

                  The following exchanges of a part of this Global Note for an
interest in another Global Note or for a Definitive Note, or exchanges of a part
of another Global Note or Definitive Note for an interest in this Global Note,
have been made:

<TABLE>
<CAPTION>

                                                                      Principal Amount of
                                                                       this Global Note         Signature of
                       Amount of decrease      Amount of increase       following such           authorized
                       in Principal Amount    in Principal Amount        decrease (or            officer of
Date of Exchange       of this Global Note    of this Global Note          increase)        Trustee or Custodian
----------------       -------------------    -------------------     --------------------  --------------------
<S>                    <C>                    <C>                     <C>                   <C>

</TABLE>

                                      A-11
<PAGE>

                                                                      EXHIBIT B

                            FORM OF CONVERSION NOTICE

Enzon Pharmaceuticals, Inc.

Wilmington Trust Company

Re:  4% Convertible Senior Notes due 2013
     -- REPURCHASE NOTICE (CUSIP [ ])

                  Reference is hereby made to the Indenture, dated as of May 23,
2006 (the "Indenture"), between Enzon Pharmaceuticals, Inc., as issuer (the
"Company"), and Wilmington Trust Company, as trustee (the "Trustee").
Capitalized terms used but not defined herein shall have the meanings given to
them in the Indenture.

                  (the "Owner") owns and proposes to convert the Note[s] or
interest in such Note[s] specified herein, in the principal amount of $_____ in
such Note[s] or interests (the "Conversion") pursuant to Article VI of the
Indenture. In connection with the Conversion, the Owner hereby certifies that,
as Owner of this Note, he/she hereby irrevocably exercises the option to convert
this Note, or such portion of this Note in the principal amount designated above
into the number of shares of Common Stock of the Company equal to (x) the
aggregate principal amount of Notes to be converted divided by 1,000 multiplied
by (y) the Applicable Conversion Rate. The Owner directs that such shares,
together with a check in payment for any fractional share and any Notes
representing any unconverted principal amount hereof, be delivered to and be
registered in the name of the undersigned unless a different name has been
indicated below. If shares of Common Stock or Notes are to be registered in the
name of a Person other than the undersigned, (a) the undersigned will pay all
transfer taxes payable with respect thereto and (b) signature(s) must be
guaranteed by an Eligible Guarantor Institution with membership in an approved
signature guarantee program pursuant to Rule 17Ad-15 under the Securities
Exchange Act of 1934. Any amount required to be paid by the undersigned on
account of interest accompanies this Note.

Dated:_____________________
                                       _______________________________________
                                       Signature(s)

                                      B-1
<PAGE>

If shares of Common Stock or Notes are to be registered in the name of a Person
other than the Holder, please print such Person's name and address:

____________________________________________
(Name)

____________________________________________
(Address)

____________________________________________
Social Security or other Identification
Number, if
any.

____________________________________________
[Signature Guaranteed]

If only a portion of a Note is to be converted, please indicate:

1. Principal amount to be converted:$

2. Principal amount and denomination of Notes representing unpurchased principal
amount to be issued:

Amount: $                                  Denominations: $

($1,000 or any integral multiple of $1,000, provided that the unconverted
portion of such principal amount is $1,000 or any integral multiple of $1,000.)

                                      B-2
<PAGE>

                                                                     EXHIBIT C

                    FORM OF TRANSFER CERTIFICATE FOR TRANSFER
                           OF RESTRICTED COMMON STOCK

                [NAME AND ADDRESS OF COMMON STOCK TRANSFER AGENT]

          Re:  Enzon Pharmaceuticals, Inc. 4% Convertible Senior Notes Due 2013
               (the "Notes")

Reference is hereby made to the Indenture dated as of May 23, 2006 between the
Company and the Trustee (collectively, the "Indenture"). Capitalized terms used
but not defined herein shall have the meanings given them in the Indenture.

This letter relates to _________ shares of Common Stock [that are to be]
[represented by the accompanying certificate(s) that were] issued upon
conversion of Notes and which are held in the name of [name of transferor] (the
"Transferor") to effect the transfer of such Common Stock.

In connection with the transfer of such shares of Common Stock, the undersigned
confirms that such shares of Common Stock are being transferred and do not
require registration under the Securities Act (as defined below) because:

CHECK ONE BOX BELOW:

|_|   Such Common Stock is being acquired for the Transferor's own account
without transfer.

|_|   Such Common Stock is being transferred to a "qualified institutional
buyer" (as defined in Rule 144A under the Securities Act of 1933, as amended
(the "Securities Act")), in accordance with Rule 144A under the Securities Act.

|_|   Such Common Stock is being transferred pursuant to an exemption from
registration in accordance with Rule 144 under the Securities Act (and based
upon an opinion of counsel if the Company or the Trustee so requests).

                                      C-1
<PAGE>

Unless one of the boxes is checked, the transfer agent will refuse to register
any of the Common Stock evidenced by this certificate in the name of any person
other than the registered holder thereof; provided, however, that if the second
or third box is checked, the transfer agent may require, prior to registering
any such transfer of the Common Stock such certifications and other information,
including opinions of counsel, as the Company has reasonably requested in
writing, by delivery to the transfer agent of a standing letter of instruction,
to confirm that such transfer is being made pursuant to an exemption from, or in
a transaction not subject to, the registration requirements of the Securities
Act.

                               [Name of Transferor],

                               By: ___________________________________________
                                   Name:
                                   Title:

                               Dated:

                                      C-2<PAGE>

                                                                    Exhibit 10.1

                                                               EXECUTION VERSION

                           Enzon Pharmaceuticals, Inc.

                      4% Convertible Senior Notes due 2013

                          REGISTRATION RIGHTS AGREEMENT

                                                                    May 23, 2006
Goldman, Sachs & Co.,
As representative of the several Purchasers
   named in Schedule I to the Purchase Agreement
85 Broad Street
New York, New York 10004

Ladies and Gentlemen:

         Enzon Pharmaceuticals, Inc., a Deleware corporation (the "Company"),
proposes to issue and sell to the Purchasers (as defined herein) upon the terms
set forth in the Purchase Agreement (as defined herein) up to $275 million
aggregate principal amount of its 4% Convertible Senior Notes due 2013 (the
"Securities"). As an inducement to the Purchasers to enter into the Purchase
Agreement and in satisfaction of a condition to the obligations of the
Purchasers thereunder, the Company agrees with the Purchasers for the benefit of
Holders (as defined herein) from time to time of the Registrable Securities (as
defined herein) as follows:

         1. Definitions.

         (a) Capitalized terms used herein without definition shall have the
meanings ascribed to them in the Purchase Agreement. As used in this Agreement,
the following defined terms shall have the following meanings:

         "Additional Interest" has the meaning assigned thereto in Section 7(a)
hereof.

         "Affiliate" of any specified person means any other person which,
directly or indirectly, is in control of, is controlled by, or is under common
control with such specified person. For purposes of this definition, control of
a person means the power, direct or indirect, to direct or cause the direction
of the management and policies of such person whether by contract or otherwise;
and the terms "controlling" and "controlled" have meanings correlative to the
foregoing.

         "Closing Date" means the First Time of Delivery as defined in the
Purchase Agreement.

         "Commission" means the United States Securities and Exchange
Commission, or any other federal agency at the time administering the Exchange
Act or the Securities Act, whichever is the relevant statute for the particular
purpose.

         "Common Stock" means the Company's common stock, par value $0.01 per
share, together with any associated preferred share purchase rights.

<PAGE>

         "DTC" means The Depository Trust Company.

         "Effective Date" has the meaning assigned thereto in Section 2(b)(i)
hereof.

         "Effective Failure" has the meaning assigned thereto in Section 7(b)
hereof.

         "Effectiveness Period" has the meaning assigned thereto in Section
2(b)(i) hereof.

         "Effective Time" means the time at which the Commission declares the
Shelf Registration Statement effective or at which the Shelf Registration
Statement otherwise becomes effective.

         "Electing Holder" has the meaning assigned thereto in Section 3(a)(iii)
hereof.

         "Exchange Act" means the United States Securities Exchange Act of 1934,
as amended.

         "Holder" means any person that is the record owner of Registrable
Securities (and includes any person that has a beneficial interest in any
Registrable Security in book-entry form).

         "Indenture" means the Indenture, dated as of May 23, 2006, between the
Company and Wilmington Trust Company, as amended and supplemented from time to
time in accordance with its terms.

         "Managing Underwriters" means the investment banker or investment
bankers and manager or managers that shall administer an underwritten offering,
if any, conducted pursuant to Section 6 hereof.

         "NASD Rules" means the Rules of the National Association of Securities
Dealers, Inc., as amended from time to time.

         "Notice and Questionnaire" means a Notice of Registration Statement and
Selling Securityholder Questionnaire substantially in the form of Appendix A
hereto.

         The term "person" means an individual, partnership, corporation, trust
or unincorporated organization, or a government or agency or political
subdivision thereof.

         "Prospectus" means the prospectus (including, without limitation, any
preliminary prospectus, any final prospectus and any prospectus that discloses
information previously omitted from a prospectus filed as part of an effective
registration statement in reliance upon Rule 430A under the Securities Act)
included in the Shelf Registration Statement, as amended or supplemented by any
prospectus supplement with respect to the terms of the offering of any portion
of the Registrable Securities covered by the Shelf Registration Statement and by
all other amendments and supplements to such prospectus, including all material
incorporated by reference in such prospectus and all documents filed after the
date of such prospectus by the Company under the Exchange Act and incorporated
by reference therein.

                                       2
<PAGE>

         "Purchase Agreement" means the purchase agreement, dated as of May 17,
2006, between the Purchasers and the Company relating to the Securities.

         "Purchasers" means the Purchasers named in Schedule I to the Purchase
Agreement.

         "Registrable Securities" means all or any portion of the Securities
issued on the date hereof (or pursuant to the Purchasers' over-allotment option
as described in the Purchase Agreement) under the Indenture in registered form
and the shares of Common Stock issuable upon conversion of such Securities;
provided, however, that a security ceases to be a Registrable Security when it
is no longer a Restricted Security.

         "Registration Default" has the meaning assigned thereto in Section 7(a)
hereof.

         "Restricted Security" means any Security or share of Common Stock
issuable upon conversion thereof except any such Security or share of Common
Stock that (i) has been effectively registered under the Securities Act and sold
in a manner contemplated by the Shelf Registration Statement, (ii) has been
transferred in compliance with Rule 144 under the Securities Act (or any
successor provision thereto) or is transferable pursuant to paragraph (k) of
such Rule 144 (or any successor provision thereto) or (iii) has otherwise been
transferred and a new Security or share of Common Stock not subject to transfer
restrictions under the Securities Act has been delivered by or on behalf of the
Company in accordance with Section 2.1 of the Indenture.

         "Rules and Regulations" means the published rules and regulations of
the Commission promulgated under the Securities Act or the Exchange Act, as
applicable, as in effect at any relevant time.

         "Securities Act" means the United States Securities Act of 1933, as
amended.

         "Shelf Registration" means a registration effected pursuant to Section
2 hereof.

         "Shelf Registration Statement" means a "shelf" registration statement
filed under the Securities Act providing for the registration of, and the sale
on a continuous or delayed basis by the Holders of, all of the Registrable
Securities pursuant to Rule 415 under the Securities Act and/or any similar rule
that may be adopted by the Commission, filed by the Company pursuant to the
provisions of Section 2 of this Agreement, including the Prospectus contained
therein, any amendments and supplements to such registration statement,
including post-effective amendments, and all exhibits and all material
incorporated by reference in such registration statement.

         "Trust Indenture Act" means the Trust Indenture Act of 1939, or any
successor thereto, and the rules, regulations and forms promulgated thereunder,
as the same shall be amended from time to time.

         The term "underwriter" means any underwriter of Registrable Securities
in connection with an offering thereof under a Shelf Registration Statement.

                                       3
<PAGE>

         (b) Wherever there is a reference in this Agreement to a percentage of
the "principal amount" of Registrable Securities or to a percentage of
Registrable Securities, Common Stock constituting Registrable Securities shall
be treated as representing the principal amount of Securities that was
surrendered for conversion or exchange in order to receive such number of shares
of Common Stock.

         2. Shelf Registration.

         (a) The Company shall file with the Commission, no later than 90
calendar days following the Closing Date, if at such time the Company is
eligible to file a registration statement on Form S-3 or, if the company is not
eligible to file a Shelf Registration Statement on Form S-3, no later than 135
calendar days after the Closing Date, a Shelf Registration Statement relating to
the offer and sale of the Registrable Securities by the Holders from time to
time in accordance with the methods of distribution elected by such Holders and
set forth in such Shelf Registration Statement and, thereafter, if the Company
is required to file a Shelf Registration Statement covering resales of the
Registrable Securities no later than 90 calendar days after the Closing Date,
shall use its reasonable best efforts to cause such Shelf Registration Statement
to be declared effective under the Securities Act no later than 180 calendar
days following the Closing Date or, if the Company is required to file such
Shelf Registration Statement no later than 135 calendar days after the Closing
Date, use its reasonable best efforts to cause the Shelf Registration Statement
to be declared effective under the Securities Act no later than 225 days after
the Closing Date; provided, however, that the Company may, upon written notice
to all Holders, postpone having the Shelf Registration Statement declared
effective for a reasonable period not to exceed 90 days if the Company possesses
material non-public information, the disclosure of which would have a material
adverse effect on the Company and its subsidiaries taken as a whole; provided,
further, however, that no Holder shall be entitled to be named as a selling
securityholder in the Shelf Registration Statement or to use the Prospectus
forming a part thereof for resales of Registrable Securities unless such Holder
is an Electing Holder.

         (b) The Company shall use its reasonable best efforts:

             (i) to keep the Shelf Registration Statement continuously
         effective under the Securities Act in order to permit the Prospectus
         forming a part thereof to be usable by Holders until the earliest of
         (1) the sale of all Registrable Securities registered under the Shelf
         Registration Statement; (2) the expiration of the period referred to in
         Rule 144(k) of the Securities with respect to all Registrable
         Securities held by Persons that are not Affiliates of the Company; and
         (3) two years from the date (the "Effective Date") such Shelf
         Registration Statement is declared effective (such period being
         referred to herein as the "Effectiveness Period");

             (ii) after the Effective Time of the Shelf Registration Statement,
         promptly upon the request of any Holder of Registrable Securities that
         is not then an Electing Holder, to take any action reasonably necessary
         to enable such Holder to use the Prospectus forming a part thereof for
         resales of Registrable Securities, including, without limitation, any
         action necessary to identify such Holder as a selling securityholder in
         the Shelf Registration Statement; provided, however, that nothing in
         this subparagraph shall relieve such Holder of the obligation to return
         a completed and signed Notice and Questionnaire to the Company in
         accordance with Section 3(a)(ii) hereof; and

                                       4
<PAGE>

             (iii) if at any time the Securities, pursuant to Section 4.2 of
         the Indenture, are convertible into securities other than Common Stock,
         to cause, or to cause any successor under the Indenture to cause, such
         securities to be included in the Shelf Registration Statement no later
         than the date on which the Securities may then be convertible into such
         securities.

The Company shall be deemed not to have used its reasonable best efforts to keep
the Shelf Registration Statement effective during the requisite period if the
Company voluntarily takes any action that would result in Holders of Registrable
Securities covered thereby not being able to offer and sell any of such
Registrable Securities during that period, unless such action is (A) required by
applicable law and the Company thereafter promptly complies with the
requirements of paragraph 3(j) below or (B) permitted pursuant to Section 2(c)
below.

         (c) The Company may suspend the use of the Prospectus for a period
not to exceed 30 days in any 90-day period or an aggregate of 90 days in any
12-month period if the Board of Directors of the Company shall have determined
in good faith that because of valid business reasons (not including avoidance of
the Company's obligations hereunder), including the acquisition or divestiture
of assets, pending corporate developments and similar events, it is in the best
interests of the Company to suspend such use, and prior to suspending such use
the Company provides the Holders with written notice of such suspension, which
notice need not specify the nature of the event giving rise to such suspension.

         3. Registration Procedures. In connection with the Shelf Registration
Statement, the following provisions shall apply:

         (a) (i) Not less than 30 calendar days prior to the Effective Time of
the Shelf Registration Statement, the Company shall mail the Notice and
Questionnaire to the Holders of Registrable Securities or provide the Notice and
Questionnaire to DTC, as applicable. No Holder shall be entitled to be named as
a selling securityholder in the Shelf Registration Statement as of the Effective
Time, and no Holder shall be entitled to use the Prospectus forming a part
thereof for resales of Registrable Securities at any time, unless such Holder
has returned a completed and signed Notice and Questionnaire to the Company by
the deadline for response set forth therein; provided, however, Holders of
Registrable Securities shall have at least 28 calendar days from the date on
which the Notice and Questionnaire is first mailed to such Holders to return a
completed and signed Notice and Questionnaire to the Company.

             (ii) After the Effective Time of the Shelf Registration Statement,
         the Company shall, upon the request of any Holder of Registrable
         Securities that is not then an Electing Holder, promptly send a Notice
         and Questionnaire to such Holder. The Company shall not be required to
         take any action to name such Holder as a selling securityholder in the
         Shelf Registration Statement or to enable such Holder to use the
         Prospectus forming a part thereof for resales of Registrable Securities
         until such Holder has returned a completed and signed Notice and
         Questionnaire to the Company.

                                       5
<PAGE>

             (iii) The term "Electing Holder" shall mean any Holder of
         Registrable Securities that has returned a completed and signed Notice
         and Questionnaire to the Company in accordance with Section 3(a)(i) or
         3(a)(ii) hereof.

         (b) Upon the Electing Holders' request, the Company shall furnish to
each Electing Holder, prior to the Effective Time, a copy of the Shelf
Registration Statement initially filed with the Commission, and shall furnish to
such Holders, prior to the filing thereof with the Commission, copies of each
amendment thereto and each amendment or supplement, if any, to the Prospectus
included therein, and shall use all reasonable efforts to reflect in each such
document, at the Effective Time or when so filed with the Commission, as the
case may be, such comments as such Holders and their respective counsel
reasonably may propose.

         (c) The Company shall promptly take such action as may be necessary so
that (i) each of the Shelf Registration Statement and any amendment thereto and
the Prospectus forming a part thereof and any amendment or supplement thereto
(and each report or other document incorporated therein by reference in each
case) complies in all material respects with the Securities Act and the Exchange
Act and the respective rules and regulations thereunder, (ii) each of the Shelf
Registration Statement and any amendment thereto does not, when it becomes
effective, contain an untrue statement of a material fact or omit to state a
material fact required to be stated therein or necessary to make the statements
therein not misleading and (iii) each of the Prospectus forming a part of the
Shelf Registration Statement, and any amendment or supplement to such
Prospectus, does not at any time during the Effectiveness Period include an
untrue statement of a material fact or omit to state a material fact necessary
in order to make the statements therein, in the light of the circumstances under
which they were made, not misleading.

         (d) The Company shall promptly advise each Electing Holder, and shall
confirm such advice in writing if so requested by any such Electing Holder:

             (i) when a Shelf Registration Statement or any post-effective
         amendment thereto has become effective, in each case making a public
         announcement thereof by release made to Reuters Economic Services and
         Bloomberg Business News;

             (ii) of the issuance by the Commission of any stop order suspending
         the effectiveness of the Shelf Registration Statement or the initiation
         of any proceedings for such purpose;

             (iii) of the receipt by the Company of any notification with
         respect to the suspension of the qualification of the securities
         included in the Shelf Registration Statement for sale in any
         jurisdiction or the initiation of any proceeding for such purpose; and

             (iv) of the occurrence of any event or the existence of any state
         of facts that requires the making of any changes in the Shelf
         Registration Statement or the Prospectus included therein so that, as
         of such date, such Shelf Registration Statement and Prospectus do not
         contain an untrue statement of a material fact and do not omit to state
         a material fact required to be stated therein or necessary to make the
         statements therein (in the case of the Prospectus, in light of the
         circumstances under which they were made) not misleading (which advice
         shall be accompanied by an instruction to such Holders to suspend the
         use of the Prospectus until the requisite changes have been made).

                                       6
<PAGE>

         (e) The Company shall use all reasonable efforts to prevent the
issuance, and if issued to obtain the withdrawal at the earliest possible time,
of any order suspending the effectiveness of the Shelf Registration Statement.

         (f) If such Electing Holder so requests in writing, the Company shall
furnish to each Electing Holder, without charge, at least one copy of the Shelf
Registration Statement and all post-effective amendments thereto, including
financial statements and schedules, and, all reports, other documents and
exhibits that are filed with or incorporated by reference in the Shelf
Registration Statement.

         (g) The Company shall, during the Effectiveness Period, deliver to each
Electing Holder, without charge, as many copies of the Prospectus (including
each preliminary Prospectus) included in the Shelf Registration Statement and
any amendment or supplement thereto as such Electing Holder may reasonably
request; and the Company consents (except during the periods specified in
Section 2(c) above or during the continuance of any event or the existence of
any state of facts described in Sections 3(d)(iii) and (iv) above) to the use of
the Prospectus and any amendment or supplement thereto by each of the Electing
Holders in connection with the offering and sale of the Registrable Securities
covered by the Prospectus and any amendment or supplement thereto during the
Effectiveness Period.

         (h) Prior to any offering of Registrable Securities pursuant to the
Shelf Registration Statement, the Company shall use all reasonable efforts to
(i) register or qualify or cooperate with the Electing Holders and their
respective counsel in connection with the registration or qualification of such
Registrable Securities for offer and sale under the securities or "blue sky"
laws of such jurisdictions within the United States as any Electing Holder may
reasonably request, (ii) keep such registrations or qualifications in effect and
comply with such laws so as to permit the continuance of offers and sales in
such jurisdictions for so long as may be necessary to enable any Electing Holder
or underwriter, if any, to complete its distribution of Registrable Securities
pursuant to the Shelf Registration Statement, and (iii) take any and all other
actions necessary or advisable to enable the disposition in such jurisdictions
of such Registrable Securities; provided, however, that in no event shall the
Company be obligated to (A) qualify as a foreign corporation or as a dealer in
securities in any jurisdiction where it would not otherwise be required to so
qualify but for this Section 3(h) or (B) file any general consent to service of
process in any jurisdiction where it is not as of the date hereof so subject.

         (i) Unless any Registrable Securities shall be in book-entry only form,
the Company shall cooperate with the Electing Holders to facilitate the timely
preparation and delivery of certificates representing Registrable Securities to
be sold pursuant to the Shelf Registration Statement, which certificates, if so
required by any securities exchange upon which any Registrable Securities are
listed, shall be penned, lithographed or engraved, or produced by any
combination of such methods, on steel engraved borders, and which certificates
shall be free of any restrictive legends and in such permitted denominations and
registered in such names as Electing Holders may request in connection with the
sale of Registrable Securities pursuant to the Shelf Registration Statement.

                                       7
<PAGE>

         (j) Upon the occurrence of any event or the existence of any state of
facts contemplated by paragraph 3(d)(iv) above, the Company shall promptly
prepare a post-effective amendment to any Shelf Registration Statement or an
amendment or supplement to the related Prospectus or file any other required
document so that, as thereafter delivered to purchasers of the Registrable
Securities included therein, the Prospectus will not include an untrue statement
of a material fact or omit to state any material fact necessary to make the
statements therein, in the light of the circumstances under which they were
made, not misleading. If the Company notifies the Electing Holders of the
occurrence of any event or the existence of any state of facts contemplated by
paragraph 3(d)(iv) above, the Electing Holder shall suspend the use of the
Prospectus until the requisite changes to the Prospectus have been made.

         (k) Not later than the Effective Time of the Shelf Registration
Statement, the Company shall provide a CUSIP number for the Registrable
Securities that are debt securities.

         (l) The Company shall use all reasonable efforts to comply with all
applicable Rules and Regulations, and to make generally available to its
securityholders as soon as practicable, but in any event not later than eighteen
months after (i) the effective date (as defined in Rule 158(c) under the
Securities Act) of the Shelf Registration Statement, (ii) the effective date of
each post-effective amendment to the Shelf Registration Statement, and (iii) the
date of each filing by the Company with the Commission of an Annual Report on
Form 10-K that is incorporated by reference in the Shelf Registration Statement,
an earnings statement of the Company and its subsidiaries complying with Section
11(a) of the Securities Act and the rules and regulations of the Commission
thereunder (including, at the option of the Company, Rule 158).

         (m) Not later than the Effective Time of the Shelf Registration
Statement, the Company shall cause the Indenture to be qualified under the Trust
Indenture Act; in connection with such qualification, the Company shall
cooperate with the Trustee under the Indenture and the Holders (as defined in
the Indenture) to effect such changes to the Indenture as may be required for
such Indenture to be so qualified in accordance with the terms of the Trust
Indenture Act; and the Company shall execute, and shall use all reasonable
efforts to cause the Trustee to execute, all documents that may be required to
effect such changes and all other forms and documents required to be filed with
the Commission to enable such Indenture to be so qualified in a timely manner.
In the event that any such amendment or modification referred to in this Section
3(m) involves the appointment of a new trustee under the Indenture, the Company
shall appoint a new trustee thereunder pursuant to the applicable provisions of
the Indenture.

         (n) In the event of an underwritten offering conducted pursuant to
Section 6 hereof, the Company shall, if requested, promptly include or
incorporate in a Prospectus supplement or post-effective amendment to the Shelf
Registration Statement such information as the Managing Underwriters reasonably
agree should be included therein and to which the Company does not reasonably
object and shall make all required filings of such Prospectus supplement or
post-effective amendment as soon as practicable after it is notified of the
matters to be included or incorporated in such Prospectus supplement or
post-effective amendment.

                                        8
<PAGE>

         (o) The Company shall enter into such customary agreements (including
an underwriting agreement in customary form in the event of an underwritten
offering conducted pursuant to Section 6 hereof) and take all other appropriate
action in order to expedite and facilitate the registration and disposition of
the Registrable Securities, and in connection therewith, if an underwriting
agreement is entered into, cause the same to contain indemnification provisions
and procedures substantially identical to those set forth in Section 5 hereof
with respect to all parties to be indemnified pursuant to Section 5 hereof.

         (p) The Company shall:

             (i)(A) make reasonably available for inspection by the Electing
         Holders, any underwriter participating in any disposition pursuant to
         the Shelf Registration Statement, and any attorney, accountant or other
         agent retained by such Electing Holders or any such underwriter all
         relevant financial and other records, pertinent corporate documents and
         properties of the Company and its subsidiaries, and (B) cause the
         Company's officers, directors and employees to supply all information
         reasonably requested by such Electing Holders or any such underwriter,
         attorney, accountant or agent in connection with the Shelf Registration
         Statement, in each case, as is customary for similar due diligence
         examinations; provided, however, that all records, information and
         documents that are designated in writing by the Company, in good faith,
         as confidential shall be kept confidential by such Electing Holders and
         any such underwriter, attorney, accountant or agent, unless such
         disclosure is made in connection with a court proceeding or required by
         law, or such records, information or documents become available to the
         public generally or through a third party without an accompanying
         obligation of confidentiality; and provided further that, if the
         foregoing inspection and information gathering would otherwise disrupt
         the Company's conduct of its business, such inspection and information
         gathering shall, to the greatest extent possible, be coordinated on
         behalf of the Electing Holders and the other parties entitled thereto
         by one counsel designated by and on behalf of the Electing Holders and
         other parties;

             (ii) in connection with any underwritten offering conducted
         pursuant to Section 6 hereof, make such representations and warranties
         to the Electing Holders participating in such underwritten offering and
         to the Managing Underwriters, in form, substance and scope as are
         customarily made by the Company to underwriters in primary underwritten
         offerings of equity and convertible debt securities and covering
         matters including, but not limited to, those set forth in the Purchase
         Agreement;

             (iii) in connection with any underwritten offering conducted
         pursuant to Section 6 hereof, obtain opinions of counsel to the Company
         (which counsel and opinions (in form, scope and substance) shall be
         reasonably satisfactory to the Managing Underwriters) addressed to each
         Electing Holder participating in such underwritten offering and the
         underwriters, covering such matters as are customarily covered in
         opinions requested in primary underwritten offerings of equity and
         convertible debt securities and such other matters as may be reasonably
         requested by such Electing Holders and underwriters (it being agreed
         that the matters to be covered by such opinions shall include, without
         limitation, as of the date of the opinion and as of the Effective Time
         of the Shelf Registration Statement or most recent post-effective
         amendment thereto, as the case may be, the absence from the Shelf
         Registration Statement and the Prospectus, including the documents
         incorporated by reference therein, of an untrue statement of a material
         fact or the omission of a material fact required to be stated therein
         or necessary to make the statements therein not misleading;

                                       9
<PAGE>

             (iv) in connection with any underwritten offering conducted
         pursuant to Section 6 hereof, obtain "cold comfort" letters and updates
         thereof from the independent public accountants of the Company (and, if
         necessary, from the independent public accountants of any subsidiary of
         the Company or of any business acquired by the Company for which
         financial statements and financial data are, or are required to be,
         included in the Shelf Registration Statement), addressed to each
         Electing Holder participating in such underwritten offering (if such
         Electing Holder has provided such letter, representations or
         documentation, if any, required for such cold comfort letter to be so
         addressed) and the underwriters, in customary form and covering matters
         of the type customarily covered in "cold comfort" letters in connection
         with primary underwritten offerings;

             (v) in connection with any underwritten offering conducted pursuant
         to Section 6 hereof, deliver such documents and certificates as may be
         reasonably requested by any Electing Holders participating in such
         underwritten offering and the Managing Underwriters, if any, including,
         without limitation, certificates to evidence compliance with Section
         3(j) hereof and with any conditions contained in the underwriting
         agreement or other agreements entered into by the Company.

         (q) The Company will use its reasonable best efforts to cause the
Common Stock issuable upon conversion of the Securities to be listed on the
Nasdaq National Stock Market or other stock exchange or trading system on which
the Common Stock primarily trades on or prior to the Effective Time of the Shelf
Registration Statement hereunder.

         (r) In the event that any broker-dealer registered under the Exchange
Act shall be an "affiliate" (as defined in Rule 2720(b)(1) of the NASD Rules (or
any successor provision thereto)) of the Company or has a "conflict of interest"
(as defined in Rule 2720(b)(7) of the NASD Rules (or any successor provision
thereto)) and such broker-dealer shall underwrite, participate as a member of an
underwriting syndicate or selling group or assist in the distribution of any
Registrable Securities covered by the Shelf Registration Statement, whether as a
Holder of such Registrable Securities or as an underwriter, a placement or sales
agent or a broker or dealer in respect thereof, or otherwise, the Company shall
assist such broker-dealer in complying with the requirements of the NASD Rules,
including, without limitation, by (A) engaging a "qualified independent
underwriter" (as defined in Rule 2720(b)(15) of the NASD Rules (or any successor
provision thereto)) to participate in the preparation of the registration
statement relating to such Registrable Securities, to exercise usual standards
of due diligence in respect thereto and to recommend the public offering price
of such Registrable Securities, (B) indemnifying such qualified independent
underwriter to the extent of the indemnification of underwriters provided in
Section 5 hereof, and (C) providing such information to such broker-dealer as
may be required in order for such broker-dealer to comply with the requirements
of the NASD Rules.

                                       10
<PAGE>

         (s) The Company shall use its reasonable best efforts to take all other
steps necessary to effect the registration, offering and sale of the Registrable
Securities covered by the Shelf Registration Statement contemplated hereby.

         4. Registration Expenses. Except as otherwise provided in Section 3,
the Company shall bear all fees and expenses incurred in connection with the
performance of its obligations under Sections 2, 3 and 6 hereof and shall bear
or reimburse the Electing Holders for the reasonable fees and documented
disbursements of a single counsel selected by a plurality of all Electing
Holders who own an aggregate of not less than 25% of the Registrable Securities
covered by the Shelf Registration Statement to act as counsel therefore in
connection with the Shelf Registration Statement. Each Electing Holder shall pay
all underwriting discounts and commissions and transfer taxes, if any, relating
to the sale or disposition of such Electing Holder's Registrable Securities
pursuant to the Shelf Registration Statement.

         5. Indemnification and Contribution.

         (a) Indemnification by the Company. Upon the registration of the
Registrable Securities pursuant to Section 2 hereof, the Company shall indemnify
and hold harmless each Electing Holder and each underwriter, selling agent or
other securities professional, if any, which facilitates the disposition of
Registrable Securities, and each of their respective officers and directors and
each person who controls such Electing Holder, underwriter, selling agent or
other securities professional within the meaning of Section 15 of the Securities
Act or Section 20 of the Exchange Act (each such person being sometimes referred
to as an "Indemnified Person") against any losses, claims, damages or
liabilities, joint or several, to which such Indemnified Person may become
subject under the Securities Act or otherwise, insofar as such losses, claims,
damages or liabilities (or actions in respect thereof) arise out of or are based
upon an untrue statement or alleged untrue statement of a material fact
contained in any Shelf Registration Statement under which such Registrable
Securities are to be registered under the Securities Act, or any Prospectus
contained therein or furnished by the Company to any Indemnified Person, or any
amendment or supplement thereto, or arise out of or are based upon the omission
or alleged omission to state therein a material fact required to be stated
therein or necessary to make the statements therein not misleading, and the
Company hereby agrees to reimburse such Indemnified Person for any legal or
other expenses reasonably incurred by them in connection with investigating or
defending any such action or claim as such expenses are incurred; provided,
however, that the Company shall not be liable to any such Indemnified Person in
any such case to the extent that any such loss, claim, damage or liability
arises out of or is based upon an untrue statement or alleged untrue statement
or omission or alleged omission made in such Shelf Registration Statement or
Prospectus, or amendment or supplement, in reliance upon and in conformity with
written information furnished to the Company by such Indemnified Person
expressly for use therein.

                                       11
<PAGE>

         (b) Indemnification by the Electing Holders and any Agents and
Underwriters. Each Electing Holder agrees, as a consequence of the inclusion of
any of such Electing Holder's Registrable Securities in such Shelf Registration
Statement, and each underwriter, selling agent or other securities professional,
if any, which facilitates the disposition of Registrable Securities shall agree,
as a consequence of facilitating such disposition of Registrable Securities,
severally and not jointly, to (i) indemnify and hold harmless the Company, its
directors, officers who sign any Shelf Registration Statement and each person,
if any, who controls the Company within the meaning of either Section 15 of the
Securities Act or Section 20 of the Exchange Act, against any losses, claims,
damages or liabilities to which the Company or such other persons may become
subject, under the Securities Act or otherwise, insofar as such losses, claims,
damages or liabilities (or actions in respect thereof) arise out of or are based
upon an untrue statement or alleged untrue statement of a material fact
contained in such Shelf Registration Statement or Prospectus, or any amendment
or supplement, or arise out of or are based upon the omission or alleged
omission to state therein a material fact required to be stated therein or
necessary to make the statements therein not misleading, in each case to the
extent, but only to the extent, that such untrue statement or alleged untrue
statement or omission or alleged omission was made in reliance upon and in
conformity with written information furnished to the Company by such Electing
Holder, underwriter, selling agent or other securities professional expressly
for use therein, and (ii) reimburse the Company for any legal or other expenses
reasonably incurred by the Company in connection with investigating or defending
any such action or claim as such expenses are incurred.

         (c) Notices of Claims, Etc. Promptly after receipt by an indemnified
party under subsection (a) or (b) above of notice of the commencement of any
action, such indemnified party shall, if a claim in respect thereof is to be
made against an indemnifying party under this Section 5, notify such
indemnifying party in writing of the commencement thereof; but the omission so
to notify the indemnifying party shall not relieve it from any liability which
it may have to any indemnified party otherwise than under the indemnification
provisions of or contemplated by subsection (a) or (b) above. In case any such
action shall be brought against any indemnified party and it shall notify an
indemnifying party of the commencement thereof, such indemnifying party shall be
entitled to participate therein and, to the extent that it shall wish, jointly
with any other indemnifying party similarly notified, to assume the defense
thereof, with counsel reasonably satisfactory to such indemnified party (who
shall not, except with the consent of the indemnified party, be counsel to the
indemnifying party), and, after notice from the indemnifying party to such
indemnified party of its election so to assume the defense thereof, such
indemnifying party shall not be liable to such indemnified party under this
Section 5 for any legal expenses of other counsel or any other expenses, in each
case subsequently incurred by such indemnified party, in connection with the
defense thereof other than reasonable costs of investigation. No indemnifying
party shall, without the written consent of the indemnified party, effect the
settlement or compromise of, or consent to the entry of any judgment with
respect to, any pending or threatened action or claim in respect of which
indemnification or contribution may be sought hereunder (whether or not the
indemnified party is an actual or potential party to such action or claim)
unless such settlement, compromise or judgment (i) includes an unconditional
release of the indemnified party from all liability arising out of such action
or claim and (ii) does not include a statement as to, or an admission of, fault,
culpability or a failure to act, by or on behalf of any indemnified party.

                                       12
<PAGE>

         (d) Contribution. If the indemnification provided for in this Section 5
is unavailable to or insufficient to hold harmless an indemnified party under
subsection (a) or (b) above in respect of any losses, claims, damages or
liabilities (or actions in respect thereof) referred to therein, then each
indemnifying party shall contribute to the amount paid or payable by such
indemnified party as a result of such losses, claims, damages or liabilities (or
actions in respect thereof) in such proportion as is appropriate to reflect the
relative fault of the indemnifying party and the indemnified party in connection
with the statements or omissions which resulted in such losses, claims, damages
or liabilities (or actions in respect thereof), as well as any other relevant
equitable considerations. The relative fault of such indemnifying party and
indemnified party shall be determined by reference to, among other things,
whether the untrue or alleged untrue statement of a material fact or omission or
alleged omission to state a material fact relates to information supplied by
such indemnifying party or by such indemnified party, and the parties' relative
intent, knowledge, access to information and opportunity to correct or prevent
such statement or omission. The parties hereto agree that it would not be just
and equitable if contribution pursuant to this Section 5(d) were determined by
pro rata allocation (even if the Electing Holders or any underwriters, selling
agents or other securities professionals or all of them were treated as one
entity for such purpose) or by any other method of allocation which does not
take account of the equitable considerations referred to in this Section 5(d).
The amount paid or payable by an indemnified party as a result of the losses,
claims, damages or liabilities (or actions in respect thereof) referred to above
shall be deemed to include any legal or other fees or expenses reasonably
incurred by such indemnified party in connection with investigating or defending
any such action or claim. No person guilty of fraudulent misrepresentation
(within the meaning of Section 11(f) of the Securities Act) shall be entitled to
contribution from any person who was not guilty of such fraudulent
misrepresentation. The obligations of the Electing Holders and any underwriters,
selling agents or other securities professionals in this Section 5(d) to
contribute shall be several in proportion to the percentage of principal amount
of Registrable Securities registered or underwritten, as the case may be, by
them and not joint.

         (e) Notwithstanding any other provision of this Section 5, in no event
will any (i) Electing Holder be required to undertake liability to any person
under this Section 5 for any amounts in excess of the dollar amount of the
proceeds to be received by such Holder from the sale of such Holder's
Registrable Securities (after deducting any fees, discounts and commissions
applicable thereto) pursuant to any Shelf Registration Statement under which
such Registrable Securities are to be registered under the Securities Act and
(ii) underwriter, selling agent or other securities professional be required to
undertake liability to any person hereunder for any amounts in excess of the
discount, commission or other compensation payable to such underwriter, selling
agent or other securities professional with respect to the Registrable
Securities underwritten by it and distributed to the public.

         (f) The obligations of the Company under this Section 5 shall be in
addition to any liability which the Company may otherwise have to any Electing
Holder and the obligations of any Electing Holder under this Section 5 shall be
in addition to any liability which such Electing Holder may otherwise have to
the Company. The remedies provided in this Section 5 are not exclusive and shall
not limit any rights or remedies which may otherwise be available to an
indemnified party at law or in equity.

                                       13
<PAGE>

         6. Underwritten Offering. Any Holder of Registrable Securities who
desires to do so may sell Registrable Securities (in whole or in part) in an
underwritten offering; provided that (i) the Electing Holders of at least
33-1/3% in aggregate principal amount of the Registrable Securities then covered
by the Shelf Registration Statement shall request such an offering and (ii) at
least such aggregate principal amount of such Registrable Securities shall be
included in such offering; and provided further that the Company shall not be
obligated to cooperate with more than one underwritten offering during the
Effectiveness Period. Upon receipt of such a request, the Company shall provide
all Holders of Registrable Securities written notice of the request, which
notice shall inform such Holders that they have the opportunity to participate
in the offering. In any such underwritten offering, the investment banker or
bankers and manager or managers that will administer the offering will be
selected by, and the underwriting arrangements with respect thereto (including
the size of the offering) will be approved by, the holders of a majority of the
Registrable Securities to be included in such offering; provided, however, that
such investment bankers and managers and underwriting arrangements must be
reasonably satisfactory to the Company. No Holder may participate in any
underwritten offering contemplated hereby unless (a) such Holder agrees to sell
such Holder's Registrable Securities to be included in the underwritten offering
in accordance with any approved underwriting arrangements, (b) such Holder
completes and executes all reasonable questionnaires, powers of attorney,
indemnities, underwriting agreements, lock-up letters and other documents
required under the terms of such approved underwriting arrangements, and (c) if
such Holder is not then an Electing Holder, such Holder returns a completed and
signed Notice and Questionnaire to the Company in accordance with Section
3(a)(ii) hereof within a reasonable amount of time before such underwritten
offering. The Holders participating in any underwritten offering shall be
responsible for any underwriting discounts and commissions and fees and, subject
to Section 4 hereof, expenses of their own counsel. The Company shall pay all
expenses customarily borne by issuers in an underwritten offering, including but
not limited to filing fees, the fees and disbursements of its counsel and
independent public accountants and any printing expenses incurred in connection
with such underwritten offering. Notwithstanding the foregoing or the provisions
of Section 3(n) hereof, upon receipt of a request from the Managing Underwriter
or a representative of Holders of a majority of the Registrable Securities to be
included in an underwritten offering to prepare and file an amendment or
supplement to the Shelf Registration Statement and Prospectus in connection with
an underwritten offering, the Company may delay the filing of any such amendment
or supplement for up to 90 days if the Board of Directors of the Company shall
have determined in good faith that the Company has a bona fide business reason
for such delay.

         7. Additional Interest.

         (a) Notwithstanding any postponement of effectiveness permitted by
Section 2(a) hereof, if (i) a Shelf Registration Statement has not been filed
with the Commission on or prior to the 90th day following the Closing Date, if
at such time the Company is eligible to file a registration statement on Form
S-3 or, if the Company is not eligible to file a registration statement on Form
S-3 at such time, the 135th day after the Closing Date, or (ii) the Shelf
Registration Statement is not declared effective by the Commission on or prior
to the 180th day following the Closing Date, if the Company is required to file
a Shelf Registration Statement covering resales of Registrable Securities within
90 calendar days after the Closing Date or the 225th day after the Closing Date
if the Company is required to file such Shelf Registration Statement on or prior
to the 135th calendar day after the Closing date (each, a "Registration
Default"), the Company shall be required to pay additional interest ("Additional
Interest"), from and including the day following such Registration Default until
such Shelf Registration Statement is either so filed or so filed and
subsequently declared effective, as applicable, at a rate per annum equal to an
additional one-quarter of one percent (0.25%) of the principal amount of
Registrable Securities, to and including the 90th day following such
Registration Default and one-half of one percent (0.50%) thereof from and after
the 91st day following such Registration Default.

                                       14
<PAGE>

         (b) In the event that (i) the Shelf Registration Statement ceases to be
effective when so required to be effective, (ii) the Company suspends the use of
the Prospectus pursuant to Section 2(c) or 3(j) hereof, (iii) the Holders are
not authorized to use the Prospectus pursuant to Section 3(g) hereto or (iv) the
Holders are otherwise prevented or restricted by the Company from effecting
sales pursuant to the Shelf Registration Statement (an "Effective Failure") for
more than 30 days, whether or not consecutive, in any 90-day period, or for more
than 90 days, whether or not consecutive, during any 12-month period, then the
Company shall pay Additional Interest at a rate per annum equal to an additional
one-quarter of one pecent (0.25%) of the principal amount of the Registrable
Securities for the first 90 days after the occurrence of the event and an amount
equal to one-half of one percent (0.50%) of the principal amount of Registrable
Securities from the 91st day after the occurrence of the event until the earlier
of (1) the time the Holders of Registrable Securities are again able to make
sales under the Shelf Registration Statement or (2) the expiration of the
Effectiveness Period.

         (c) Notwithstanding the foregoing, in no event will Additional Interest
be payable in connection with a failure to register the Common Stock. For the
avoidance of doubt, if the Company fails to register both the Securities and the
Common Stock, then the Additional Interest shall be payable in connection with
the failure to register the Securities.

         (d) Any amounts to be paid as Additional Interest pursuant to
paragraphs (a) or (b) of this Section 7 shall be paid in cash semi-annually in
arrears, with the first semi-annual payment due on the first [Interest Payment
Date] (as defined in the Indenture), as applicable, following the date of such
Registration Default or Effective Failure, as applicable. Such Additional
Interest will accrue in respect of the Securities at the rates set forth in
paragraphs (a) or (b) of this Section 7, as applicable, on the principal amount
of the Securities.

         (e) Except as provided in Section 8(b) hereof, the Additional Interest
as set forth in this Section 7 shall be the exclusive monetary remedy available
to the Holders of Securities for such Registration Default or Effective Failure.
In no event shall the Company be required to pay Additional Interest in excess
of the applicable maximum amount of one-half of one percent (0.50%) set forth
above, regardless of whether one or multiple Registration Defaults or Effective
Failures exist.

                                       15
<PAGE>

         8. Miscellaneous.

         (a) Other Registration Rights. The Company may grant registration
rights that would permit any person that is a third party the right to
piggy-back on any Shelf Registration Statement, provided that if the Managing
Underwriter of any underwritten offering conducted pursuant to Section 6 hereof
notifies the Company and the Electing Holders that the total amount of
securities which the Electing Holders and the holders of such piggy-back rights
intend to include in any Shelf Registration Statement is so large as to
materially threaten the success of such offering (including the price at which
such securities can be sold), then the amount, number or kind of securities to
be offered for the account of holders of such piggy-back rights will be reduced
to the extent necessary to reduce the total amount of securities to be included
in such offering to the amount, number and kind recommended by the Managing
Underwriter prior to any reduction in the amount of Registrable Securities to be
included in such Shelf Registration Statement.

         (b) Specific Performance. The parties hereto acknowledge that there
would be no adequate remedy at law if the Company fails to perform any of its
obligations hereunder and that the Purchasers and the Holders from time to time
may be irreparably harmed by any such failure, and accordingly agree that the
Purchasers and such Holders, in addition to any other remedy to which they may
be entitled at law or in equity and without limiting the remedies available to
the Electing Holders under Section 7 hereof, shall be entitled to compel
specific performance of the obligations of the Company under this Registration
Rights Agreement in accordance with the terms and conditions of this
Registration Rights Agreement, in any court of the United States or any State
thereof having jurisdiction.

         (c) Amendments and Waivers. This Agreement, including this Section
8(c), may be amended, and waivers or consents to departures from the provisions
hereof may be given, only by a written instrument duly executed by the Company
and the Holders of a majority in aggregate principal amount of Registrable
Securities then outstanding. Each Holder of Registrable Securities outstanding
at the time of any such amendment, waiver or consent or thereafter shall be
bound by any amendment, waiver or consent effected pursuant to this Section
8(c), whether or not any notice, writing or marking indicating such amendment,
waiver or consent appears on the Registrable Securities or is delivered to such
Holder.

         (d) Notices. All notices and other communications provided for or
permitted hereunder shall be given as provided in the Indenture.

         (e) Parties in Interest. The parties to this Agreement intend that all
Holders of Registrable Securities shall be entitled to receive the benefits of
this Agreement and that any Electing Holder shall be bound by the terms and
provisions of this Agreement by reason of such election with respect to the
Registrable Securities which are included in a Shelf Registration Statement. All
the terms and provisions of this Agreement shall be binding upon, shall inure to
the benefit of and shall be enforceable by the respective successors and assigns
of the parties hereto and any Holder from time to time of the Registrable
Securities to the aforesaid extent. In the event that any transferee of any
Holder of Registrable Securities shall acquire Registrable Securities, in any
manner, whether by gift, bequest, purchase, operation of law or otherwise, such
transferee shall, without any further writing or action of any kind, be entitled
to receive the benefits of and, if an Electing Holder, be conclusively deemed to
have agreed to be bound by and to perform all of the terms and provisions of
this Agreement to the aforesaid extent.

                                       16
<PAGE>

         (f) Counterparts. This Agreement may be executed in any number of
counterparts and by the parties hereto in separate counterparts, each of which
when so executed shall be deemed to be an original and all of which taken
together shall constitute one and the same agreement.

         (g) Headings. The headings in this Agreement are for convenience of
reference only and shall not limit or otherwise affect the meaning hereof.

         (h) Governing Law. This Agreement shall be governed by and construed in
accordance with the laws of the State of New York.

         (i) Severability. In the event that any one or more of the provisions
contained herein, or the application thereof in any circumstances, is held
invalid, illegal or unenforceable in any respect for any reason, the validity,
legality and enforceability of any such provision in every other respect and of
the remaining provisions hereof shall not be in any way impaired or affected
thereby, it being intended that all of the rights and privileges of the parties
hereto shall be enforceable to the fullest extent permitted by law.

         (j) Survival. The respective indemnities, agreements, representations,
warranties and other provisions set forth in this Agreement or made pursuant
hereto shall remain in full force and effect, regardless of any investigation
(or any statement as to the results thereof) made by or on behalf of any
Electing Holder, any director, officer or partner of such Holder, any agent or
underwriter, any director, officer or partner of such agent or underwriter, or
any controlling person of any of the foregoing, and shall survive the transfer
and registration of the Registrable Securities of such Holder.

                                       17
<PAGE>

         Please confirm that the foregoing correctly sets forth the agreement
between the Company and you.

                                           Very truly yours,

                                           ENZON PHARMACEUTICALS, INC.

                                           By:  /S/ JEFFREY H. BUCHALTER
                                              --------------------------------

                                                Name:  Jeffrey H. Buchalter
                                                Title: Chairman, President & CEO

Accepted as of the date hereof:
GOLDMAN, SACHS & CO.

By:       /s/ GOLDMAN, SACHS & CO.
   --------------------------------------------------

             (Goldman, Sachs & Co.)
             On behalf of each of the Purchasers

                                       18
<PAGE>

                                                                      APPENDIX A

                           Enzon Pharmaceuticals, Inc.

                         INSTRUCTION TO DTC PARTICIPANTS

                                (Date of Mailing)

                     URGENT - IMMEDIATE ATTENTION REQUESTED

                           DEADLINE FOR RESPONSE: [ ]

                  The Depository Trust Company ("DTC") has identified you as a
DTC Participant through which beneficial interests in the Enzon Pharmaceuticals,
Inc. (the "Company) 4% Convertible Senior Notes due 2013 (the "Securities") are
held.

                  The Company is in the process of registering the Securities
under the Securities Act of 1933 for resale by the beneficial owners thereof. In
order to have their Securities included in the registration statement,
beneficial owners must complete and return the enclosed Notice of Registration
Statement and Selling Securityholder Questionnaire.

                  It is important that beneficial owners of the Securities
receive a copy of the enclosed materials as soon as possible as their rights to
have the Securities included in the registration statement depend upon their
returning the Notice and Questionnaire by [ ]. Please forward a copy of the
enclosed documents to each beneficial owner that holds interests in the
Securities through you. If you require more copies of the enclosed materials or
have any questions pertaining to this matter, please contact [Investor
Relations], 685 Route 202/206, Bridgewater, New Jersey 08807.

<PAGE>

                           Enzon Pharmaceuticals, Inc.

                        Notice of Registration Statement
                                       and
                      Selling Securityholder Questionnaire

                                     [Date]

                  Enzon Pharmaceuticals, Inc. (the "Company") has filed with the
United States Securities and Exchange Commission (the "Commission") a
registration statement on [Form S-1] [Form S-3] (the "Shelf Registration
Statement") for the registration and resale under Rule 415 of the United States
Securities Act of 1933, as amended (the "Securities Act"), of the Company's 4%
Convertible Senior Notes due 2013 (the "Securities") and the shares of common
stock, par value $0.01 per share (the "Common Stock"), issuable upon conversion
thereof, in accordance with the Registration Rights Agreement, dated as of
May 23, 2006 (the "Registration Rights Agreement"), between the Company and the
purchasers named therein. A copy of the Registration Rights Agreement is
attached hereto. All capitalized terms not otherwise defined herein shall have
the meanings ascribed thereto in the Registration Rights Agreement.

                  In order to have Registrable Securities included in the Shelf
Registration Statement (or a supplement or amendment thereto), this Notice of
Registration Statement and Selling Securityholder Questionnaire ("Notice and
Questionnaire") must be completed, executed and delivered to the Company at the
address set forth herein for receipt ON OR BEFORE [DEADLINE FOR RESPONSE].
Beneficial owners of Registrable Securities who do not complete, execute and
return this Notice and Questionnaire by such date (i) will not be named as
selling securityholders in the Shelf Registration Statement and (ii) may not use
the Prospectus forming a part thereof for resales of Registrable Securities.

                  Certain legal consequences arise from being named as a selling
securityholder in the Shelf Registration Statement and related Prospectus.
Accordingly, holders and beneficial owners of Registrable Securities are advised
to consult their own securities law counsel regarding the consequences of being
named or not being named as a selling securityholder in the Shelf Registration
Statement and related Prospectus.

                                       20
<PAGE>

                  The term "Registrable Securities" is defined in the
Registration Rights Agreement to mean all or any portion of the Securities
issued on May 23, 2006 under the Indenture in registered form and the shares of
Common Stock issuable upon conversion of such Securities; provided, however,
that a security ceases to be a Registrable Security when it is no longer a
Restricted Security.

                  The term "Restricted Security" is defined in the Registration
Rights Agreement to mean any Security or share of Common Stock issuable upon
conversion thereof except any such Security or share of Common Stock which (i)
has been effectively registered under the Securities Act and sold in a manner
contemplated by the Shelf Registration Statement, (ii) has been transferred in
compliance with Rule 144 under the Securities Act (or any successor provision
thereto) or is transferable pursuant to paragraph (k) of such Rule 144 (or any
successor provision thereto), or (iii) has otherwise been transferred and a new
Security or share of Common Stock not subject to transfer restrictions under the
Securities Act has been delivered by or on behalf of the Company in accordance
with Section 2.1 of the Indenture.

                                    ELECTION

                  The undersigned holder (the "Selling Securityholder") of
Registrable Securities hereby elects to include in the Shelf Registration
Statement the Registrable Securities beneficially owned by it and listed below
in Item (3). The undersigned, by signing and returning this Notice and
Questionnaire, agrees to be bound with respect to such Registrable Securities by
the terms and conditions of this Notice and Questionnaire and the Registration
Rights Agreement, including, without limitation, Section 5 of the Registration
Rights Agreement, as if the undersigned Selling Securityholder were an original
party thereto.

                  Upon any sale of Registrable Securities pursuant to the Shelf
Registration Statement, the Selling Securityholder will be required to deliver
to the Company and the Trustee the Notice of Transfer (completed and signed) set
forth in Exhibit 1 to this Notice and Questionnaire.

                  The Selling Securityholder hereby provides the following
information to the Company and represents and warrants that such information is
accurate and complete:

                                       21
<PAGE>

                                  QUESTIONNAIRE

(1)  (a)    Full Legal Name of Selling Securityholder:

            -------------------------------------------------------------------
     (b)    Full Legal Name of Registered Holder (if not the same as in (a)
            above) of Registrable Securities Listed in Item (3) Below:

            -------------------------------------------------------------------
     (c)    Full Legal Name of DTC Participant (if applicable and if not the
            same as (b) above) Through Which Registrable Securities Listed in
            Item (3) Below are Held:

            -------------------------------------------------------------------

(2)         Address for Notices to Selling Securityholder:

                                _______________________________________
                                _______________________________________
                                _______________________________________
            Telephone:          _______________________________________
            Fax:                _______________________________________
            Contact Person:     _______________________________________

(3)         Beneficial Ownership of Securities:

            Except as set forth below in this Item (3), the undersigned Selling
            Securityholder does not beneficially own any Securities or shares of
            Common Stock issued upon conversion, repurchase or redemption of any
            Securities.

     (a)    Principal amount of Securities constituting Registrable Securities
            beneficially owned: CUSIP No(s). of such Registrable Securities:
            ____________________________________________________________________

            Number of shares of Common Stock Securities constituting Registrable
            Securities (if any): _______________________________________________

     (b)    Principal amount of Securities other than Registrable Securities
            beneficially owned: ________________________________________________
            CUSIP No(s). of such other Securities: _____________________________

            Number of shares of Common Stock (if any) issued upon conversion of
            such other Securities: _____________________________________________

     (c)    Principal amount of Registrable Securities which the undersigned
            wishes to be included in the Shelf Registration Statement:
            ____________________________________________________________________
            CUSIP No(s). of such Registrable Securities to be included in the
            Shelf Registration Statement: ______________________________________

            Number of shares of Common Stock (if any) constituting Registrable
            Securities which are to be included in the Shelf Registration
            Statement: _________________________________________________________

                                       22
<PAGE>

     (4)    Beneficial Ownership of Other Securities of the Company:

            Except as set forth below in this Item (4), the undersigned Selling
            Securityholder is not the beneficial or registered owner of any
            shares of Common Stock or any other securities of the Company, other
            than the Securities and shares of Common Stock listed above in Item
            (3).

            State any exceptions here:

     (5)    Relationships with the Company:

            Except as set forth below, neither the Selling Securityholder nor
            any of its affiliates, officers, directors or principal equity
            holders (5% or more) has held any position or office or has had any
            other material relationship with the Company (or its predecessors or
            affiliates) during the past three years.

            State any exceptions here:

     (6)    Plan of Distribution:

            Except as set forth below, the undersigned Selling Securityholder
            intends to distribute the Registrable Securities listed above in
            Item (3) only as follows (if at all): Such Registrable Securities
            may be sold from time to time directly by the undersigned Selling
            Securityholder or, alternatively, through underwriters,
            broker-dealers or agents. Such Registrable Securities may be sold in
            one or more transactions at fixed prices, at prevailing market
            prices at the time of sale, at varying prices determined at the time
            of sale, or at negotiated prices. Such sales may be effected in
            transactions (which may involve crosses or block transactions) (i)
            on any national securities exchange or quotation service on which
            the Registrable Securities may be listed or quoted at the time of
            sale, (ii) in the over-the-counter market, (iii) in transactions
            otherwise than on such exchanges or services or in the
            over-the-counter market, or (iv) through the writing of options. In
            connection with sales of the Registrable Securities or otherwise,
            the Selling Securityholder may enter into hedging transactions with
            broker-dealers, which may in turn engage in short sales of the
            Registrable Securities in the course of hedging the positions they
            assume. The Selling Securityholder may also sell Registrable
            Securities short and deliver Registrable Securities to close out
            such short positions, or loan or pledge Registrable Securities to
            broker-dealers that in turn may sell such securities.

            State any exceptions here:

                   Note: In no event may such method(s) of distribution take the
form of an underwritten offering of the Registrable Securities without the prior
agreement of the Company.

                                       23
<PAGE>

                  By signing below, the Selling Securityholder acknowledges that
it understands its obligation to comply, and agrees that it will comply, with
the prospectus delivery and other provisions of the Securities Act and the
Exchange Act and the rules and regulations thereunder, particularly Regulation
M.

                  In the event that the Selling Securityholder transfers all or
any portion of the Registrable Securities listed in Item (3) above after the
date on which such information is provided to the Company, the Selling
Securityholder agrees to notify the transferee(s) at the time of the transfer of
its rights and obligations under this Notice and Questionnaire and the
Registration Rights Agreement.

                  By signing below, the Selling Securityholder consents to the
disclosure of the information contained herein in its answers to Items (1)
through (6) above and the inclusion of such information in the Shelf
Registration Statement and related Prospectus. The Selling Securityholder
understands that such information will be relied upon by the Company in
connection with the preparation of the Shelf Registration Statement and related
Prospectus.

                  In accordance with the Selling Securityholder's obligation
under Section 3(a) of the Registration Rights Agreement to provide such
information as may be required by law for inclusion in the Shelf Registration
Statement, the Selling Securityholder agrees to promptly notify the Company of
any inaccuracies or changes in the information provided herein which may occur
subsequent to the date hereof at any time while the Shelf Registration Statement
remains in effect. All notices hereunder and pursuant to the Registration Rights
Agreement shall be made in writing, by hand-delivery, first-class mail, or air
courier guaranteeing overnight delivery as follows:

           (i) To the Company:

                                                  -------------------------

                                                  -------------------------

                                                  -------------------------

                                                  -------------------------

                                                  -------------------------

           (ii) With a copy to:

                                                  -------------------------

                                                  -------------------------

                                                  -------------------------

                                                  -------------------------

                                                  -------------------------

                  Once this Notice and Questionnaire is executed by the Selling
Securityholder and received by the Company, the terms of this Notice and
Questionnaire, and the representations and warranties contained herein, shall be
binding on, shall inure to the benefit of and shall be enforceable by the
respective successors, heirs, personal representatives, and assigns of the
Company and the Selling Securityholder (with respect to the Registrable
Securities beneficially owned by such Selling Securityholder and listed in Item
(3) above). This Agreement shall be governed in all respects by the laws of the
State of New York.

                                       24
<PAGE>

                  IN WITNESS WHEREOF, the undersigned, by authority duly given,
has caused this Notice and Questionnaire to be executed and delivered either in
person or by its duly authorized agent.

Dated: _____________________________

                  ______________________________________________________________

                  Selling Securityholder
                  (Print/type full legal name of beneficial owner of Registrable
                  Securities)

                  By:  _________________________________________________________
                  Name:
                  Title:

PLEASE RETURN THE COMPLETED AND EXECUTED NOTICE AND QUESTIONNAIRE FOR RECEIPT ON
OR BEFORE [DEADLINE FOR RESPONSE] TO THE COMPANY AT:

                                    -------------------------

                                    -------------------------

                                    -------------------------

                                    -------------------------

                                    -------------------------

                                       25
<PAGE>

                                                                       EXHIBIT 1
                                                                   TO APPENDIX A

              NOTICE OF TRANSFER PURSUANT TO REGISTRATION STATEMENT

Enzon Pharmaceuticals, Inc.
685 Route 202/206
Bridgewater, New Jersey 08807

Attention:  Scott Waldman

Wilmington Trust Company
[Address of Trustee]

Attention:  [Corporate Trust Services]

                  Re:  Enzon Pharmaceuticals, Inc. (the "Company")
                       4% Convertible Senior Notes due 2013 (the "Notes")

Dear Sirs:

                  Please be advised that _____________________ has transferred
$___________ aggregate principal amount of the above-referenced Notes or shares
of the Company's common stock, issued upon conversion, repurchase or redemption
of Notes, pursuant to an effective Registration Statement on Form S-3 (File No.
333-____) filed by the Company.

                  We hereby certify that the prospectus delivery requirements,
if any, of the Securities Act of 1933, as amended, have been satisfied with
respect to the transfer described above and that the above-named beneficial
owner of the Notes or common stock is named as a selling securityholder in the
Prospectus dated [date], or in amendments or supplements thereto, and that the
aggregate principal amount of the Notes or number of shares of common stock
transferred are the Notes or shares of common stock listed in such Prospectus as
amended or supplemented opposite such owner's name.

Dated:

                                                        Very truly yours,

                                                        ________________________
                                                        (Name)

                                      By:               ________________________

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00104-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00104-of-00352.parquet"}]]